author,citation,title,year,cohort,missing.data,include.sensitivity,include.multimethods,method,grouped.method,participant.id,participant.age,participant.sex,reported.exposure,participant.country,sample.date,sample.timepoints,sample.tissue,sample.amplification,sequencing.method,sequencing.region,sequencing.length,sequencing.number,subtype,grouped.subtype,minimum.number.of.founders,multiple.founders,viral.load,cd4.count,feibig.stage,participant.seropositivity,Max Hamming distance (HD),Mean DNA distance (%) (from variable measures),Hypermutation,POISSON Estimated days since TMRCA,POISSON Lower 95% CI,POISSON Upper 95% CI,BEAST estimated days since MRCA (95% CI),BEAST Lower 95% CI,BEAST Upper 95% CI,lambda,Goodness of fit P value,Deviation
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,N133M,,M,HSX:FTM,ZM-09,,LT,,SGA,PacBio SMRT,WG,,22,C,C,NA,single,,,III/IV,positive,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z1044M,,M,HSX:FTM,ZM-09,,LT,,SGA,PacBio SMRT,WG,,11,C,C,NA,single,,,III/IV,positive,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z1047M,,M,HSX:FTM,ZM-09,,LT,,SGA,PacBio SMRT,WG,,5,C,C,NA,single,,,II,negative,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z1094F,,F,HSX:MTF,ZM-09,,LT,,SGA,PacBio SMRT,WG,,13,C,C,NA,single,,,III/IV,positive,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z1123M,,M,HSX:FTM,ZM-09,,LT,,SGA,PacBio SMRT,WG,,8,C,C,NA,single,,,I,negative,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z1124F,,F,HSX:MTF,ZM-09,,LT,,SGA,PacBio SMRT,WG,,10,C,C,NA,single,,,III/IV,positive,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z1165M,,M,HSX:FTM,ZM-09,,LT,,SGA,PacBio SMRT,WG,,11,C,C,NA,single,,,III/IV,positive,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z1658F,,F,HSX:MTF,ZM-09,,LT,,SGA,PacBio SMRT,WG,,16,C,C,NA,multiple,,,III/IV,positive,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z1788F,,F,HSX:MTF,ZM-09,,LT,,SGA,PacBio SMRT,WG,,9,C,C,NA,single,,,III/IV,positive,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z1808F,,F,HSX:MTF,ZM-09,,LT,,SGA,PacBio SMRT,WG,,10,C,C,NA,single,,,II,negative,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z2006M,,M,HSX:FTM,ZM-09,,LT,,SGA,PacBio SMRT,WG,,9,C,C,NA,single,,,III/IV,positive,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z326M,,M,HSX:FTM,ZM-09,,LT,,SGA,PacBio SMRT,WG,,9,C,C,NA,single,,,III/IV,positive,,,,,,,,,,,,
Brooks,PLoS Pathog. 2020 Jun 3;16(6):e1008378.doi: 10.1371/journal.ppat.1008378.,HIV-1 Variants Are Archived Throughout Infection and Persist in the Reservoir,2020,ZEHRP,,,,phylo_recip_topol,phylogenetic,Z634F,,F,HSX:MTF,ZM-09,,LT,,SGA,PacBio SMRT,WG,,16,C,C,NA,single,,,III/IV,positive,,,,,,,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1004,34.1,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,97000,489,,positive,,,,132,83,181,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1006,24.5,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,F1,F,NA,single,1900,362,,positive,,,,179,127,231,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1019,27.1,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,F1/B,recombinant,NA,single,47400,542,,positive,,,,198,135,260,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1030,28.6,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,32600,519,,positive,,,,123,85,161,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1035,42.7,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,11200,481,,positive,,,,219,164,273,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1037,24.9,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,C/B,recombinant,NA,multiple,6200,429,,positive,,,,227,132,321,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1043,35.4,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B/F1,recombinant,NA,single,54700,591,,positive,,,,113,9,218,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1074,35.3,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,5230,581,,positive,,,,116,15,218,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1088,35.4,M,HSX:FTM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,2880,450,,positive,,,,75,29,121,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1109,28.9,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,F1/B,recombinant,NA,single,29500,647,,positive,,,,86,4,168,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1124,24.7,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,5520,591,,positive,,,,150,106,194,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1129,34.3,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,72100,587,,positive,,,,128,74,181,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1171,38.3,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,1820,1218,,positive,,,,105,38,171,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,1178,44,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,D/F1,recombinant,NA,single,4242,616,,positive,,,,127,38,217,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,2005,27.7,M,HSX:FTM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,F1/B,recombinant,NA,single,3500,726,,positive,,,,209,170,248,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,2015,44.3,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,14000,330,,positive,,,,172,138,207,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,2018,28.2,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,F1/B,recombinant,NA,single,31900,268,,positive,,,,117,78,156,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,2019,31.1,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,676,499,,positive,,,,127,83,172,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,2024,48,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,multiple,30600,1571,,positive,,,,667,8,1346,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,2038,43.9,F,HSX:MTF,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,5100,698,,positive,,,,165,76,254,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,2043,23.7,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,2040,596,,positive,,,,196,89,303,,,,,,
Leda,Virology. 2020 Feb;541:13-24. doi: 10.1016/j.virol.2019.11.006,HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals,2020,,,,,"PoissonFitter, ispoisson and isstarlike, tmrca",math_model,2054,42.6,M,MSM,BR,,LT,PMBC,PCR-RT,Roche 454,pol,,NGS,B,B,NA,single,40980,449,,positive,,,,42,22,106,,,,,,
Liu,AIDS Res Hum Retroviruses. 2020 May;36(5):440-449. doi: 10.1089/AID.2019.0242.,The Genetic Diversity of HIV-1 Quasispecies Within Primary Infected Individuals.,2020,Beijing You'an,,,,Highlighter,haplotype,YA-81,36,M,MSM,CN-BJ,,LT,,SGA,Sanger,gp120,,20,B,B,1,single,,,III,positive,,,,,,,,,,,,
Liu,AIDS Res Hum Retroviruses. 2020 May;36(5):440-449. doi: 10.1089/AID.2019.0242.,The Genetic Diversity of HIV-1 Quasispecies Within Primary Infected Individuals.,2020,Beijing You'an,,,,Highlighter,haplotype,YA-87,40,M,MSM,CN-BJ,,LT,,SGA,Sanger,gp120,,24,CRF01_AE,CRF01_AE,1,single,,,V/VI,positive,,,,,,,,,,,,
Liu,AIDS Res Hum Retroviruses. 2020 May;36(5):440-449. doi: 10.1089/AID.2019.0242.,The Genetic Diversity of HIV-1 Quasispecies Within Primary Infected Individuals.,2020,Beijing You'an,,,,Highlighter,haplotype,YA-90,34,M,MSM,CN-BJ,,LT,,SGA,Sanger,gp120,,9,CRF01_AE,CRF01_AE,1,single,,,V/VI,positive,,,,,,,,,,,,
Liu,AIDS Res Hum Retroviruses. 2020 May;36(5):440-449. doi: 10.1089/AID.2019.0242.,The Genetic Diversity of HIV-1 Quasispecies Within Primary Infected Individuals.,2020,Beijing You'an,,,,Highlighter,haplotype,YA-91,50,M,MSM,CN-BJ,,LT,,SGA,Sanger,gp120,,15,CRF01_AE,CRF01_AE,3,multiple,,,V/VI,positive,,,,,,,,,,,,
Liu,AIDS Res Hum Retroviruses. 2020 May;36(5):440-449. doi: 10.1089/AID.2019.0242.,The Genetic Diversity of HIV-1 Quasispecies Within Primary Infected Individuals.,2020,Beijing You'an,,,,Highlighter,haplotype,YA-106,27,M,MSM,CN-BJ,,LT,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,3,multiple,,,V/VI,positive,,,,,,,,,,,,
Liu,AIDS Res Hum Retroviruses. 2020 May;36(5):440-449. doi: 10.1089/AID.2019.0242.,The Genetic Diversity of HIV-1 Quasispecies Within Primary Infected Individuals.,2020,Beijing You'an,,,,Highlighter,haplotype,YA-107,44,M,MSM,CN-BJ,,LT,,SGA,Sanger,gp120,,4,CRF01_AE,CRF01_AE,1,single,,,V/VI,positive,,,,,,,,,,,,
Liu,AIDS Res Hum Retroviruses. 2020 May;36(5):440-449. doi: 10.1089/AID.2019.0242.,The Genetic Diversity of HIV-1 Quasispecies Within Primary Infected Individuals.,2020,Beijing You'an,,,,Highlighter,haplotype,YA-112,50,M,MSM,CN-BJ,,LT,,SGA,Sanger,gp120,,31,CRF01_AE,CRF01_AE,1,single,,,V/VI,positive,,,,,,,,,,,,
Liu,AIDS Res Hum Retroviruses. 2020 May;36(5):440-449. doi: 10.1089/AID.2019.0242.,The Genetic Diversity of HIV-1 Quasispecies Within Primary Infected Individuals.,2020,Beijing You'an,,,,Highlighter,haplotype,YA-120,54,M,MSM,CN-BJ,,LT,,SGA,Sanger,gp120,,16,CRF01_AE,CRF01_AE,1,single,,,V/VI,positive,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,,phylogenetic,Macharia1,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia2,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia3,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia4,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia5,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia6,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia7,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia8,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia9,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia10,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia11,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia12,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia13,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia14,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia15,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,multiple,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia16,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia17,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia18,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia19,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia20,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia21,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia22,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia23,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia24,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia25,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia26,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia27,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia28,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia29,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia30,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia31,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia32,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia33,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia34,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia35,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia36,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia37,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Macharia,PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853,"Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection",2020,KEMRI,1,,,"monophyletic clade with boot-strap support >70 percent, distribution of Hamming distances, highlighter plots",phylogenetic,Macharia38,,M,MSM,KE,,S,plasma,SGA,Sanger,3' half,,,,A,NA,single,,,,negative,,,,,,,,,,,,
Martinez,mBio. 2020 Mar 10;11(2):e00176-20. doi: 10.1128/mBio.00176-20,"Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants",2020,CHAVI009,,,,PoissonFitter,math_model,155.1,,INF,MTCT:IP,US,,S,PMBC,SGA,Sanger,gp140,,23,B,B,1,single,,,,infant,,,,,,,,,,,,
Martinez,mBio. 2020 Mar 10;11(2):e00176-20. doi: 10.1128/mBio.00176-20,"Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants",2020,CHAVI009,,,,PoissonFitter,math_model,601,,INF,MTCT:IP,MW,,S,PMBC,SGA,Sanger,gp140,,31,C,C,1,single,,,,infant,,,,,,,,,,,,
Martinez,mBio. 2020 Mar 10;11(2):e00176-20. doi: 10.1128/mBio.00176-20,"Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants",2020,CHAVI009,,,,PoissonFitter,math_model,9105,,INF,MTCT:IU,MW,,S,PMBC,SGA,Sanger,gp140,,20,C,C,1,single,,,,infant,,,,,,,,,,,,
Martinez,mBio. 2020 Mar 10;11(2):e00176-20. doi: 10.1128/mBio.00176-20,"Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants",2020,CHAVI009,,,,PoissonFitter,math_model,3902,,INF,MTCT:IU,MW,,S,PMBC,SGA,Sanger,gp140,,47,C,C,3,multiple,,,,infant,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,10066,,F,HSX:MTF,UG,,LT,,SGA,Sanger,env,,10,D/A1,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,10203,,F,HSX:MTF,UG,,LT,,SGA,Sanger,env,,20,A1,A,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,10220,,F,HSX:MTF,UG,,LT,,SGA,Sanger,env,,20,A1,A,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,10428,,F,HSX:MTF,UG,,LT,,SGA,Sanger,env,,30,D/A1,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,10435,,F,HSX:MTF,UG,,LT,,SGA,Sanger,env,,20,A1,A,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,10463,,F,HSX:MTF,UG,,LT,,SGA,Sanger,env,,19,A1/D,recombinant,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20225,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,32,C/A1,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20245,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,10,A1,A,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20263,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,21,A1,A,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20314,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,10,D/A1,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20337,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,20,C,C,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20368,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,0,A1/A2/D,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20442,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,19,A1/D/C,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20502,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,42,A1/D,recombinant,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20507,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,10,C/A1/D,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20509,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,10,A1,A,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20511,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,20,A1/D,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,20631,,F,HSX:MTF,KE,,LT,,SGA,Sanger,env,,9,A1/C/D,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,30112,,F,HSX:MTF,TZ,,LT,,SGA,Sanger,env,,20,A1,A,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,30124,,F,HSX:MTF,TZ,,LT,,SGA,Sanger,env,,30,A1,A,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,30190,,F,HSX:MTF,TZ,,LT,,SGA,Sanger,env,,31,C,C,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,30812,,F,HSX:MTF,TZ,,LT,,SGA,Sanger,env,,30,C,C,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,30924,,F,HSX:MTF,TZ,,LT,,SGA,Sanger,env,,30,A1,A,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40007,,M,MSM,TH,,LT,,SGA,Sanger,env,,20,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40061,,F,HSX:MTF,TH,,LT,,SGA,Sanger,env,,21,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40094,,M,MSM,TH,,LT,,SGA,Sanger,env,,22,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40100,,M,MSM,TH,,LT,,SGA,Sanger,env,,31,CRF01_AE,CRF01_AE,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40123,,M,MSM,TH,,LT,,SGA,Sanger,env,,4,CRF01_AE,CRF01_AE,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40168,,M,MSM,TH,,LT,,SGA,Sanger,env,,19,B/CRF01_AE,recombinant,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40231,,M,MSM,TH,,LT,,SGA,Sanger,env,,19,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40250,,M,MSM,TH,,LT,,SGA,Sanger,env,,10,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40257,,M,MSM,TH,,LT,,SGA,Sanger,env,,10,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40265,,M,MSM,TH,,LT,,SGA,Sanger,env,,20,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40353,,M,MSM,TH,,LT,,SGA,Sanger,env,,2,B,B,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40363,,M,MSM,TH,,LT,,SGA,Sanger,env,,21,CRF01_AE,CRF01_AE,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40436,,M,MSM,TH,,LT,,SGA,Sanger,env,,29,CRF01_AE,CRF01_AE,NA,multiple,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40511,,M,MSM,TH,,LT,,SGA,Sanger,env,,10,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40512,,M,MSM,TH,,LT,,SGA,Sanger,env,,30,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Rolland,PLoS Pathog. 2020 Feb; 16(2): e1008179. Feb 6. doi: 10.1371/journal.ppat.1008179,Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand,2020,RV217,,,Y,"Phylo-Topology, Poisson GOF, Spectral Density, Pwise Distance",pooled,40577,,M,MSM,TH,,LT,,SGA,Sanger,env,,30,CRF01_AE,CRF01_AE,NA,single,,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,PSF,,,Y,phylo_tp_asr_topol,phylogenetic,RW36M,,M,HSX:FTM,RW,,S,PBMC,SGA,Sanger,gp160,,41,A1,A,1,single,,,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,,,,phylo_tp_asr_topol,phylogenetic,SR5,,F,HSX:MTF,UG-110,,S,Plasma,SGA,Sanger,gp160,2570,12,A1/D,recombinant,1,single,,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_1,38,M,HSX:FTM,FR,2002/02/12,LT,plasma,SGA,Sanger,gp120,640,43,B,B,1,single,851138,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_2,28,M,MSM,FR,1998/03/25,LT,plasma,SGA,Sanger,gp120,646,25,B,B,3,multiple,50119,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_3,36,F,HSX:MTF,FR,1999/01/02,LT,plasma,SGA,Sanger,gp120,610,26,B,B,4,multiple,27542,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_4,21,M,MSM,FR,2000/06/26,LT,plasma,SGA,Sanger,gp120,611,33,B,B,1,multiple,331131,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_5,28,F,HSX:MTF,FR,1999/03/01,LT,plasma,SGA,Sanger,gp120,628,30,B,B,1,single,1174898,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_6,39,M,MSM,FR,2007/04/18,LT,plasma,SGA,Sanger,gp120,625,27,B,B,2,multiple,10233,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_7,29,M,MSM,FR,1999/06/16,LT,plasma,SGA,Sanger,gp120,635,19,B,B,1,single,67608,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_8,19,F,HSX:MTF,FR,2008/10/24,LT,plasma,SGA,Sanger,gp120,363,31,B,B,2,multiple,41687,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Butler et al. 2010,,,,phylo_tp_asr_topol,phylogenetic,SM_cluster_ABC.RecA,42,M,MSM,,,S,Plasma,SGA,Sanger,gp120,338,10,B,B,1,single,83176,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Butler et al. 2010,,,,phylo_tp_asr_topol,phylogenetic,SM_cluster_ABC.RecB,42,M,MSM,,,S,Plasma,SGA,Sanger,gp120,317,8,B,B,1,single,1202264,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Butler et al. 2010,,,,phylo_tp_asr_topol,phylogenetic,SM_cluster_ABC.RecC,47,M,MSM,,,S,Plasma,SGA,Sanger,gp120,182,5,B,B,3,multiple,15488166,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Butler et al. 2010,,,,phylo_tp_asr_topol,phylogenetic,SM_pair_D,36,M,MSM,,,S,Plasma,SGA,Sanger,gp120,332,13,B,B,3,multiple,69183,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Butler et al. 2010,,,,phylo_tp_asr_topol,phylogenetic,SM_pair_E,39,M,MSM,,,S,Plasma,SGA,Sanger,gp120,314,18,B,B,1,single,11220,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Butler et al. 2010,,,,phylo_tp_asr_topol,phylogenetic,SM_pair_F,30,M,MSM,,,S,Plasma,SGA,Sanger,gp120,327,19,B,B,3,multiple,6310,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,CH0148-to-CH0040,,M,MSM,US-NC,2006/07/27,S,Plasma,SGA,Sanger,NFLG,2541,9,B,B,1,single,298026,,I-II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,CH0728-to-CH0302,,F,HSX:MTF,US,2008/04/16,S,Plasma,SGA,Sanger,NFLG,9047,10,B,B,1,single,16218,,V,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,CH0742-0378-0831.700010831,,M,MSM,US,2008/11/14,S,Plasma,SGA,Sanger,NFLG,8919,16,B,B,1,single,261752,,III,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,CH0742-0378-0831.701010378,,M,MSM,US,2008/08/05,S,Plasma,SGA,Sanger,NFLG,8919,24,B,B,1,single,265936,,V,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,FORENSIC,,,,phylo_tp_asr_topol,phylogenetic,Texas_forensic_cluster.CC03,,F,HSX:MTF,US-TX,,S,PBMC,SGA,Sanger,,861,19,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,FORENSIC,,,,phylo_tp_asr_topol,phylogenetic,Texas_forensic_cluster.CC04,,F,HSX:MTF,US-TX,,S,PBMC,SGA,Sanger,,861,21,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,FORENSIC,,,,phylo_tp_asr_topol,phylogenetic,Texas_forensic_cluster.CC07,,F,HSX:MTF,US-TX,,S,PBMC,SGA,Sanger,,858,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,FORENSIC,,,,phylo_tp_asr_topol,phylogenetic,Washington_forensic_cluster.WA01,,F,HSX:MTF,US-WA,,S,PBMC,SGA,Sanger,,858,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,FORENSIC,,,,phylo_tp_asr_topol,phylogenetic,Washington_forensic_cluster.WA02,,F,HSX:MTF,US-WA,,S,PBMC,SGA,Sanger,,861,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,FORENSIC,,,,phylo_tp_asr_topol,phylogenetic,Washington_forensic_cluster.WA03,,F,HSX:MTF,US-WA,,S,PBMC,SGA,Sanger,,861,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,FORENSIC,,,,phylo_tp_asr_topol,phylogenetic,Washington_forensic_cluster.WA05,,F,HSX:MTF,US-WA,,S,PBMC,SGA,Sanger,,861,19,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,FORENSIC,,,,phylo_tp_asr_topol,phylogenetic,Washington_forensic_cluster.WA06,,F,HSX:MTF,US-WA,,S,PBMC,SGA,Sanger,,861,17,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Frost et al. 2005,,,,phylo_tp_asr_topol,phylogenetic,SM_0007.004,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,2567,12,B,B,8,multiple,,,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Frost et al. 2005,,,,phylo_tp_asr_topol,phylogenetic,SM_0206.0201,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,2579,11,B,B,1,single,,,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Frost et al. 2005,,,,phylo_tp_asr_topol,phylogenetic,SM_0206.0204,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,2573,12,B,B,1,single,,,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Frost et al. 2005,,,,phylo_tp_asr_topol,phylogenetic,SM_0551.0550,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,2579,12,B,B,1,single,,,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Frost et al. 2005,,,,phylo_tp_asr_topol,phylogenetic,SM_0564.0557,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,2428,15,B,B,1,single,,,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Li et al. 2010,,,Y,phylo_tp_asr_topol,phylogenetic,pair_AD17_AD18,,M,MSM,US-NY,1999/06/14,S,Plasma,SGA,Sanger,gp160,3827,149,B,B,1,single,47600000,NA,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Li et al. 2010,,,Y,phylo_tp_asr_topol,phylogenetic,pair_AD75_AD77,,M,MSM,US-NY,2002/11/15,S,Plasma,SGA,Sanger,gp160,2570,54,B,B,8,multiple,130000,NA,V,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Li et al. 2010,,,Y,phylo_tp_asr_topol,phylogenetic,pair_AD83_4013240,,M,MSM,US-NY,2003/01/21,S,Plasma,SGA,Sanger,gp160,2556,66,B,B,6,multiple,2240000,297,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Li et al. 2010,,,Y,phylo_tp_asr_topol,phylogenetic,pair_LACU_HOBR,,M,MSM,US-AL,1991/10/31,S,Plasma,SGA,Sanger,gp160,2643,42,B,B,1,single,599238,794,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,WPIC,,,,phylo_tp_asr_topol,phylogenetic,PIC1362-1365,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,9036,9,B,B,1,single,,,I,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Liu et al. 2008,,,,phylo_tp_asr_topol,phylogenetic,SH-J,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp120,1189,10,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Liu et al. 2008,,,,phylo_tp_asr_topol,phylogenetic,SM-A,,M,MSM,,,S,Plasma,SGA,Sanger,gp120,1568,13,B,B,4,multiple,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Liu et al. 2008,,,,phylo_tp_asr_topol,phylogenetic,SM-B,,M,MSM,,,S,Plasma,SGA,Sanger,gp120,1569,14,B,B,6,multiple,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Liu et al. 2008,,,,phylo_tp_asr_topol,phylogenetic,SM-D,,M,MSM,,,S,Plasma,SGA,Sanger,gp120,1711,11,B,B,6,multiple,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Liu et al. 2008,,,,phylo_tp_asr_topol,phylogenetic,SM-E,,M,MSM,,,S,Plasma,SGA,Sanger,gp120,1554,16,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Liu et al. 2008,,,,phylo_tp_asr_topol,phylogenetic,SM-G,,M,MSM,,,S,Plasma,SGA,Sanger,gp120,1566,13,B,B,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,SHCS/ZPHI,,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair1,,M,MSM,CH,,LT,Plasma,SGA,Sanger,gp160,2582,23,B,B,1,single,"2,325,000",,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,SHCS/ZPHI,,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair2,,F,HSX:MTF,CH,,LT,Plasma,SGA,Sanger,gp160,2570,27,B,B,1,single,"412,857",,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,SHCS/ZPHI,,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair3,,M,MSM,CH,,LT,Plasma,SGA,Sanger,gp160,2525,11,B,B,1,single,"14,400",,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,SHCS/ZPHI,,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair4,,F,HSX:MTF,CH,,LT,Plasma,SGA,Sanger,gp160,2570,10,B,B,1,single,"66,000",,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,SHCS/ZPHI,,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair5,,M,MSM,CH,,LT,Plasma,SGA,Sanger,gp160,2570,19,B,B,1,single,"373,000",,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,SHCS/ZPHI,,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair6,,F,HSX:MTF,CH,,LT,Plasma,SGA,Sanger,gp160,2582,18,B,B,10,multiple,"428,000",,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,SHCS/ZPHI,,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair9,,M,MSM,CH,,LT,Plasma,SGA,Sanger,gp160,2570,8,B,B,1,single,1550,,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,WPIC,,,Y,phylo_tp_asr_topol,phylogenetic,SM_pair_11286_55751,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,9021,9,B,B,6,multiple,"2,804,000",,V,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,WPIC,,,Y,phylo_tp_asr_topol,phylogenetic,SM_pair_38051_88403,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,9054,9,B,B,5,multiple,"620,820",,I,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,WPIC,,,Y,phylo_tp_asr_topol,phylogenetic,SM_pair_38417_51550,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,9023,10,B,B,1,single,"472,810",,V,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Zhu et al. 1996,,,,phylo_tp_asr_topol,phylogenetic,AD38-39,,M,MSM,,,LT,Plasma,RT-PCR,Sanger,gp120,1070,7,B,B,3,multiple,,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,703010131_703010159_acute,18,F,HSX:MTF,MW,2007/03/23,S,Plasma,SGA,Sanger,gp160,,14,C,C,7,multiple,73453,,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,CH0212-to-CH0162,,M,HSX:FTM,ZA,2007/07/13,S,Plasma,SGA,Sanger,NFLG,9007,7,C,C,1,single,18260,,III,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,CH0492-to-CH0427,,M,HSX:FTM,MW,2008/01/23,S,Plasma,SGA,Sanger,NFLG,8885,21,C,C,1,single,1644231,,I-II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,CH0596-to-CH0455,,M,HSX:FTM,MW,2008/01/29,S,Plasma,SGA,Sanger,NFLG,8771,8,C,C,1,single,502665,,III,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,CH1064-to-CH0848,,M,HSX:FTM,MW,2008/07/29,S,Plasma,SGA,Sanger,NFLG,8962,8,C,C,1,single,361254,,IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Chen et al. 2015,,,,phylo_tp_asr_topol,phylogenetic,F130510,46,F,HSX:MTF,CN-YN,2013/08/05,S,Plasma,SGA,Sanger,gp120,524,22,C,C,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,13_MF,,F,HSX:MTF,ZM,,S,PBMC,SGA,Sanger,gag,888,16,C,C,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,109_MF,,F,HSX:MTF,ZM,,S,PBMC,SGA,Sanger,gag,1499,14,C,C,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,135_FM,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gag,1499,20,C,C,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,53_FM,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gag,1499,23,C,C,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,55_MF,,F,HSX:MTF,ZM,,S,PBMC,SGA,Sanger,gag,1499,20,C,C,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,83_FM,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gag,1490,11,C,C,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,PSF,,,Y,phylo_tp_asr_topol,phylogenetic,RW56F,,F,HSX:MTF,RW,2005/04/21,S,PBMC,SGA,Sanger,gp160,,20,C,C,1,single,,,,NA,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM190F,,F,HSX:MTF,ZM,2003/12/06,S,PBMC,SGA,Sanger,gp160,873,48,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM198F,,F,HSX:MTF,ZM,2004/03/04,S,PBMC,SGA,Sanger,gp160,880,41,C,C,3,multiple,,,III/IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM201M,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gag,1499,46,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM205F,,F,HSX:MTF,ZM,2003/03/27,S,PBMC,SGA,Sanger,gp160,1204,42,C,C,3,multiple,,,III/IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM216M,,M,HSX:FTM,ZM,2004/01/17,S,PBMC,SGA,Sanger,gp160,907,59,C,C,2,multiple,,,III/IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM221M,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gp160,918,22,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM229M,,M,HSX:FTM,ZM-09,2002/10/19,LT,PBMC,SGA,Sanger,gp160,1253,29,C,C,11,multiple,,,VI,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM238M,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gag,1499,23,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM242F,,F,HSX:MTF,ZM,,S,PBMC,SGA,Sanger,gag,1499,25,C,C,6,multiple,,,III/IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM243F,,F,HSX:MTF,ZM,2004/03/09,S,PBMC,SGA,Sanger,gp160,877,45,C,C,2,multiple,,,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM292M,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gp160,878,39,C,C,1,single,,,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM331,,M,HSX:FTM,ZM,2009/04/18,S,Plasma,SGA,Sanger,NFLG,9021,9,C,C,1,single,2864668,,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM3618,,M,HSX:FTM,ZM,2009/06/18,S,Plasma,SGA,Sanger,NFLG,9021,8,C,C,1,single,16600000,,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM3678,,M,HSX:FTM,ZM,2009/09/17,S,Plasma,SGA,Sanger,NFLG,9021,8,C,C,1,single,3017616,,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM4248,,M,HSX:FTM,ZM,2010/06/04,S,Plasma,SGA,Sanger,NFLG,9021,6,C,C,1,single,24993584,,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM4473,,M,HSX:FTM,ZM,2011/06/07,S,Plasma,SGA,Sanger,NFLG,9021,9,C,C,1,single,16891328,,II,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,,,,phylo_tp_asr_topol,phylogenetic,394,MTF,F,HSX:MTF,UG-110,,S,Plasma,SGA,Sanger,gp160,2570,8,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,,,,phylo_tp_asr_topol,phylogenetic,888,MTF,F,HSX:MTF,UG-110,,S,Plasma,SGA,Sanger,gp160,2570,8,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,,,,phylo_tp_asr_topol,phylogenetic,890,MTF,F,HSX:MTF,UG-110,,S,Plasma,SGA,Sanger,gp160,2582,9,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,,,,phylo_tp_asr_topol,phylogenetic,927,MTF,F,HSX:MTF,UG-110,,S,Plasma,SGA,Sanger,gp160,2570,8,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,,,,phylo_tp_asr_topol,phylogenetic,2769,MTF,F,HSX:MTF,UG-110,,S,Plasma,SGA,Sanger,gp160,2582,8,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,,,,phylo_tp_asr_topol,phylogenetic,2810,MTF,F,HSX:FTM,UG-110,,S,Plasma,SGA,Sanger,gp160,2570,8,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,,,,phylo_tp_asr_topol,phylogenetic,HF,FTM,M,HSX:MTF,UG-110,,S,Plasma,SGA,Sanger,gp160,2570,8,D,D,1,single,,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,,,,phylo_tp_asr_topol,phylogenetic,SR20,MTF,F,HSX:MTF,UG-110,,S,Plasma,SGA,Sanger,gp160,2570,12,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,71_FM,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gag,1172,20,G,G,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM248F,,F,HSX:MTF,ZM,2003/06/05,S,PBMC,SGA,Sanger,gp160,,22,NA,NA,1,single,,,III/IV,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple11,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,Roche 454,gp41,323,6,A,A,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple8,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,Roche 454,gp41,403,19,A,A,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,SH_Rakai_G030323-H030324,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,,gp160,2570,13,A1/C/D,recombinant,1,single,,,,negative,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple1,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,Roche 454,gp41,323,5,D,D,3,multiple,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple10,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,Roche 454,gp41,323,15,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple12,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,Roche 454,gp41,323,10,D,D,2,multiple,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple15,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,Roche 454,gp41,323,12,D,D,2,multiple,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple6,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,Roche 454,gp41,323,5,D,D,4,multiple,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple09,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,Roche 454,gp41,323,8,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_D053826-F053828,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,,gp160,2570,12,D,D,1,single,,,,positive,,,,,,,,,,,,
Villabona-Arenas,Science. 2020 Jul 3;369(6499):103-108.doi: 10.1126/science.aba5443.,Number of HIV-1 Founder Variants Is Determined by the Recency of the Source Partner Infection,2020,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,SH-09,,,HSX:unknown,UG-110,,S,Plasma,RT-PCR,,gp160,2570,8,D,D,1,single,,,,positive,,,,,,,,,,,,
Zhang,Front Microbiol. 2020 Jan 24;11:21. doi: 10.3389/fmicb.2020.00021,Triple HIV-1 Infection Is Associated With Faster CD4+ T-Cell Decline,2020,PRIMO,,,,"NJ phylogeny, recipient only, number of phyly >80% bootstrap",phylogenetic,YA286,,M,MSM,CN-BJ,,LT,PMBC,SGA,Sanger,gp41,,119,CRF01_AE/B,recombinant,2,multiple,,,,negative,,,,,,,,,,,,
Zhang,Front Microbiol. 2020 Jan 24;11:21. doi: 10.3389/fmicb.2020.00021,Triple HIV-1 Infection Is Associated With Faster CD4+ T-Cell Decline,2020,PRIMO,,,,"NJ phylogeny, recipient only, number of phyly >80% bootstrap",phylogenetic,YA290,,M,MSM,CN-BJ,,LT,PMBC,SGA,Sanger,gp41,,85,CRF01_AE/CRF07_BC,recombinant,2,multiple,,,,negative,,,,,,,,,,,,
Zhang,Front Microbiol. 2020 Jan 24;11:21. doi: 10.3389/fmicb.2020.00021,Triple HIV-1 Infection Is Associated With Faster CD4+ T-Cell Decline,2020,PRIMO,,,,"NJ phylogeny, recipient only, number of phyly >80% bootstrap",phylogenetic,YA310,,M,MSM,CN-BJ,,LT,PMBC,SGA,Sanger,gp41,,94,CRF01_AE,CRF01_AE,3,multiple,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,701010016,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,21,B,B,NA,multiple,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,  9026-07,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,16,B,B,NA,multiple,,,,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,  9076-08,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,33,B,B,NA,multiple,,,,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,1006-11,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,43,B,B,NA,single,,,III,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,1054-07,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,37,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,1056-10,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,47,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,12008-09,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,31,B,B,NA,multiple,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,61792-03,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,19,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,62130-04,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,12,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,62357-14,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,15,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,6240-08,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,18,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,6244-13,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,12,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,62615-03,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,29,B,B,NA,multiple,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,62995-05,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,27,B,B,NA,single,,,I,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,63054-04,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,21,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,63068-05,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,21,B,B,NA,multiple,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,63396-07,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,22,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9010-09,,F,unknown,,,S,Plasma,SGA,Sanger,gp160,,20,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9014-01,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,14,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9015-07,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,37,B,B,NA,single,,,,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9017-01,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,27,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9019-03,,F,unknown,,,S,Plasma,SGA,Sanger,gp160,,18,B,B,NA,single,,,,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9020-20,,F,unknown,,,S,Plasma,SGA,Sanger,gp160,,26,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9021-14,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,35,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9023-21,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,19,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9024-12,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,24,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9025-11,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,20,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9028-07,,F,unknown,,,S,Plasma,SGA,Sanger,gp160,,24,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9032-08,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,40,B,B,NA,single,,,,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9033-16,,M,unknown,,,S,Plasma,SGA,Sanger,gp160,,21,B,B,NA,single,,,III,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9075-03,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,23,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9077-12,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,24,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,9079-09,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,27,B,B,NA,single,,,,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,BORI 0637,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,28,B,B,NA,multiple,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,CAAN5342,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,41,B,B,NA,multiple,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,PRB926-04,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,15,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,PRB931-06,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,20,B,B,NA,single,,,III,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,PRB956-04,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,28,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,PRB957-06,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,34,B,B,NA,multiple,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,PRB958-06,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,25,B,B,NA,single,,,III,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,PRB959-02,,NA,unknown,,,S,Plasma,SGA,Sanger,gp160,,33,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,REJO4541,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,22,B,B,NA,single,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,SC05,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,30,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,SC11,,F,HSX:MTF,,,S,Plasma,SGA,Sanger,gp160,,20,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,SC20,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,41,B,B,NA,single,,,IV,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,SC33,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,27,B,B,NA,multiple,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,SC42,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,26,B,B,NA,multiple,,,IV,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,SC45,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,30,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,THRO4156,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,28,B,B,NA,single,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,TRJO4551,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,17,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,TT27P,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,39,B,B,NA,multiple,,,IV,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,TT28P,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,29,B,B,NA,single,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,TT29P,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,21,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,TT34P,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,30,B,B,NA,single,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,WEAU0575,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,44,B,B,NA,multiple,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,WITO4160,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,17,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z02,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,22,B,B,NA,single,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z03,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,21,B,B,NA,multiple,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z05,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,16,B,B,NA,single,,,II,negative,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z10,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,18,B,B,NA,multiple,,,VI,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z13,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,31,B,B,NA,multiple,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z16,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,20,B,B,NA,multiple,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z18,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,35,B,B,NA,multiple,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z20,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,27,B,B,NA,single,,,III,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z23,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,16,B,B,NA,single,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z27,,M,HSX:FTM,,,S,Plasma,SGA,Sanger,gp160,,26,B,B,NA,single,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z29,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,17,B,B,NA,multiple,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z30,,F,HSX:MTF,,,S,Plasma,SGA,Sanger,gp160,,30,B,B,NA,multiple,,,V,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z32,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,11,B,B,NA,single,,,IV,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z34,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,19,B,B,NA,single,,,III,positive,,,,,,,,,,,,
Lewitus,Virus Evol. 2019 Jul; 5(2): vez044. Nov 4. doi: 10.1093/ve/vez044,A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity,2019,Keele,,,Y,phylo_specdensity,phylogenetic,Z35,,M,MSM,,,S,Plasma,SGA,Sanger,gp160,,22,B,B,NA,multiple,,,IV,positive,,,,,,,,,,,,
Sivay,Clin Infect Dis. 2019 Dec 3;ciz1081.doi: 10.1093/cid/ciz1081.,"Phylogenetic Analysis of Human Immunodeficiency Virus From People Who Inject Drugs in Indonesia, Ukraine, and Vietnam: HPTN 074",2019,HPTN074,,,Y,poisson_gof,pooled,P4,31,F,PWID,UA,,S,Plasma,RT-PCR,Illumina MiSeq,gp41,,NGS,A1,A,2,multiple,5012,,,NA,,,,,,,,,,,,
Sivay,Clin Infect Dis. 2019 Dec 3;ciz1081.doi: 10.1093/cid/ciz1081.,"Phylogenetic Analysis of Human Immunodeficiency Virus From People Who Inject Drugs in Indonesia, Ukraine, and Vietnam: HPTN 074",2019,HPTN074,,,Y,"poisson_gof,highlighter",pooled,P1,22,F,PWID,ID,,S,Plasma,RT-PCR,Illumina MiSeq,gp41,,NGS,CRF01_AE,CRF01_AE,1,single,5012,,,NA,,,,,,,,,,,,
Sivay,Clin Infect Dis. 2019 Dec 3;ciz1081.doi: 10.1093/cid/ciz1081.,"Phylogenetic Analysis of Human Immunodeficiency Virus From People Who Inject Drugs in Indonesia, Ukraine, and Vietnam: HPTN 074",2019,HPTN074,,,Y,poisson_gof,pooled,P2,36,M,PWID,ID,,S,Plasma,RT-PCR,Illumina MiSeq,gp41,,NGS,CRF01_AE,CRF01_AE,2,multiple,158489,,,NA,,,,,,,,,,,,
Sivay,Clin Infect Dis. 2019 Dec 3;ciz1081.doi: 10.1093/cid/ciz1081.,"Phylogenetic Analysis of Human Immunodeficiency Virus From People Who Inject Drugs in Indonesia, Ukraine, and Vietnam: HPTN 074",2019,HPTN074,,,Y,poisson_gof,pooled,P3,29,M,PWID,ID,,S,Plasma,RT-PCR,Illumina MiSeq,gp41,,NGS,CRF01_AE,CRF01_AE,1,single,5011872,,,NA,,,,,,,,,,,,
Sivay,Clin Infect Dis. 2019 Dec 3;ciz1081.doi: 10.1093/cid/ciz1081.,"Phylogenetic Analysis of Human Immunodeficiency Virus From People Who Inject Drugs in Indonesia, Ukraine, and Vietnam: HPTN 074",2019,HPTN074,,,Y,poisson_gof,pooled,P5,22,M,PWID,VN,,S,Plasma,RT-PCR,Illumina MiSeq,gp41,,NGS,CRF01_AE,CRF01_AE,1,single,158489,,,NA,,,,,,,,,,,,
Sivay,Clin Infect Dis. 2019 Dec 3;ciz1081.doi: 10.1093/cid/ciz1081.,"Phylogenetic Analysis of Human Immunodeficiency Virus From People Who Inject Drugs in Indonesia, Ukraine, and Vietnam: HPTN 074",2019,HPTN074,,,Y,poisson_gof,pooled,P6,27,M,PWID,VN,,S,Plasma,RT-PCR,Illumina MiSeq,gp41,,NGS,CRF01_AE,CRF01_AE,2,multiple,398107,,,NA,,,,,,,,,,,,
Sivay,Clin Infect Dis. 2019 Dec 3;ciz1081.doi: 10.1093/cid/ciz1081.,"Phylogenetic Analysis of Human Immunodeficiency Virus From People Who Inject Drugs in Indonesia, Ukraine, and Vietnam: HPTN 074",2019,HPTN074,,,Y,poisson_gof,pooled,P7,32,M,PWID,VN,,S,Plasma,RT-PCR,Illumina MiSeq,gp41,,NGS,CRF01_AE,CRF01_AE,1,single,125893,,,NA,,,,,,,,,,,,
Todesco,AIDS. 2019 Mar 15;33(4):691-699. doi: 10.1097/QAD.0000000000002105.,Caution is needed in interpreting HIV transmission chains by ultradeep sequencing,2019,,,,,phylo_tp_asr_topol,phylogenetic,5410,,M,MSM,FR-75,,S,Plasma,-,Roche 454,RT,,NGS,B,B,2,multiple,,,,positive,,,,,,,,,,,,
Todesco,AIDS. 2019 Mar 15;33(4):691-699. doi: 10.1097/QAD.0000000000002105.,Caution is needed in interpreting HIV transmission chains by ultradeep sequencing,2019,,,,,phylo_tp_asr_topol,phylogenetic,1730,,M,MSM,FR-75,,S,Plasma,-,Roche 454,RT,,NGS,B,B,NA,NA,,,,positive,,,,,,,,,,,,
Todesco,AIDS. 2019 Mar 15;33(4):691-699. doi: 10.1097/QAD.0000000000002105.,Caution is needed in interpreting HIV transmission chains by ultradeep sequencing,2019,,,,,phylo_tp_asr_topol,phylogenetic,5260,,M,MSM,FR-75,,S,Plasma,-,Roche 454,RT,,NGS,B,B,NA,NA,,,,positive,,,,,,,,,,,,
Todesco,AIDS. 2019 Mar 15;33(4):691-699. doi: 10.1097/QAD.0000000000002105.,Caution is needed in interpreting HIV transmission chains by ultradeep sequencing,2019,,,,,phylo_tp_asr_topol,phylogenetic,844,,M,MSM,FR-75,,S,Plasma,-,Roche 454,RT,,NGS,C,C,NA,NA,,,,positive,,,,,,,,,,,,
Todesco,AIDS. 2019 Mar 15;33(4):691-699. doi: 10.1097/QAD.0000000000002105.,Caution is needed in interpreting HIV transmission chains by ultradeep sequencing,2019,,,,,phylo_tp_asr_topol,phylogenetic,1962,,M,MSM,FR-75,,S,Plasma,-,Roche 454,RT,,NGS,C,C,2,multiple,,,,positive,,,,,,,,,,,,
Todesco,AIDS. 2019 Mar 15;33(4):691-699. doi: 10.1097/QAD.0000000000002105.,Caution is needed in interpreting HIV transmission chains by ultradeep sequencing,2019,,,,,phylo_tp_asr_topol,phylogenetic,253345,,M,MSM,FR-75,,S,Plasma,-,Roche 454,RT,,NGS,CRF02_AG,CRF02_AG,NA,NA,,,,positive,,,,,,,,,,,,
Todesco,AIDS. 2019 Mar 15;33(4):691-699. doi: 10.1097/QAD.0000000000002105.,Caution is needed in interpreting HIV transmission chains by ultradeep sequencing,2019,,,,,phylo_tp_asr_topol,phylogenetic,3170,,M,MSM,FR-75,,S,Plasma,-,Roche 454,RT,,NGS,CRF07_BC,CRF07_BC,NA,NA,,,,positive,,,,,,,,,,,,
Todesco,AIDS. 2019 Mar 15;33(4):691-699. doi: 10.1097/QAD.0000000000002105.,Caution is needed in interpreting HIV transmission chains by ultradeep sequencing,2019,,,,,phylo_tp_asr_topol,phylogenetic,3446,,M,MSM,FR-75,,S,Plasma,-,Roche 454,RT,,NGS,CRF02_AG,CRF02_AG,NA,NA,,,,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2544636,29,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,5,B/CRF01_AE,recombinant,NA,single,257040,,II,negative,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2545573,228,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,49,CRF01_AE,CRF01_AE,NA,single,3162278,,II,negative,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2546083,29,F,HSX:MTF,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,22,CRF01_AE,CRF01_AE,NA,single,575440,,IV,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2549583,30,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,46,CRF01_AE,CRF01_AE,NA,single,389045,,III,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2543832,36,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,21,CRF01_AE,CRF01_AE,NA,single,36307805,,II,negative,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2545436,32,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,21,CRF01_AE,CRF01_AE,NA,single,30902954,,III,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2543625,21,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,20,CRF01_AE,CRF01_AE,NA,multiple,331131,,III,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2543733,30,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,48,CRF01_AE,CRF01_AE,NA,single,117490,,II,negative,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2549844,24,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,20,CRF01_AE,CRF01_AE,NA,single,1318257,,V,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2546609,29,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,58,CRF01_AE,CRF01_AE,NA,multiple,4073803,,III,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2546340,29,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,70,CRF01_AE,CRF01_AE,NA,multiple,23442288,,IV,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2548123,45,F,HSX:MTF,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,10,CRF01_AE,CRF01_AE,NA,single,25703958,,III,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2547279,27,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,11,CRF01_AE,CRF01_AE,NA,single,7244360,,IV,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2545383,37,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,10,CRF01_AE,CRF01_AE,NA,multiple,25703958,,III,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2548105,40,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,10,CRF01_AE,CRF01_AE,NA,multiple,691831,,V,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2549813,22,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,10,CRF01_AE,CRF01_AE,NA,multiple,5128614,,II,negative,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2547268,23,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,10,CRF01_AE,CRF01_AE,NA,multiple,8912509,,III,positive,,,,,,,,,,,,
Tovanabutra,Cells. 2019 Aug; 8(8): 902. 2019 Aug 15. doi: 10.3390/cells8080902,Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection,2019,RV254,,,,Haplotype/Highlighter,haplotype,2548522,29,M,MSM,TH,,S,Plasma,SGA,PacBio SMRT,gp120,,10,CRF01_AE,CRF01_AE,NA,single,56234133,,III,positive,,,,,,,,,,,,
Ashokkumar,J Virol. 2018 May 1; 92(9): e00063-18.Published online 2018 Apr 13. Prepublished online 2018 Feb 28.,Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses,2018,,,,,highlighter,haplotype,IN_03,0.12,INF,MTCT:unknown,IN,2014,S,Plasma,PCR,Sanger,gp120,,15,C,C,1,single,,,,infant,,,,,,,,,,,,
Ashokkumar,J Virol. 2018 May 1; 92(9): e00063-18.Published online 2018 Apr 13. Prepublished online 2018 Feb 28.,Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses,2018,,,,,highlighter,haplotype,IN_04,0.33,INF,MTCT:unknown,IN,2014,S,Plasma,PCR,Sanger,gp120,,4,C,C,1,single,,,,infant,,,,,,,,,,,,
Ashokkumar,J Virol. 2018 May 1; 92(9): e00063-18.Published online 2018 Apr 13. Prepublished online 2018 Feb 28.,Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses,2018,,,,,highlighter,haplotype,IN_05,1.17,INF,MTCT:unknown,IN,2015,S,Plasma,PCR,Sanger,gp120,,7,C,C,1,single,,,,infant,,,,,,,,,,,,
Ashokkumar,J Virol. 2018 May 1; 92(9): e00063-18.Published online 2018 Apr 13. Prepublished online 2018 Feb 28.,Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses,2018,,,,,highlighter,haplotype,IN_06,0.33,INF,MTCT:unknown,IN,2014,S,Plasma,PCR,Sanger,gp120,,22,C,C,1,single,,,,infant,,,,,,,,,,,,
Ashokkumar,J Virol. 2018 May 1; 92(9): e00063-18.Published online 2018 Apr 13. Prepublished online 2018 Feb 28.,Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses,2018,,,,,highlighter,haplotype,IN_07,0.17,INF,MTCT:unknown,IN,2015,S,Plasma,PCR,Sanger,gp120,,22,C,C,1,single,,,,infant,,,,,,,,,,,,
Ashokkumar,J Virol. 2018 May 1; 92(9): e00063-18.Published online 2018 Apr 13. Prepublished online 2018 Feb 28.,Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses,2018,,,,,highlighter,haplotype,IN_08,0.33,INF,MTCT:unknown,IN,2015,S,Plasma,PCR,Sanger,gp120,,16,C,C,2,multiple,,,,infant,,,,,,,,,,,,
Ashokkumar,J Virol. 2018 May 1; 92(9): e00063-18.Published online 2018 Apr 13. Prepublished online 2018 Feb 28.,Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses,2018,,,,,highlighter,haplotype,IN_09,0.5,INF,MTCT:unknown,IN,2014,S,Plasma,PCR,Sanger,gp120,,7,C,C,1,single,,,,infant,,,,,,,,,,,,
Ashokkumar,J Virol. 2018 May 1; 92(9): e00063-18.Published online 2018 Apr 13. Prepublished online 2018 Feb 28.,Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses,2018,,,,,highlighter,haplotype,IN_10,1.08,INF,MTCT:unknown,IN,2014,S,Plasma,PCR,Sanger,gp120,,15,C,C,2,multiple,,,,infant,,,,,,,,,,,,
Dukhovlinova,AIDS Res Hum Retroviruses. 2018 Oct 1; 34(10): 867–878.,Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use,2018,,,,,poisson_both,math_model,AHI_A,,M,PWID,RU-SPE,,S,,SGA,Sanger,WG,,29,A,A,1,single,,,III/IV,positive,,,NO,26,11,40,,,,,0.939,
Dukhovlinova,AIDS Res Hum Retroviruses. 2018 Oct 1; 34(10): 867–878.,Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use,2018,,,,,poisson_both,math_model,AHI_B,,F,PWID,RU-SPE,,S,,SGA,Sanger,WG,,20,A,A,1,single,,,I/II,negative,,,NO,15,9,21,,,,,,
Dukhovlinova,AIDS Res Hum Retroviruses. 2018 Oct 1; 34(10): 867–878.,Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use,2018,,,,,poisson_both,math_model,AHI_D,,M,PWID,RU-SPE,,S,,SGA,Sanger,WG,,11,A,A,1,single,,,I/II,negative,,,NO,17,9,25,,,,,,
Dukhovlinova,AIDS Res Hum Retroviruses. 2018 Oct 1; 34(10): 867–878.,Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use,2018,,,,,poisson_both,math_model,AHI_K,,,PWID,RU-SPE,,S,,SGA,Sanger,WG,,28,A,A,1,single,,,III/IV,positive,,,NO,26,11,42,,,,,,
Dukhovlinova,AIDS Res Hum Retroviruses. 2018 Oct 1; 34(10): 867–878.,Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use,2018,,,,,poisson_both,math_model,AHI_M,,,PWID,RU-SPE,,S,,SGA,Sanger,WG,,19,A,A,1,single,,,III/IV,positive,,,NO,44,29,59,,,,,,
Dukhovlinova,AIDS Res Hum Retroviruses. 2018 Oct 1; 34(10): 867–878.,Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use,2018,,,,,poisson_both,math_model,AHI_N,,,PWID,RU-SPE,,S,,SGA,Sanger,WG,,41,A,A,1,single,,,III/IV,positive,,,NO,45,39,52,,,,,,
Dukhovlinova,AIDS Res Hum Retroviruses. 2018 Oct 1; 34(10): 867–878.,Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use,2018,,,,,poisson_both,math_model,AHI_O,,,PWID,RU-SPE,,S,,SGA,Sanger,WG,,15,A,A,1,single,,,I/II,negative,,,NO,13,4,21,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MB_pair_B201,,INF,MTCT:unknown,,,,,,,,,,A,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MB_pair_B539,,INF,MTCT:unknown,,,,,,,,,,A,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MB_pair_CC20_DECT,,INF,MTCT:unknown,,,,,,,,,,A,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC2,,INF,MTCT:unknown,,,,,,,,,,A,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC564,,INF,MTCT:unknown,,,,,,,,,,A,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Pat14-Pat25,,,HSX:unknown,,,,,,,,,,A,A,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple8,,,HSX:unknown,UG,,,,,,,,,A1,A,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MB_pair_290-291,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MB_pair_370-371,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MB_pair_520,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC-IP2,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC-IP5,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC-IP6,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC-IU1,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC-IU2,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC-IU3,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC-IU4,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC-IU5,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,MC-IU6,,INF,MTCT:unknown,,,,,,,,,,A1,A,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SH_pair_PP133,,,HSX:unknown,,,,,,,,,,A1,A,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,PSF,,,Y,phylo_tp_asr_topol,phylogenetic,RW36M,,M,HSX:FTM,RW,,S,PBMC,SGA,Sanger,gp160,,41,A1,A,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,PSF,,,Y,phylo_tp_asr_topol,phylogenetic,RW56F,,F,HSX:MTF,RW,,S,PBMC,SGA,Sanger,gp160,,20,A1,A,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM292M,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gp160,,39,A1,A,NA,,,,II,negative,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,,,Y,phylo_tp_asr_topol,phylogenetic,700010025_700010019,,F,PWID,US-NC,2006/06/20,S,Plasma,SGA,Sanger,gp160,,33,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,,,,phylo_tp_asr_topol,phylogenetic,700010081_700010135,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,1,,,phylo_tp_asr_topol,phylogenetic,700010174_700010150,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,,,,phylo_tp_asr_topol,phylogenetic,700010246_701010114,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,1,,,phylo_tp_asr_topol,phylogenetic,700010287_700010252,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,,,,phylo_tp_asr_topol,phylogenetic,700010734_700010607,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,,,,phylo_tp_asr_topol,phylogenetic,700010914_700010920,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,,,,phylo_tp_asr_topol,phylogenetic,701010108_700010260,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,,,,phylo_tp_asr_topol,phylogenetic,701010504_700010685,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,1,,,phylo_tp_asr_topol,phylogenetic,701010533_700010867,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,CHAVI001,,,,phylo_tp_asr_topol,phylogenetic,701010541_700010937,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,11113-11213,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,15-16,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,2E4_2E5,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,341_701010186,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,AD38-39,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,,,,phylo_tp_asr_topol,phylogenetic,B-C-E,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,bite1,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Bonn_cohort,,,NOSO,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,chain_10,,,HSX:unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,chain_CAN,,,NOSO,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,dental_chain,,,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,HE1,,,NOSO,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,IT-TA,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Korean_hemophilia,,,NOSO,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,LAI_LW,,,NOSO,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,M1001-P1024,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,M1002-P1031,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,M1003-P1189,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,M1007-P1046,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_16_17,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC001,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC004,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC005,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC010,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC013,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC1001-1024,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC1002-1031,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC1003-1189,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC1004-1115,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC1005-1026,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC10-1,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC102,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC10-4,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC10-5,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC10-8,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC10-9,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC133,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC137,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC3-2,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC4-L,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC5-A,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC5-B,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC5-C,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC5-D,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC5-E,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC5-F,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC6-A,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC6-B,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC7,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC-DU,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC-G,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,NOS_D36,,,NOSO,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,NOS-X-Y,,,NOSO,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,P13-P14,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,pair-6-9,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,LI,1,,,phylo_tp_asr_topol,phylogenetic,pair_AD17_AD18,,M,MSM,US-NY,1999/06/14,S,Plasma,SGA,Sanger,gp160,3827,149,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,LI,1,,,phylo_tp_asr_topol,phylogenetic,pair_AD75_AD77,,M,MSM,US-NY,2002/11/15,S,Plasma,SGA,Sanger,gp160,2570,54,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,LI,1,,,phylo_tp_asr_topol,phylogenetic,pair_AD83_4013240,,M,MSM,US-NY,2003/01/21,S,Plasma,SGA,Sanger,gp160,2556,66,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,LI,1,,,phylo_tp_asr_topol,phylogenetic,pair_LACU_HOBR,,M,MSM,US-AL,1991/10/31,S,Plasma,SGA,Sanger,gp160,2643,42,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,PAN01-PAN02,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,PA-SI-RO,,,unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,pediatric_LTNP_pair,,INF,MTCT:unknown,,,,,,,,,,B,B,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,PIC1362-1365,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SH1,,,HSX:unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SH-J,,,HSX:unknown,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ANRS PRIMO,1,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_1,38,M,HSX:FTM,FR,2002/02/12,LT,plasma,SGA,Sanger,gp120,640,43,B,B,NA,,851138,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ANRS PRIMO,1,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_2,28,M,MSM,FR,1998/03/25,LT,plasma,SGA,Sanger,gp120,646,25,B,B,NA,,50119,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ANRS PRIMO,1,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_3,36,F,HSX:MTF,FR,1999/01/02,LT,plasma,SGA,Sanger,gp120,610,26,B,B,NA,,27542,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ANRS PRIMO,1,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_4,21,M,MSM,FR,2000/06/26,LT,plasma,SGA,Sanger,gp120,611,33,B,B,NA,,331131,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_0007,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_0206,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_0564,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM3,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-A1-A2,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-A,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-B4-B3,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-B,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_chain_CHAVI,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_cluster_ABC,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-C,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-D6-D5,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-D,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-E,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_English2011,,M,MSM,GB,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-F9-F10,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM-G,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ANRS PRIMO,1,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_5,28,F,HSX:MTF,FR,1999/03/01,LT,plasma,SGA,Sanger,gp120,628,30,B,B,NA,,1174898,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,WPIC,,,Y,phylo_tp_asr_topol,phylogenetic,SM_pair_38051_88403,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,9054,9,B,B,NA,,"620,820",,I,negative,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,WPIC,,,Y,phylo_tp_asr_topol,phylogenetic,SM_pair_38417_51550,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,9023,10,B,B,NA,,"472,810",,V,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_6,39,M,MSM,FR,2007/04/18,LT,plasma,SGA,Sanger,gp120,625,27,B,B,NA,,10233,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_7,29,M,MSM,FR,1999/06/16,LT,plasma,SGA,Sanger,gp120,635,19,B,B,NA,,67608,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ANRS PRIMO,,,Y,phylo_tp_asr_topol,phylogenetic,FRANGE_8,19,F,HSX:MTF,FR,2008/10/24,LT,plasma,SGA,Sanger,gp120,363,31,B,B,NA,,41687,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,ESP1-ESP2,,,HSX:unknown,,,,,,,,,,O,NA,NA,,,,,,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_pair_E,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_pair_F,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_pair_M1_M2,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SM_trio,,M,MSM,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,SHCS/ZPHI,1,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair1,,M,MSM,CH,,LT,Plasma,SGA,Sanger,,,23,B,B,NA,,"2,325,000",,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,SHCS/ZPHI,1,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair2,,F,HSX:MTF,CH,,LT,Plasma,SGA,Sanger,,,27,B,B,NA,,"412,857",,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,SHCS/ZPHI,1,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair3,,M,MSM,CH,,LT,Plasma,SGA,Sanger,,,11,B,B,NA,,"14,400",,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,SHCS/ZPHI,1,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair4,,F,HSX:MTF,CH,,LT,Plasma,SGA,Sanger,,,10,B,B,NA,,"66,000",,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,SHCS/ZPHI,1,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair5,,M,MSM,CH,,LT,Plasma,SGA,Sanger,,,19,B,B,NA,,"373,000",,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,SHCS/ZPHI,1,,Y,phylo_tp_asr_topol,phylogenetic,Swiss_cohorts_pair6,,F,HSX:MTF,CH,,LT,Plasma,SGA,Sanger,,,18,B,B,NA,,"428,000",,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Texas_forensic_cluster,,,HSX:unknown,US-TX,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,twins_coinfected,,,NOSO,,,,,,,,,,B,B,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,CASE10,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,CASE11,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,CASE15,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,CASE18,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,CASE19,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,CASE21,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,CASE4,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,CH0212-to-CH0162,,,HSX:unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,CH0596-to-CH0455,,,HSX:unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,chain_11,,,unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_130-131,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_1468,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_1472,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_1485,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_1639,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_1646,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_1669,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_1702,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_1851,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_2080,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_2400,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_2437,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_2502,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_2512,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_2544,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_2797,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_3274,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_3321,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_i10-m10,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_i20-m20,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_i38-m38,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_i40-m40,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_i61-m61,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_i6-m6,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MB_pair_i74-m74,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC1084,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC1288,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC1751,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC-252,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC-2660,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC-2953,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC566,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC-834,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC902,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,13_MF,,F,HSX:MTF,ZM,,S,,SGA,Sanger,gag,,16,C,C,NA,,,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,53_FM,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gag,,18,C,C,NA,,,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,55_MF,,F,HSX:MTF,ZM,,S,,SGA,Sanger,gag,,16,C,C,NA,,,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,83_FM,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gag,,13,C,C,NA,,,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,109_MF,,F,HSX:MTF,ZM,,S,,SGA,Sanger,gag,,13,C,C,NA,,,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,135_FM,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gag,,20,C,C,NA,,,,,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MF_pair,,,HSX:unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Mother-child_pair14,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Mother-child-pair14,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Mother-child-pair17,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Mother-child-pair1,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Mother-child-pair3,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Mother-child-pair5,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Mother-child-pair6,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Mother-child-pair7,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,Mother-child-pair9,,INF,MTCT:unknown,,,,,,,,,,C,C,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SU_pair_11-12,,,unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SU_pair_1168,,,unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SU_pair_2173,,,unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SU_pair_2899,,,unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SU_pair_3-4,,,unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SU_pair_5-6,,,unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SU_pair_7-8,,,unknown,,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,,phylo_tp_asr_topol,phylogenetic,ZM185MF,,F,HSX:MTF,ZM,,,,,,,,,C,C,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM190F,,F,HSX:MTF,ZM,2003/12/06,S,PBMC,SGA,Sanger,gp160,,48,C,C,NA,,,,III/IV,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM198F,,F,HSX:MTF,ZM,2004/03/04,S,PBMC,SGA,Sanger,gp160,,41,C,C,NA,,,,III/IV,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM201M,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gag,,46,C,C,NA,,,,III/IV,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM205F,,F,HSX:MTF,ZM,2003/03/27,S,PBMC,SGA,Sanger,gp160,,42,C,C,NA,,,,III/IV,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM216M,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gp160,,59,C,C,NA,,,,III/IV,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM221M,,M,HSX:FTM,ZM,2003/03/07,S,PBMC,SGA,Sanger,gp160,,73,C,C,NA,,,,III/IV,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM229M,,M,HSX:FTM,ZM-09,2002/10/19,LT,PBMC,SGA,Sanger,gp160,2592,29,C,C,NA,,,,VI,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM238M,,M,HSX:FTM,ZM,,S,PBMC,SGA,Sanger,gag,,39,C,C,NA,,,,III/IV,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM242F,,F,HSX:MTF,ZM,,S,PBMC,SGA,Sanger,gag,,31,C,C,NA,,,,III/IV,positive,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM243F,,F,HSX:MTF,ZM,2004/03/09,S,PBMC,SGA,Sanger,gp160,,45,C,C,NA,,,,II,negative,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM331,,M,HSX:FTM,ZM,2009/04/18,S,Plasma,SGA,Sanger,NFLG,9021,9,C,C,NA,,2864668,,II,negative,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM3618,,M,HSX:FTM,ZM,2009/06/18,S,Plasma,SGA,Sanger,NFLG,9021,8,C,C,NA,,16600000,,II,negative,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM3678,,M,HSX:FTM,ZM,2009/09/17,S,Plasma,SGA,Sanger,NFLG,9021,8,C,C,NA,,3017616,,II,negative,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM4248,,M,HSX:FTM,ZM,2010/06/04,S,Plasma,SGA,Sanger,NFLG,9021,6,C,C,NA,,24993584,,II,negative,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,ZEHRP,1,,Y,phylo_tp_asr_topol,phylogenetic,ZM4473,,M,HSX:FTM,ZM,2011/06/07,S,Plasma,SGA,Sanger,NFLG,9021,9,C,C,NA,,16891328,,II,negative,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,chain3,,,HSX:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,HN23,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,HN47,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,HN51,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,HN60,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,HN88,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,HP13,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,HP25,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC11-56,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC11-60,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC11-95,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-0377,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-0540,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-0779,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-0858,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-0978,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-1005,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-1021,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-1110,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-1224,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-1333,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-1361,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC12-1391,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC8-1,,INF,MTCT:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,NYU_dual_infection_pair,,,HSX:unknown,,,,,,,,,,CRF01_AE,CRF01_AE,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,knife_fight,,,unknown,,,,,,,,,,CRF07_BC,CRF07_BC,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SH3,,,HSX:unknown,,,,,,,,,,CRF14_BG,CRF14_BG,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,Rakai_couple_C1,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,Rakai_couple_C2,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,Rakai_couple_C3,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,Rakai_couple_C4,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,Rakai_couple_C5,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,Rakai_couple_C6,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,Rakai_couple_C7,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,Rakai_couple_C8,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,,phylo_tp_asr_topol,phylogenetic,Rakai_couple_C9,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_D053826-F053828,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple10,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple12,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,RCCS,1,,Y,phylo_tp_asr_topol,phylogenetic,SH_Rakai_Couple15,,,HSX:unknown,UG,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SH_pair_PP67,,,HSX:unknown,,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SH-P-W,,,HSX:unknown,,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SR20,,,HSX:unknown,,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,SR5,,,HSX:unknown,,,,,,,,,,D,D,NA,,,,,NA,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC114,,INF,MTCT:unknown,,,,,,,,,,G,G,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,,1,,,phylo_tp_asr_topol,phylogenetic,MC127,,INF,MTCT:unknown,,,,,,,,,,G,G,NA,,,,,infant,,,,,,,,,,,,
Leitner,Nat Microbiol. 2018 Sep;3(9):983-988. doi: 10.1038/s41564-018-0204-9. Epub 2018 Jul 30.,Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants,2018,Derdeyn et al. 2004,1,,Y,phylo_tp_asr_topol,phylogenetic,71_FM,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gag,,11,G,G,NA,,,,,positive,,,,,,,,,,,,
Song,Nat Commun. 2018 May 15;9(1):1928.doi: 10.1038/s41467-018-04217-5.,Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection,2018,CHAVI001,1,,,highlighter,haplotype,700010654,,M,MSM,US,,LT,,SGA,Sanger,"vif,vpr,env,nef",,,B,B,2,multiple,,,III,positive,,,,,,,,,,,,
Song,Nat Commun. 2018 May 15;9(1):1928.doi: 10.1038/s41467-018-04217-5.,Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection,2018,CHAVI001,,,Y,highlighter,haplotype,703010010,,M,HSX:FTM,MW,,LT,,SGA,Sanger,"vif,vpr,env,nef",,,C,C,6,multiple,,,III,positive,,,,,,,,,,,,
Song,Nat Commun. 2018 May 15;9(1):1928.doi: 10.1038/s41467-018-04217-5.,Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection,2018,CHAVI001,,,Y,highlighter,haplotype,703010200,,M,HSX:FTM,MW,,LT,,SGA,Sanger,"vif,vpr,env,nef",,,C,C,5,multiple,,,III,positive,,,,,,,,,,,,
Song,Nat Commun. 2018 May 15;9(1):1928.doi: 10.1038/s41467-018-04217-5.,Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection,2018,CHAVI001,,,,highlighter,haplotype,703010288,,M,HSX:FTM,MW,,LT,,SGA,Sanger,"vif,vpr,env,nef",,,C,C,3,multiple,,,III,positive,,,,,,,,,,,,
Song,Nat Commun. 2018 May 15;9(1):1928.doi: 10.1038/s41467-018-04217-5.,Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection,2018,CHAVI001,,,,highlighter,haplotype,703010275,,M,HSX:FTM,MW,,LT,,SGA,Sanger,"vif,vpr,env,nef",,,C,C,2,multiple,,,III,positive,,,,,,,,,,,,
Song,Nat Commun. 2018 May 15;9(1):1928.doi: 10.1038/s41467-018-04217-5.,Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection,2018,CHAVI001,,,Y,highlighter,haplotype,703011754,,M,HSX:FTM,MW,,LT,,SGA,Sanger,"vif,vpr,env,nef",,,C,C,7,multiple,,,III,positive,,,,,,,,,,,,
Song,Nat Commun. 2018 May 15;9(1):1928.doi: 10.1038/s41467-018-04217-5.,Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection,2018,CHAVI001,,,,highlighter,haplotype,703011244,,M,HSX:FTM,MW,,LT,,SGA,Sanger,"vif,vpr,env,nef",,,C,C,8,multiple,,,IV,positive,,,,,,,,,,,,
Song,Nat Commun. 2018 May 15;9(1):1928.doi: 10.1038/s41467-018-04217-5.,Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection,2018,CHAVI001,,,Y,highlighter,haplotype,705010078,,M,HSX:FTM,ZA,,LT,,SGA,Sanger,"vif,vpr,env,nef",,,C,C,2,multiple,,,III,positive,,,,,,,,,,,,
Song,Nat Commun. 2018 May 15;9(1):1928.doi: 10.1038/s41467-018-04217-5.,Tracking HIV-1 Recombination to Resolve Its Contribution to HIV-1 Evolution in Natural Infection,2018,CHAVI001,,,Y,highlighter,haplotype,702010047,,M,HSX:FTM,MW,,LT,,SGA,Sanger,"vif,vpr,env,nef",,,C,C,2,multiple,,,III,positive,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0012,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,11,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0049,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0071,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0090,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0102,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0122,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,12,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0280,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0332,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,24,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0390,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0396,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0645,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0686,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,12,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0695,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0724,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,19,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0772,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,6,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0821,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0840,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,4,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0896,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0933,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,21,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0997,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,13,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_0998,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,22,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1012,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1144,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,20,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1174,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1226,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,11,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1270,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1276,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1278,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,30,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1295,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1358,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1371,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1413,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,11,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1569,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1672,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1677,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1730,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,11,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1763,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,20,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1931,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,11,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1958,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1962,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1982,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,10,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_1993,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,20,B,B,NA,single,,,,NA,,,,,,,,,,,,
deCamp,PLoS One. 2017; 12(11): e0185959 Nov 17. doi: 10.1371/journal.pone.0185959,Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120,2017,HTVN505,1,,,phylo_recip_topol,phylogenetic,505_2150,,M,MSM,US,,LT,Plasma,SGA,Sanger,gp120,,11,B,B,NA,single,,,,NA,,,,,,,,,,,,
Kijak,PLoS Pathog. 2017 Jul; 13(7): e1006510. Jul 31. doi: 10.1371/journal.ppat.1006510,Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.,2017,RV217,,,Y,"poisson_both, highlighter",pooled,20225,24,F,HSX:MTF,KE,,LT,PMBC,SGA,Sanger,WG,,10,A1/C,recombinant,1,single,,,I/II,negative,,,,,,,,,,,,
Kijak,PLoS Pathog. 2017 Jul; 13(7): e1006510. Jul 31. doi: 10.1371/journal.ppat.1006510,Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.,2017,RV217,,,Y,"poisson_both, highlighter",pooled,10463,24,F,HSX:MTF,UG,,LT,PMBC,SGA,Sanger,WG,,10,A1/D,recombinant,2,multiple,,,I/II,negative,,,,,,,,,,,,
Kijak,PLoS Pathog. 2017 Jul; 13(7): e1006510. Jul 31. doi: 10.1371/journal.ppat.1006510,Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.,2017,RV217,,,Y,"poisson_both, highlighter",pooled,40100,18,M,HSX:FTM,TH,,LT,PMBC,SGA,Sanger,WG,,10,CRF01_AE,CRF01_AE,2,multiple,,,I/II,negative,,,,,,,,,,,,
Kijak,PLoS Pathog. 2017 Jul; 13(7): e1006510. Jul 31. doi: 10.1371/journal.ppat.1006510,Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.,2017,RV217,,,Y,"poisson_both, highlighter",pooled,40061,48,F,HSX:MTF,TH,,LT,PMBC,SGA,Sanger,WG,,11,CRF01_AE,CRF01_AE,2,multiple,,,I/II,negative,,,,,,,,,,,,
Kijak,PLoS Pathog. 2017 Jul; 13(7): e1006510. Jul 31. doi: 10.1371/journal.ppat.1006510,Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.,2017,RV217,,,Y,"poisson_both, highlighter",pooled,40436,29,M,HSX:FTM,TH,,LT,PMBC,SGA,Sanger,WG,,10,CRF01_AE,CRF01_AE,3,multiple,,,I/II,negative,,,,,,,,,,,,
Kijak,PLoS Pathog. 2017 Jul; 13(7): e1006510. Jul 31. doi: 10.1371/journal.ppat.1006510,Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.,2017,RV217,,,Y,"poisson_both, highlighter",pooled,40265,23,M,HSX:FTM,TH,,LT,PMBC,SGA,Sanger,WG,,12,CRF01_AE,CRF01_AE,2,multiple,,,I/II,negative,,,,,,,,,,,,
Lyer,Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599. doi: 10.1073/pnas.1620144114.,Resistance to type 1 interferons is a major determinantof HIV-1 transmission fitness,2017,CHAVI001,,,Y,Highlighter,haplotype,CH0148-to-CH0040,,M,MSM,US-NC,2006/07/27,S,Plasma,SGA,Sanger,NFLG,2541,9,B,B,1,single,298026,,I-II,negative,,,,,,,,,,,,
Lyer,Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599. doi: 10.1073/pnas.1620144114.,Resistance to type 1 interferons is a major determinantof HIV-1 transmission fitness,2017,CHAVI001,,,Y,Highlighter,haplotype,CH0728-to-CH0302,,F,HSX:MTF,US,2008/04/16,S,Plasma,SGA,Sanger,NFLG,9047,10,B,B,1,single,16218,,V,positive,,,,,,,,,,,,
Lyer,Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599. doi: 10.1073/pnas.1620144114.,Resistance to type 1 interferons is a major determinantof HIV-1 transmission fitness,2017,CHAVI001,,,Y,Highlighter,haplotype,CH0742-0378-0831.700010831,,M,MSM,US,2008/11/14,S,Plasma,SGA,Sanger,NFLG,8919,16,B,B,1,single,261752,,III,positive,,,,,,,,,,,,
Lyer,Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599. doi: 10.1073/pnas.1620144114.,Resistance to type 1 interferons is a major determinantof HIV-1 transmission fitness,2017,CHAVI001,,,Y,Highlighter,haplotype,CH0742-0378-0831.701010378,,M,MSM,US,2008/08/05,S,Plasma,SGA,Sanger,NFLG,8919,24,B,B,2,multiple,265936,,V,positive,,,,,,,,,,,,
Lyer,Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599. doi: 10.1073/pnas.1620144114.,Resistance to type 1 interferons is a major determinantof HIV-1 transmission fitness,2017,CHAVI001,,,Y,Highlighter,haplotype,CH0212-to-CH0162,,M,HSX:FTM,ZA,2007/07/13,S,Plasma,SGA,Sanger,NFLG,9007,7,C,C,1,single,18260,,III,positive,,,,,,,,,,,,
Lyer,Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599. doi: 10.1073/pnas.1620144114.,Resistance to type 1 interferons is a major determinantof HIV-1 transmission fitness,2017,CHAVI001,,,Y,Highlighter,haplotype,CH0492-to-CH0427,,M,HSX:FTM,MW,2008/01/23,S,Plasma,SGA,Sanger,NFLG,8885,21,C,C,1,single,1644231,,I-II,negative,,,,,,,,,,,,
Lyer,Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599. doi: 10.1073/pnas.1620144114.,Resistance to type 1 interferons is a major determinantof HIV-1 transmission fitness,2017,CHAVI001,,,Y,Highlighter,haplotype,CH0596-to-CH0455,,M,HSX:FTM,MW,2008/01/29,S,Plasma,SGA,Sanger,NFLG,8771,8,C,C,1,single,502665,,III,positive,,,,,,,,,,,,
Lyer,Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599. doi: 10.1073/pnas.1620144114.,Resistance to type 1 interferons is a major determinantof HIV-1 transmission fitness,2017,CHAVI001,,,Y,Highlighter,haplotype,CH1064-to-CH0848,,M,HSX:FTM,MW,2008/07/29,S,Plasma,SGA,Sanger,NFLG,8962,8,C,C,1,single,361254,,IV,positive,,,,,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,,,,HIghlighter,haplotype,Z1800M,,M,HSX:FTM,ZM,,LT,Plasma,SGA,Sanger,gp160,,39,C,C,1,single,145000,,,negative,,,,29,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,,,,HIghlighter,haplotype,Z1792M,,M,HSX:FTM,ZM,,LT,Plasma,SGA,Sanger,gp160,,32,C,C,1,single,40600,,,negative,,,,14,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,1,,,HIghlighter,haplotype,Z185F,,F,HSX:MTF,ZM,,LT,Plasma,SGA,Sanger,gp160,,,C,C,1,single,222000,,,negative,,,,87,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,PSF,,,,HIghlighter,haplotype,R1141M,,M,HSX:FTM,RW,,LT,Plasma,SGA,Sanger,gp160,,42,A1,A,1,single,13500,,,negative,,,,26,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,,,,HIghlighter,haplotype,Z1024F,,F,HSX:MTF,ZM,,LT,Plasma,SGA,Sanger,gp160,,56,C,C,1,single,29600,,,negative,,,,19,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,PSF,,,,HIghlighter,haplotype,R1142F,,F,HSX:MTF,RW,,LT,Plasma,SGA,Sanger,gp160,,48,A/C,recombinant,1,single,51400,,,negative,,,,16,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,1,,,HIghlighter,haplotype,Z221M,,M,HSX:FTM,ZM,,LT,Plasma,SGA,Sanger,gp160,,,C,C,1,single,82400,,,negative,,,,68,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,,,,HIghlighter,haplotype,Z1022M,,M,HSX:FTM,ZM,,LT,Plasma,SGA,Sanger,gp160,,35,C,C,1,single,129000,,,negative,,,,27,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,,,,HIghlighter,haplotype,Z1023M,,M,HSX:FTM,ZM,,LT,Plasma,SGA,Sanger,gp160,,54,C,C,1,single,146000,,,negative,,,,94,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,,,,HIghlighter,haplotype,Z1781M,,M,HSX:FTM,ZM,,LT,Plasma,SGA,Sanger,gp160,,12,C,C,1,single,182,,,negative,,,,17,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,1,,,HIghlighter,haplotype,Z205F,,F,HSX:MTF,ZM,,LT,Plasma,SGA,Sanger,gp160,,,C,C,1,single,4330,,,negative,,,,100,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,PSF,,,,HIghlighter,haplotype,R53F,,F,HSX:MTF,RW,,LT,Plasma,SGA,Sanger,gp160,,77,A1,A,1,single,999,,,negative,,,,29,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,PSF,,,,HIghlighter,haplotype,R283F,,F,HSX:MTF,RW,,S,Plasma,SGA,Sanger,gp160,,5,A1,A,1,single,733,,,negative,,,,7,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,PSF,,,,HIghlighter,haplotype,R774F,,F,HSX:MTF,RW,,LT,Plasma,SGA,Sanger,gp160,,37,A1,A,1,single,13900,,,negative,,,,51,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,PSF,,,,HIghlighter,haplotype,R880F,,F,HSX:MTF,RW,,LT,Plasma,SGA,Sanger,gp160,,104,A1,A,1,single,49,,,negative,,,,23,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,1,,,HIghlighter,haplotype,Z153M,,M,HSX:FTM,ZM,,LT,Plasma,SGA,Sanger,gp160,,,C,C,1,single,,,,negative,,,,70,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,PSF,,,,HIghlighter,haplotype,R463F,,F,HSX:MTF,RW,,LT,Plasma,SGA,Sanger,gp160,,80,A1,A,1,single,398000,,,negative,,,,96,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,,,,HIghlighter,haplotype,Z1047M,,M,HSX:FTM,ZM,,LT,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,241000,,,negative,,,,47,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,ZEHRP,1,,,HIghlighter,haplotype,Z201M,,M,HSX:FTM,ZM,,LT,Plasma,SGA,Sanger,gp160,,,C,C,1,single,204,,,negative,,,,74,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,PSF,,,,HIghlighter,haplotype,R66M,,M,HSX:FTM,RW,,LT,Plasma,SGA,Sanger,gp160,,80,A/C,recombinant,1,single,750000,,,negative,,,,,,,,,,,,
Abigail-Smith,PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989.,"Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth",2016,PSF,,,,HIghlighter,haplotype,R1135M,,M,HSX:FTM,RW,,LT,Plasma,SGA,Sanger,gp160,,20,A1,A,1,single,49,,,negative,,,,13,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,505_2474,36,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,363078,268,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,505_2483,22,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,363078,258,,negative,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R3,31,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,38905,370,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R4,43,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,3981072,853,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R5,37,M,PWID,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,5248,507,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R6,55,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,257040,858,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R7,29,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,7762,501,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R8,37,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,724436,543,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R9,25,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,79433,586,,negative,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R10,26,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,144544,715,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R11,34,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,239883,248,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R12,31,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,151356,425,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R13,47,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,339,586,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R14,59,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,36308,472,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R15,42,M,PWID,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,758578,647,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R16,43,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,169824,614,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R17,47,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,15488166,767,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R18,25,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,3467,695,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R19,32,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,1023,1382,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R20,26,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,89125,642,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R21,56,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,812831,394,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R22,35,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,245471,504,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R23,20,M,PWID,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,323594,508,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R24,36,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,2630268,466,,negative,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R25,30,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,41687,538,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R26,28,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,47863,264,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R27,25,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,37154,326,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R28,31,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,6166,962,,positive,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R29,23,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,multiple,1174898,292,,negative,,,,,,,,,,,,
Chaillon,Virus Evol. 2016 Jun 8;2(1):vew012. doi: 10.1093/ve/vew012.,Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM,2016,SDPIRC,,,Y,"TN93 distance, Phylo-Topology",pooled,R30,43,M,MSM,US-CA,,S,Plasma,Nested RT- PCR,Roche 454,gp120,,NGS,B,B,NA,single,72444,388,,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,1,,Y,SPMM,math_model,,,NA,unknown,US-MS,1997/07/29,S,Plasma,SGA,Sanger,gp160,2562,25,B,B,1,single,>500000,,II,negative,4,0.061,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Montreal,,,Y,SPMM,math_model,HDNDRPI034,47,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,167,B,B,9,multiple,75857758,240,III,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Montreal,,,Y,SPMM,math_model,HDNDRPI029,18,F,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,29,B,B,2,multiple,21878,440,IV,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Montreal,,,Y,SPMM,math_model,HTM385,24,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,22,B,B,1,single,234423,406,V,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Montreal,,,Y,SPMM,math_model,CQLDR03,42,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,22,B,B,1,single,102329,NA,V,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Montreal,,,Y,SPMM,math_model,HDNDRPI001,36,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,25,B,B,4,multiple,870964,690,V,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Montreal,,,Y,SPMM,math_model,HTM319,39,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,31,B,B,8,multiple,26915,520,V,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Montreal,,,Y,SPMM,math_model,HDNDRPI032,37,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,19,B,B,3,multiple,3388,1040,V,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Montreal,,,Y,SPMM,math_model,ACT54869022,28,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,27,B,B,1,single,2692,723,VI,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,700010040,,M,MSM,US-NC,2006/07/27,S,Plasma,SGA,Sanger,gp160,2541,29,B,B,1,single,298026,,V,positive,5,0.053,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,700010077,,M,unknown,US-NC,2006/09/08,S,Plasma,SGA,Sanger,gp160,2544,51,B,B,1,single,144145,,V,positive,6,0.079,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,700010058,,M,unknown,US-NC,2006/08/31,S,Plasma,SGA,Sanger,gp160,2545,46,B,B,1,single,394649,,III,positive,10,0.081,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,700010019,,F,PWID,US-NC,2006/06/20,S,Plasma,SGA,Sanger,gp160,2640,33,B,B,4,multiple,741499,,V,positive,63,2.386,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,701010016,,M,unknown,US-NC,2006/07/24,S,Plasma,SGA,Sanger,gp160,2568,20,B,B,2,multiple,1802,,V,positive,22,0.857,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1006-11,,M,unknown,US-AL,1997/06/05,S,Plasma,SGA,Sanger,gp160,2550,42,B,B,1,single,1600000,,III,positive,4,0.022,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1054-07,,M,unknown,US-SC,1997/11/30,S,Plasma,SGA,Sanger,gp160,2562,39,B,B,1,single,320000,,II,negative,5,0.035,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1056-10,,M,unknown,US-SC,1998/01/14,S,Plasma,SGA,Sanger,gp160,2589,46,B,B,1,single,140000,,II,negative,4,0.027,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Aug-40,,M,unknown,US-MO,1995/11/22,S,Plasma,SGA,Sanger,gp160,2601,17,B,B,1,single,120000,,II,negative,4,0.044,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,6244-13,,M,unknown,US-TX,1996/06/25,S,Plasma,SGA,Sanger,gp160,2637,11,B,B,1,single,274000,,II,negative,4,0.047,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Sep-10,,F,unknown,US-SC,1997/11/25,S,Plasma,SGA,Sanger,gp160,2574,19,B,B,1,single,146954,,II,negative,4,0.045,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Jan-14,,M,unknown,US-SC,1997/11/13,S,Plasma,SGA,Sanger,gp160,2637,14,B,B,1,single,25680,,II,negative,3,0.041,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Jul-15,,M,unknown,US-SC,1997/12/27,S,Plasma,SGA,Sanger,gp160,2553,36,B,B,1,single,500000,,II,negative,4,0.026,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Jan-17,,M,unknown,US-SC,1997/12/26,S,Plasma,SGA,Sanger,gp160,2568,26,B,B,1,single,32390,,II,negative,4,0.021,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Mar-19,,F,unknown,US-SC,1997/12/28,S,Plasma,SGA,Sanger,gp160,2607,18,B,B,1,single,571000,,V,positive,3,0.054,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,9020-20,,F,unknown,US-CA,1998/06/16,S,Plasma,SGA,Sanger,gp160,2562,25,B,B,1,single,69238,,II,negative,5,0.058,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,9021-14,,M,unknown,US-CA,1998/06/10,S,Plasma,SGA,Sanger,gp160,2592,34,B,B,1,single,143379,,II,negative,5,0.02,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,9023-21,,M,unknown,US-NC,1998/07/07,S,Plasma,SGA,Sanger,gp160,2568,18,B,B,1,single,>500000,,II,negative,5,0.052,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Nov-25,,M,unknown,US-OR,1998/08/16,S,Plasma,SGA,Sanger,gp160,2562,19,B,B,1,single,>500000,,II,negative,4,0.037,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Jul-28,,F,unknown,US-NC,1998/07/29,S,Plasma,SGA,Sanger,gp160,2544,23,B,B,1,single,>500000,,II,negative,2,0.021,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Aug-32,,M,unknown,US-AL,1998/07/30,S,Plasma,SGA,Sanger,gp160,2583,39,B,B,1,single,40815,,III,positive,2,0.022,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,9033-16,,M,unknown,US-OR,1998/03/29,S,Plasma,SGA,Sanger,gp160,2571,20,B,B,1,single,454553,,III,positive,4,0.047,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Mar-75,,NA,unknown,US-OH,1996/09/13,S,Plasma,SGA,Sanger,gp160,2556,22,B,B,1,single,360000,,II,negative,3,0.025,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Dec-77,,NA,unknown,US-NC,1999/12/04,S,Plasma,SGA,Sanger,gp160,2574,24,B,B,1,single,158300,,II,negative,4,0.034,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Sep-79,,NA,unknown,US-CA,1999/12/11,S,Plasma,SGA,Sanger,gp160,2620,26,B,B,1,single,148320,,II,negative,5,0.032,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,61792-03,,NA,unknown,US-TX,1996/07/29,S,Plasma,SGA,Sanger,gp160,2598,19,B,B,1,single,3700000,,II,negative,3,0.034,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,62130-04,,NA,unknown,US-OH,1996/09/03,S,Plasma,SGA,Sanger,gp160,2566,11,B,B,1,single,600000,,II,negative,4,0.043,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,62357-14,,M,unknown,US-TX,1996/10/02,S,Plasma,SGA,Sanger,gp160,2541,14,B,B,1,single,302000,,II,negative,3,0.044,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,62995-05,,NA,unknown,US,1997/01/03,S,Plasma,SGA,Sanger,gp160,2568,27,B,B,1,single,75000,,I,negative,3,0.03,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,63054-04,,NA,unknown,US,1997/01/19,S,Plasma,SGA,Sanger,gp160,2583,20,B,B,1,single,1153260,,II,negative,4,0.056,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,63396-07,,NA,unknown,US-CA,1997/03/12,S,Plasma,SGA,Sanger,gp160,2601,21,B,B,1,single,420000,,II,negative,2,0.005,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,PRB926-04,,NA,unknown,US,1994/02/19,S,Plasma,SGA,Sanger,gp160,2563,14,B,B,1,single,756060,,II,negative,6,0.061,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,PRB931-06,,NA,unknown,US-WI,1995/09/11,S,Plasma,SGA,Sanger,gp160,2535,19,B,B,1,single,2000000,,III,positive,6,0.095,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,PRB956-04,,NA,unknown,US-VA,1997/08/19,S,Plasma,SGA,Sanger,gp160,2583,27,B,B,1,single,600000,,II,negative,4,0.034,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,PRB958-06,,NA,unknown,US-FL,2000/02/10,S,Plasma,SGA,Sanger,gp160,2564,24,B,B,1,single,678900,,III,positive,5,0.054,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,PRB959-02,,NA,unknown,US-SC,1999/11/17,S,Plasma,SGA,Sanger,gp160,2550,32,B,B,1,single,>2000000,,II,negative,5,0.029,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,REJO4541,,M,HSX:FTM,US-AL,2001/09/28,S,Plasma,SGA,Sanger,gp160,2568,21,B,B,1,single,722349,,V,positive,5,0.052,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,SC05,,M,HSX:FTM,TT,1993/06/28,S,Plasma,SGA,Sanger,gp160,2565,30,B,B,1,single,9980952,,II,negative,4,0.049,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,SC11,,F,HSX:MTF,TT,1993/10/11,S,Plasma,SGA,Sanger,gp160,2577,20,B,B,1,single,1917073,,II,negative,2,0.008,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,SC20,,M,HSX:FTM,TT,1994/02/17,S,Plasma,SGA,Sanger,gp160,2565,43,B,B,1,single,2789313,,IV,positive,4,0.031,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,SC45,,M,HSX:FTM,TT,1995/01/18,S,Plasma,SGA,Sanger,gp160,2586,29,B,B,1,single,6318529,,II,negative,4,0.04,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,THRO4156,,M,MSM,US-AL,2000/08/01,S,Plasma,SGA,Sanger,gp160,2625,27,B,B,1,single,5413140,,V,positive,6,0.04,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,TRJO4551,,M,MSM,US-AL,2001/10/10,S,Plasma,SGA,Sanger,gp160,2574,18,B,B,1,single,8121951,,II,negative,6,0.08,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,TT28P,,M,HSX:FTM,TT,1998/01/20,S,Plasma,SGA,Sanger,gp160,2601,28,B,B,1,single,7468346,,V,positive,4,0.03,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,TT29P,,M,HSX:FTM,TT,1998/03/20,S,Plasma,SGA,Sanger,gp160,2575,20,B,B,1,single,14756436,,II,negative,3,0.019,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,TT34P,,M,HSX:FTM,TT,1998/01/13,S,Plasma,SGA,Sanger,gp160,2562,29,B,B,1,single,3050125,,V,positive,4,0.04,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,WEAU0575,,M,MSM,US-AL,1990/05/30,S,Plasma,SGA,Sanger,gp160,2581,44,B,B,1,single,216415,,II,negative,6,0.052,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,WITO4160,,M,HSX:FTM,US-AL,2000/08/04,S,Plasma,SGA,Sanger,gp160,2550,16,B,B,1,single,325064,,II,negative,5,0.054,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z02,,M,HSX:FTM,US-NC,1998/05/27,S,Plasma,SGA,Sanger,gp160,2574,21,B,B,1,single,296111,,V,positive,5,0.059,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z05,,M,HSX:FTM,US-NC,1998/09/21,S,Plasma,SGA,Sanger,gp160,2601,15,B,B,1,single,3950942,,II,negative,4,0.066,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z13,,M,HSX:FTM,US-NC,1999/05/17,S,Plasma,SGA,Sanger,gp160,2526,31,B,B,1,single,53941,,V,positive,9,0.127,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z20,,M,MSM,US-NC,2000/11/01,S,Plasma,SGA,Sanger,gp160,2574,26,B,B,1,single,13466851,,III,positive,4,0.042,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z23,,M,MSM,US-NC,2001/02/01,S,Plasma,SGA,Sanger,gp160,2589,15,B,B,1,single,210521,,V,positive,2,0.031,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z27,,M,HSX:FTM,US-NC,2001/06/20,S,Plasma,SGA,Sanger,gp160,2571,25,B,B,1,single,178125,,V,positive,6,0.074,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z32,,M,MSM,US-NC,2002/02/09,S,Plasma,SGA,Sanger,gp160,2619,10,B,B,1,single,5788591,,IV,positive,4,0.046,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z34,,M,MSM,US-NC,2002/12/17,S,Plasma,SGA,Sanger,gp160,2544,18,B,B,1,single,2501242,,III,positive,6,0.062,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z36,,M,unknown,US-NC,2003/01/29,S,Plasma,SGA,Sanger,gp160,2565,17,B,B,1,single,1480293,,VI,positive,7,0.11,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1018-10,,M,unknown,US-SC,1997/06/20,S,Plasma,SGA,Sanger,gp160,2571,50,B,B,1,single,270000,,III,positive,10,0.031,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1053-07,,M,unknown,US-SC,1997/12/03,S,Plasma,SGA,Sanger,gp160,2547,60,B,B,1,single,1400000,,III,positive,2,0.017,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Jul-48,,M,unknown,US-TX,1997/03/09,S,Plasma,SGA,Sanger,gp160,2565,20,B,B,1,single,87700000,,III,positive,5,0.087,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1001-07^,,F,unknown,US-MO,1997/02/12,S,Plasma,SGA,Sanger,gp160,2568,62,B,B,1,single,210000,,III,positive,7,0.028,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,RHPA4259^^,,F,HSX:MTF,US-AL,2000/12/05,S,Plasma,SGA,Sanger,gp160,2580,31,B,B,1,single,1458354,,V,positive,6,0.052,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Sep-22,,M,unknown,US-FL,1997/08/31,S,Plasma,SGA,Sanger,gp160,2583,23,B,B,1,single,>500000,,III,positive,2,0.014,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,63215-03,,NA,unknown,US-TX,1997/02/12,S,Plasma,SGA,Sanger,gp160,2535,19,B,B,1,single,550000,,V,positive,4,0.018,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,TT35P,,M,HSX:FTM,TT,1999/01/26,S,Plasma,SGA,Sanger,gp160,2625,43,B,B,1,single,1849301,,II,negative,4,0.031,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,63358-04,,NA,unknown,US-NC,1997/03/10,S,Plasma,SGA,Sanger,gp160,2616,27,B,B,1,single,260000,,II,negative,6,0.045,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,9031-19,,M,unknown,US-NC,1998/02/16,S,Plasma,SGA,Sanger,gp160,2661,20,B,B,1,single,237938,,IV,positive,7,0.064,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Dec-29,,M,unknown,US-NC,1998/09/10,S,Plasma,SGA,Sanger,gp160,2538,22,B,B,1,single,>500000,,II,negative,5,0.03,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1059-09,,M,unknown,US-CA,1998/03/26,S,Plasma,SGA,Sanger,gp160,2586,39,B,B,1,single,2800000,,III,positive,8,0.052,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,12007-04,,NA,unknown,US,1999/10/22,S,Plasma,SGA,Sanger,gp160,2565,25,B,B,1,single,75815,,II,negative,4,0.025,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1058-11,,M,unknown,US-SC,1998/03/18,S,Plasma,SGA,Sanger,gp160,2571,45,B,B,1,single,550000,,IV,positive,9,0.054,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,SUMA0874,,M,MSM,US-AL,1991/05/13,S,Plasma,SGA,Sanger,gp160,2568,35,B,B,1,single,939260,,II,negative,2,0.024,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1012-11,,NA,unknown,US-CA,1997/04/07,S,Plasma,SGA,Sanger,gp160,2601,43,B,B,1,single,410000,,III,positive,6,0.07,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,SC51,,M,HSX:FTM,TT,1996/01/15,S,Plasma,SGA,Sanger,gp160,2562,33,B,B,1,single,4229703,,V,positive,4,0.052,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,SC22,,F,HSX:MTF,TT,1994/03/16,S,Plasma,SGA,Sanger,gp160,2598,38,B,B,1,single,14304820,,II,negative,6,0.068,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,9030-15,,M,unknown,US-CA,1998/10/02,S,Plasma,SGA,Sanger,gp160,2561,19,B,B,1,single,>500000,,II,negative,9,0.061,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,SC31,,F,HSX:MTF,TT,1994/09/15,S,Plasma,SGA,Sanger,gp160,2547,36,B,B,1,single,4449612,,IV,positive,12,0.07,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,MEMI4948,,M,MSM,US-AL,2003/01/28,S,Plasma,SGA,Sanger,gp160,2568,32,B,B,1,single,22686,,V,positive,12,0.186,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z33,,M,MSM,US-NC,2002/10/12,S,Plasma,SGA,Sanger,gp160,2562,21,B,B,1,single,158603,,II,negative,6,0.093,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Aug-47,,M,unknown,US-FL,1997/04/07,S,Plasma,SGA,Sanger,gp160,2553,32,B,B,2,multiple,124000,,II,negative,5,0.057,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,TT31P,,F,HSX:MTF,TT,1998/10/02,S,Plasma,SGA,Sanger,gp160,2577,67,B,B,2,multiple,21826347,,II,negative,9,0.1,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z31,,M,MSM,US-NC,2001/12/09,S,Plasma,SGA,Sanger,gp160,2556,17,B,B,2,multiple,6507075,,II,negative,12,0.248,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,63068-05,,NA,unknown,US,1997/01/16,S,Plasma,SGA,Sanger,gp160,2568,20,B,B,2,multiple,100000,,II,negative,39,1.519,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,TT27P,,M,HSX:FTM,TT,1998/01/19,S,Plasma,SGA,Sanger,gp160,2625,38,B,B,3,multiple,1489202,,IV,positive,139,5.295,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,62615-03,,NA,unknown,US-TX,1996/11/08,S,Plasma,SGA,Sanger,gp160,2667,28,B,B,3,multiple,2200000,,II,negative,78,2.925,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z35,,M,MSM,US-NC,2003/01/15,S,Plasma,SGA,Sanger,gp160,2559,21,B,B,2,multiple,2281415,,IV,positive,29,1.133,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Jul-26,,NA,unknown,US-TX,1998/09/03,S,Plasma,SGA,Sanger,gp160,2586,15,B,B,2,multiple,211703,,III,positive,29,1.121,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Aug-76,,NA,unknown,US-CA,1997/04/28,S,Plasma,SGA,Sanger,gp160,2571,32,B,B,2,multiple,410000,,III,positive,31,1.206,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z18,,M,MSM,US-NC,2000/06/30,S,Plasma,SGA,Sanger,gp160,2592,34,B,B,3,multiple,2845823,,V,positive,65,2.508,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,SC33,,M,HSX:FTM,TT,1994/10/24,S,Plasma,SGA,Sanger,gp160,2610,27,B,B,2,multiple,3277559,,II,negative,105,4.023,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,CAAN5342,,M,MSM,US-AL,2004/04/13,S,Plasma,SGA,Sanger,gp160,2565,40,B,B,3,multiple,608560,,V,positive,43,1.676,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,BORI 0637,,M,MSM,US-AL,1990/08/23,S,Plasma,SGA,Sanger,gp160,2607,29,B,B,5,multiple,2400000,,II,negative,77,2.954,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,1051-12,,F,unknown,US-SC,1997/10/17,S,Plasma,SGA,Sanger,gp160,2619,50,B,B,4,multiple,280000,,III,positive,71,2.711,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z30,,F,HSX:MTF,US-NC,2001/11/05,S,Plasma,SGA,Sanger,gp160,2586,30,B,B,2,multiple,1408114,,V,positive,27,1.044,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z16,,M,MSM,US-NC,1999/08/30,S,Plasma,SGA,Sanger,gp160,2586,19,B,B,5,multiple,2375617,,V,positive,109,4.215,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,Z03,,M,MSM,US-NC,1998/08/06,S,Plasma,SGA,Sanger,gp160,2580,22,B,B,3,multiple,726859,,V,positive,63,2.442,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,PRB957-06,,NA,unknown,US-AL,1999/04/28,S,Plasma,SGA,Sanger,gp160,2610,36,B,B,4,multiple,>2000000,,II,negative,173,6.628,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Keele,,,Y,SPMM,math_model,12008-09,,NA,unknown,US-MO,1999/10/23,S,Plasma,SGA,Sanger,gp160,2647,31,B,B,2,multiple,>2000000,,II,negative,157,5.931,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,Montreal,,,Y,SPMM,math_model,PSL024,46,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,,B,B,4,multiple,28840,340,VI,positive,,,,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,89,33,M,HSX:MTF,MW,2003/04/10,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,838444,,V,positive,NA,0.06,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,334,24,M,HSX:FTM,MW,2003/06/30,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,22000000,,I/II,negative,NA,0.03,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,393,23,F,HSX:FTM,MW,2003/07/17,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,12000000,,IV,positive,NA,0.04,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,626,22,M,HSX:FTM,MW,2003/09/16,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,711061,,IV,positive,NA,0.04,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,665,27,M,HSX:FTM,MW,2003/09/24,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,67728,,IV,positive,NA,0.06,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,682,22,M,HSX:FTM,MW,2003/09/29,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,17960,,I/II,negative,NA,0.03,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,985,20,M,HSX:FTM,MW,2004/02/11,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,2894737,,I/II,negative,NA,0.02,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,1172,25,M,HSX:FTM,MW,2004/05/13,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,4805921,,I/II,negative,NA,0.03,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,2052,18,F,HSX:MTF,MW,2006/03/24,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,339475,,I/II,negative,NA,0.03,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,2060,22,M,HSX:FTM,MW,2005/04/04,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,1530364,,I/II,negative,NA,0.04,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,1086,29,M,HSX:FTM,MW,2004/03/22,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,1406208,,I/II,negative,NA,0.05,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,2010,42,M,HSX:FTM,MW,2005/01/19,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,1203333,,IV,positive,NA,0.02,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,1176,26,M,HSX:FTM,MW,2004/05/14,S,Plasma,SGA,Sanger,gp160,,21,C,C,3,multiple,200000000,,I/II,negative,NA,0.1,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,1373,26,F,HSX:MTF,MW,2004/08/27,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,3221979,,I/II,negative,NA,0.06,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,1394,23,M,HSX:FTM,MW,2004/09/07,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,7341772,,I/II,negative,NA,0.06,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,2103,30,M,HSX:FTM,MW,2005/07/21,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,152364,,I/II,negative,NA,0.02,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,595,19,F,HSX:MTF,MW,2003/09/11,S,Plasma,SGA,Sanger,gp160,,28,C,C,1,single,1006864,,IV,positive,NA,0.07,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,114,29,M,HSX:FTM,MW,2003/02/08,S,Plasma,SGA,Sanger,gp160,,27,C,C,3,multiple,99000000,,IV,positive,NA,1.75,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,478,18,M,HSX:FTM,MW,2003/04/24,S,Plasma,SGA,Sanger,gp160,,23,C,C,4,multiple,2166667,,I/II,negative,NA,1.92,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,1196,24,M,HSX:FTM,MW,2004/06/15,S,Plasma,SGA,Sanger,gp160,,23,C,C,3,multiple,30500000,,I/II,negative,NA,0.65,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,ABRAHAMS_MW,,,Y,SPMM,math_model,1335,24,M,HSX:FTM,MW,2004/08/20,S,Plasma,SGA,Sanger,gp160,,21,C,C,3,multiple,576282,,IV,positive,NA,2.15,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP45,41,F,HSX:MTF,ZA,2005/04/20,S,Plasma,SGA,Sanger,gp160,,16,C,C,1,single,12500,,I/II,negative,NA,0.02,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP129,59,F,HSX:MTF,ZA,2006/06/13,S,Plasma,SGA,Sanger,gp160,,19,C,C,1,single,1800000,,IV,positive,NA,0.03,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP174,42,F,HSX:MTF,ZA,2005/09/22,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,40000,,V,positive,NA,0.06,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP177,37,F,HSX:MTF,ZA,2006/03/07,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,359000,,I/II,negative,NA,0.03,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP188,31,F,HSX:MTF,ZA,2007/01/25,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,13800000,,I/II,negative,NA,0.04,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP200,32,F,HSX:MTF,ZA,2005/10/11,S,Plasma,SGA,Sanger,gp160,,18,C,C,1,single,398000,,IV,positive,NA,0.04,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP206,36,F,HSX:MTF,ZA,2005/06/15,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,196000,,V,positive,NA,0.05,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP210,43,F,HSX:MTF,ZA,2005/05/03,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,468000,,I/II,negative,NA,0.01,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP217,20,F,HSX:MTF,ZA,2005/12/02,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,3260000,,IV,positive,NA,0.02,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP220,25,F,HSX:MTF,ZA,2007/02/15,S,Plasma,SGA,Sanger,gp160,,15,C,C,1,single,2070,,V,positive,NA,0.08,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP221,25,F,HSX:MTF,ZA,2006/03/02,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,24300,,I/II,negative,NA,0.07,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP237,20,F,HSX:MTF,ZA,2007/03/06,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,1020000,,III,positive,NA,0.04,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP239,44,F,HSX:MTF,ZA,2005/08/10,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,95800,,V,positive,NA,0.06,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP40,31,F,HSX:MTF,ZA,2006/04/25,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,90500,,VI,positive,NA,0.14,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP63,32,F,HSX:MTF,ZA,2005/01/06,S,Plasma,SGA,Sanger,gp160,,19,C,C,1,single,3210000,,III,positive,NA,0.04,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP84,18,F,HSX:MTF,ZA,2005/02/16,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,559000,,V,positive,NA,0.04,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP85,24,F,HSX:MTF,ZA,2005/06/22,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,621000,,V,positive,NA,0.08,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP225,40,F,HSX:MTF,ZA,2005/10/25,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,63600000,,III,positive,NA,0.04,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP8,38,F,HSX:MTF,ZA,2005/05/11,S,Plasma,SGA,Sanger,gp160,,19,C,C,2,multiple,207000,,V,positive,NA,0.18,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP269,21,F,HSX:MTF,ZA,2006/09/27,S,Plasma,SGA,Sanger,gp160,,18,C,C,1,single,2170,,VI,positive,NA,0.26,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP37,20,F,HSX:MTF,ZA,2006/05/11,S,Plasma,SGA,Sanger,gp160,,20,C,C,3,multiple,248000,,IV,positive,NA,1.18,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP69,39,F,HSX:MTF,ZA,2006/01/30,S,Plasma,SGA,Sanger,gp160,,20,C,C,7,multiple,15300,,I/II,negative,NA,1.29,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP136,25,F,HSX:MTF,ZA,2006/06/29,S,Plasma,SGA,Sanger,gp160,,16,C,C,2,multiple,85300,,V,positive,NA,0.37,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP222,19,F,HSX:MTF,ZA,2006/04/05,S,Plasma,SGA,Sanger,gp160,,21,C,C,4,multiple,69700,,I/II,negative,NA,0.79,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP224,20,F,HSX:MTF,ZA,1900/01/06,S,Plasma,SGA,Sanger,gp160,,19,C,C,2,multiple,134800,,V,positive,NA,0.4,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CAPRISA002,,,Y,SPMM,math_model,CAP260,27,F,HSX:MTF,ZA,2006/11/15,S,Plasma,SGA,Sanger,gp160,,18,C,C,2,multiple,17600,,V,positive,NA,1.23,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,703010131,20,M,HSX:FTM,MW,2007/03/15,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,437369,,III,positive,NA,0.06,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,703010193,19,M,HSX:FTM,MW,2007/05/08,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,46724,,V,positive,NA,0.08,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,703010217,34,F,HSX:MTF,MW,2007/06/04,S,Plasma,SGA,Sanger,gp160,,25,C,C,1,single,102602,,V/VI,positive,NA,0.07,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,704010042,38,M,HSX:FTM,ZA,2007/02/02,S,Plasma,SGA,Sanger,gp160,,42,C,C,1,single,133000,,V,positive,NA,0.07,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,704010083,25,F,HSX:MTF,ZA,2007/02/19,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,>750000,,III,positive,NA,0.05,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,704809221,22,M,HSX:FTM,ZA,2007/08/13,S,Plasma,SGA,Sanger,gp160,,28,C,C,1,single,>750000,,I/II,negative,NA,0.06,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,706010164,27,M,HSX:FTM,ZA,2007/08/16,S,Plasma,SGA,Sanger,gp160,,19,C,C,1,single,23600,,IV,positive,NA,0.05,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,704810053,22,F,HSX:MTF,ZA,2007/09/11,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,25400,,V,positive,NA,0.05,YES,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,703010159,18,F,HSX:MTF,MW,2007/03/23,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,73453,,II,negative,NA,0.07,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,703010054,28,M,HSX:FTM,MW,2007/01/19,S,Plasma,SGA,Sanger,gp160,,27,C,C,1,single,13936,,V,positive,NA,0.18,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,704010017,21,F,HSX:MTF,ZA,2006/12/05,S,Plasma,SGA,Sanger,gp160,,25,C,C,1,single,1100,,VI,positive,NA,0.17,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,704010056,28,M,HSX:FTM,ZA,2007/02/13,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,3830,,VI,positive,NA,0.25,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,704010069,23,F,HSX:MTF,ZA,2007/02/14,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,4040,,VI,positive,NA,0.12,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,705010015,21,F,HSX:MTF,ZA,2007/01/12,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,47900,,V,positive,NA,0.11,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,705010110,23,M,HSX:FTM,ZA,2007/03/26,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,38313,,VI,positive,NA,0.09,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,706010018,19,F,HSX:MTF,ZA,2007/06/04,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,93700,,VI,positive,NA,0.24,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,705010026,25,F,HSX:MTF,ZA,2007/02/01,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,8971,,V,positive,NA,0.08,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,705010078,22,M,HSX:FTM,ZA,2007/02/27,S,Plasma,SGA,Sanger,gp160,,26,C,C,1,single,255907,,V,positive,NA,0.05,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,703010010,25,M,HSX:FTM,MW,2006/12/28,S,Plasma,SGA,Sanger,gp160,,22,C,C,3,multiple,408727,,III,positive,NA,0.41,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,703010200,24,M,HSX:FTM,MW,2007/05/18,S,Plasma,SGA,Sanger,gp160,,18,C,C,4,multiple,128677,,IV,positive,NA,1.23,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,703010228,19,M,HSX:FTM,MW,2007/06/07,S,Plasma,SGA,Sanger,gp160,,28,C,C,2,multiple,335000,,IV,positive,NA,1.45,NO,,,,,,,,,
Love,Bioinformatics. 2016 May 1; 32(9): 1308–1315.Dec 31. doi: 10.1093/bioinformatics/btv749,SPMM: estimating infection duration of multivariant HIV-1 infections,2016,CHAVI001,,,Y,SPMM,math_model,706010151,23,F,HSX:MTF,ZA,2003/08/23,S,Plasma,SGA,Sanger,gp160,,15,C,C,3,multiple,49000,,VI,positive,NA,0.93,NO,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,A-1811,30,F,HSX:MTF,BW,2004/04/13,LT,,SGA,Sanger,gp120,,19,C,C,2,multiple,,,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,B-2865,20,F,HSX:MTF,BW,2005/08/30,LT,,SGA,Sanger,gp120,,33,C,C,1,single,,,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,C-3312,32,F,HSX:MTF,BW,2005/12/07,LT,,SGA,Sanger,gp120,,30,C,C,NA,,,,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,D-5018,27,M,HSX:FTM,BW,2006/11/14,LT,,SGA,Sanger,gp120,,22,C,C,2,multiple,,,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,E-3430,35,F,HSX:MTF,BW,2006/02/07,LT,,SGA,Sanger,gp120,,12,C,C,NA,,,,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,F-3505,53,F,HSX:MTF,BW,2006/04/11,LT,,SGA,Sanger,gp120,,13,C,C,NA,,,,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,G-3603,34,M,HSX:FTM,BW,2006/06/30,LT,,SGA,Sanger,gp120,,11,C,C,1,single,,,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,H-5582,26,F,HSX:MTF,BW,2007/06/10,LT,,SGA,Sanger,gp120,,12,C,C,NA,,,,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,NA-1729,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,1,single,,,V/VI,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,O1-3354,30,F,HSX:MTF,BW,2005/12/16,LT,,SGA,Sanger,gp120,,12,C,C,NA,,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,OC-2381,25,M,HSX:FTM,BW,2005/02/15,LT,,SGA,Sanger,gp120,,7,C,C,1,single,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,OE-2530,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,OG-2604,23,F,HSX:MTF,BW,2005/06/27,LT,,SGA,Sanger,gp120,,15,C,C,2,multiple,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,OJ-2761,26,F,HSX:MTF,BW,2005/08/04,LT,,SGA,Sanger,gp120,,11,C,C,NA,,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,OM-2869,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V/VI,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,OQ-2990,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,OS-3079,42,M,HSX:FTM,BW,,LT,,SGA,Sanger,gp120,,,C,C,1,single,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,OU-3091,27,M,HSX:FTM,BW,2005/10/17,LT,,SGA,Sanger,gp120,,11,C,C,NA,,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,OW-3234,41,M,HSX:FTM,BW,2005/11/16,LT,,SGA,Sanger,gp120,,11,C,C,2,multiple,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,OX-3251,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,OY-3244,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,OZ-3285,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,PA-3390,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,PC-3481,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,PD-3508,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,PK-4872,30,M,HSX:FTM,BW,2006/08/31,LT,,SGA,Sanger,gp120,,8,C,C,2,multiple,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,PO-5062,20,F,HSX:MTF,BW,2006/12/13,LT,,SGA,Sanger,gp120,,6,C,C,NA,,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,PP-5065,23,F,HSX:MTF,BW,2006/12/15,LT,,SGA,Sanger,gp120,,8,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,QA-5099,28,M,HSX:FTM,BW,2007/01/11,LT,,SGA,Sanger,gp120,,13,C,C,NA,,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,QC-5340,22,F,HSX:MTF,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,QD-5355,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V/VI,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,QG-5511,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,QI-5715,27,F,HSX:MTF,BW,2007/07/18,LT,,SGA,Sanger,gp120,,16,C,C,NA,,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,QJ-5768,29,F,HSX:MTF,BW,2007/08/02,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,QM-5849,37,F,HSX:MTF,BW,2007/08/28,LT,,SGA,Sanger,gp120,,7,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,QP-5867,29,M,HSX:FTM,BW,2007/09/03,LT,,SGA,Sanger,gp120,,14,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,QR-5943,26,F,HSX:MTF,BW,2007/09/25,LT,,SGA,Sanger,gp120,,16,C,C,NA,,,,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,QS-6020,26,F,HSX:MTF,BW,2007/10/19,LT,,SGA,Sanger,gp120,,7,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,Y,Within/Between cluster Pwise difference,distance,QT-6024,24,F,HSX:MTF,BW,2007/10/22,LT,,SGA,Sanger,gp120,,21,C,C,NA,,,,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,QU-6029,25,F,HSX:MTF,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V/VI,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,RA-6343,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V/VI,positive,,,,,,,,,,,,
Novitsky,PLoS One 2016 Nov 28;11(11):e0166746. doi: 10.1371/journal.pone.0166746,Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages,2016,Tshedimoso,1,,,Within/Between cluster Pwise difference,distance,RB-6380,,,HSX:unknown,BW,,LT,,SGA,Sanger,gp120,,,C,C,NA,,,,V,positive,,,,,,,,,,,,
Oberle,Retrovirology. 2016; 13(1): 62. Sep 5. doi: 10.1186/s12977-016-0299-0,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.,2016,SHCS/ZPHI,1,,Y,phylo_tp_topol,phylogenetic,Swiss_cohorts_pair2,,F,HSX:MTF,CH,,LT,Plasma,SGA,Sanger,,,27,B,B,1,single,"412,857",,,NA,,,,,,,,,,,,
Oberle,Retrovirology. 2016; 13(1): 62. Sep 5. doi: 10.1186/s12977-016-0299-0,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.,2016,SHCS/ZPHI,1,,Y,phylo_tp_topol,phylogenetic,Swiss_cohorts_pair3,,M,MSM,CH,,LT,Plasma,SGA,Sanger,,,11,B,B,1,single,"14,400",,,NA,,,,,,,,,,,,
Oberle,Retrovirology. 2016; 13(1): 62. Sep 5. doi: 10.1186/s12977-016-0299-0,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.,2016,SHCS/ZPHI,1,,Y,phylo_tp_topol,phylogenetic,Swiss_cohorts_pair4,,F,HSX:MTF,CH,,LT,Plasma,SGA,Sanger,,,10,B,B,1,single,"66,000",,,NA,,,,,,,,,,,,
Oberle,Retrovirology. 2016; 13(1): 62. Sep 5. doi: 10.1186/s12977-016-0299-0,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.,2016,SHCS/ZPHI,1,,Y,phylo_tp_topol,phylogenetic,Swiss_cohorts_pair5,,M,MSM,CH,,LT,Plasma,SGA,Sanger,,,19,B,B,1,single,"373,000",,,NA,,,,,,,,,,,,
Oberle,Retrovirology. 2016; 13(1): 62. Sep 5. doi: 10.1186/s12977-016-0299-0,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.,2016,SHCS/ZPHI,1,,Y,phylo_tp_topol,phylogenetic,Swiss_cohorts_pair6,,F,HSX:MTF,CH,,LT,Plasma,SGA,Sanger,,,18,B,B,2,multiple,"428,000",,,NA,,,,,,,,,,,,
Oberle,Retrovirology. 2016; 13(1): 62. Sep 5. doi: 10.1186/s12977-016-0299-0,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.,2016,SHCS/ZPHI,1,,Y,phylo_tp_topol,phylogenetic,Swiss_cohorts_pair9,,M,MSM,CH,,LT,Plasma,SGA,Sanger,,,8,B,B,1,single,1550,,,NA,,,,,,,,,,,,
Oberle,Retrovirology. 2016; 13(1): 62. Sep 5. doi: 10.1186/s12977-016-0299-0,Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.,2016,SHCS/ZPHI,,,Y,phylo_tp_topol,phylogenetic,Swiss_cohorts_pair1,,M,MSM,CH,,LT,Plasma,SGA,Sanger,,,23,B,B,1,single,"2,325,000",,,NA,,,,,,,,,,,,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0053,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,1,single,2900000,,,NA,,,,33.6,18.3,48.9,,,,,0.14,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0062,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,6,B,B,1,single,450000,,,NA,,,,31,12,49.8,,,,,0.52,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0176,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,11,B,B,1,single,61000,,,NA,,,,88.1,64.6,111.6,,,,,0.18,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0227,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,11,B,B,2,multiple,2400000,,,NA,,,,13,4,21.9,,,,,0.44,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0287,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,4,B,B,1,single,400,,,NA,,,,63.3,30.2,94.5,,,,,0.49,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0309,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,95000,,,NA,,,,7.2,2.8,17.1,,,,,0.84,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0322,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,4700,,,NA,,,,36.2,13.8,58.6,,,,,0.47,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0341,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,7,B,B,1,single,390000,,,NA,,,,18.7,5.2,32.3,,,,,0.17,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0346,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,9,B,B,1,single,390000,,,NA,,,,32.2,16.4,47.9,,,,,0.39,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0364,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,460000,,,NA,,,,57.8,29.5,86.1,,,,,0.04,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0388,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,9,B,B,1,single,350000,,,NA,,,,28.3,1305,43.2,,,,,0.55,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0491,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,5,B,B,3,multiple,2500,,,NA,,,,10.5,1.4,22.4,,,,,0.85,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0524,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,10,B,B,1,single,100000,,,NA,,,,32.7,17.6,47.9,,,,,0.08,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0525,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,12000,,,NA,,,,14.6,0.3,29,,,,,0.55,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0572,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,7300000,,,NA,,,,7.2,2.8,17.1,,,,,0.84,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0648,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,4,B,B,1,single,4600000,,,NA,,,,29.9,7.2,52.6,,,,,0.68,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0717,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,6,B,B,1,single,120000,,,NA,,,,18.1,3.6,32.5,,,,,0.59,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0762,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,9,B,B,1,single,15000,,,NA,,,,62.2,40.4,84.1,,,,,0.43,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0823,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,7,B,B,1,single,670000,,,NA,,,,25.8,9.8,41.8,,,,,0.91,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0839,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,2,multiple,350000,,,NA,,,,65.1,43.9,86.3,,,,,0.18,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0841,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,4,B,B,1,single,69000,,,NA,,,,126.5,79.6,173.4,,,,,0.17,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0879,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,700,,,NA,,,,79,46,112,,,,,0.27,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0897,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,1,single,210000,,,NA,,,,81.1,57.5,104.6,,,,,0.4,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0923,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,8,B,B,1,single,1400000,,,NA,,,,13.4,2.7,24.2,,,,,0.49,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0938,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,9,B,B,1,single,190000,,,NA,,,,82.5,57.4,107.5,,,,,0.13,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-0961,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,2,multiple,250000,,,NA,,,,22,13.2,30.7,,,,,0.99,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1027,,M,MSM,CA,,S,Plasma,SGA,Sanger,gp120,,10,B,B,1,single,150000,,,NA,,,,125.1,95.7,154.4,,,,,0.18,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1046,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,420000,,,NA,,,,14.7,0.3,29.1,,,,,0.55,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1047,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,2300000,,,NA,,,,53.7,26.5,80.9,,,,,0.16,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1055,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,6,B,B,1,single,67000,,,NA,,,,12,0.2,23.8,,,,,0.62,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1174,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,8,B,B,3,multiple,210000,,,NA,,,,34.7,22.6,46.8,,,,,0.05,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1191,,M,MSM,CA,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,86000,,,NA,,,,157.4,110.9,203.9,,,,,0.6,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1211,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,1800000,,,NA,,,,35.5,13.5,57.5,,,,,0.47,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1399,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,5,B,B,4,multiple,97000,,,NA,,,,66.2,36.1,96.4,,,,,0.06,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1400,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,150000,,,NA,,,,57.2,29.2,85.3,,,,,0.49,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1478,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,23000,,,NA,,,,28,14.3,41.7,,,,,0.6,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1500,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,4,B,B,1,single,50000,,,NA,,,,92.4,52.6,132.2,,,,,0.29,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1504,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,13,B,B,5,multiple,58000,,,NA,,,,17.1,7.6,26.7,,,,,0.15,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1512,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,11,B,B,1,single,100000,,,NA,,,,133,103.7,162.4,,,,,0.01,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1518,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,8,B,B,2,multiple,44000,,,NA,,,,33.9,17,50.8,,,,,0.04,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1619,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,2,multiple,48000,,,NA,,,,60.6,40.3,81,,,,,0.02,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1799,,M,MSM,CA,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,4000000,,,NA,,,,10.9,1.4,23.1,,,,,0.36,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1897,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,34000,,,NA,,,,13.1,3.7,22.5,,,,,0.15,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-1926,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,6,B,B,1,single,,,,NA,,,,12.1,0.2,23.9,,,,,0.62,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2136,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,280000,,,NA,,,,28.5,8.8,48.3,,,,,0.19,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2241,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,11,B,B,1,single,130000,,,NA,,,,171.3,138.3,204.3,,,,,<0.0001,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2254,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,6,B,B,1,single,120000,,,NA,,,,134.6,95.2,174,,,,,0.58,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2289,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,81000,,,NA,,,,95.4,58.7,132.1,,,,,0.32,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2305,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,2,multiple,1100000,,,NA,,,,65.8,44.5,87.1,,,,,0.05,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2349,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,4,B,B,1,single,230000,,,NA,,,,73.1,37.3,108.9,,,,,0.26,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2437,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,10,B,B,1,single,190000,,,NA,,,,14.5,4.4,24.5,,,,,0.75,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2495,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,3,B,B,1,single,400,,,NA,,,,12,4.6,28.7,,,,,0.73,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2586,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,6,B,B,1,single,190000,,,NA,,,,187.8,141.1,234.6,,,,,<0.001,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2622,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,28000,,,NA,,,,143.2,98.8,187.6,,,,,0.66,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2649,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,9,B,B,1,single,200000,,,NA,,,,100.5,72.6,128.4,,,,,0.05,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2667,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,21000,,,NA,,,,42.5,18.5,66.6,,,,,0.43,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2696,,M,MSM,US,,S,Plasma,SGA,Sanger,gp120,,6,CRF02_AG,CRF02_AG,1,single,540000,,,NA,,,,30,11,48.6,,,,,0.16,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2717,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,7,B,B,1,single,15000,,,NA,,,,65.1,39.7,90.4,,,,,<0.0001,
Park,AIDS. 2016 Oct 23; 30(16): 2449–2458. 2016 Sep 28. doi: 10.1097/QAD.0000000000001202,Enhancement of viral escape in HIV-1 Nef by STEP vaccination.,2016,HVTN502,1,,Y,SPMM,math_model,502-2794,,M,MSM,PE,,S,Plasma,SGA,Sanger,gp120,,5,B,B,1,single,650000,,,NA,,,,42.9,18.6,67.1,,,,,<0.001,
Salazar-Gonzalez,Pathog Immun. 2016; 1(1): 129–153. Jul 20. doi: 10.20411/pai.v1i1.116,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes.,2016,,1,,,highlighter,haplotype,T8250,,,unknown,US-AL,2012/04/24,S,Plasma,SGA,Sanger,gp160,2557,19,B,B,1,single,"13,400,000",,,NA,6,,,28,20,35,,,,4.684,0.307,
Salazar-Gonzalez,Pathog Immun. 2016; 1(1): 129–153. Jul 20. doi: 10.20411/pai.v1i1.116,Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes.,2016,,1,,,highlighter,haplotype,N8261,,,unknown,US-AL,2012/05/17,S,Plasma,SGA,Sanger,gp160,2560,12,B,B,1,single,"22,450,000",,,NA,4,,,19,9,30,,,,1.167,0.856,
Song,Sci Rep. 2016 Dec 2;6:38130. doi: 10.1038/srep38130.,Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences,2016,CHAVI001,,,Y,poisson_gof,math_model,CH0200/703010200,,M,HSX:FTM,MW,,NFLG,Plasma,SGA,Sanger,,,45,C,C,2,multiple,,,I/II,positive,,,,,,,,,,,,
Song,Sci Rep. 2016 Dec 2;6:38130. doi: 10.1038/srep38130.,Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences,2016,CHAVI001,,,Y,poisson_gof,math_model,CH0228/703010228,,M,HSX:FTM,MW,,NFLG,Plasma,SGA,Sanger,,,20,C,C,2,multiple,,,III,negative,,,,,,,,,,,,
Song,Sci Rep. 2016 Dec 2;6:38130. doi: 10.1038/srep38130.,Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences,2016,CHAVI001,,,Y,poisson_gof,math_model,CH0078/705010078,,M,HSX:FTM,ZA,,NFLG,Plasma,SGA,Sanger,,,47,C,C,1,single,,,I/II,positive,,,,,,,,,,,,
Song,Sci Rep. 2016 Dec 2;6:38130. doi: 10.1038/srep38130.,Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences,2016,CHAVI001,,,Y,poisson_gof,math_model,CH0047/702010047,,M,HSX:FTM,MW,,NFLG,Plasma,SGA,Sanger,,,18,C,C,2,multiple,,,III,negative,,,,,,,,,,,,
Song,Sci Rep. 2016 Dec 2;6:38130. doi: 10.1038/srep38130.,Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences,2016,CHAVI001,,,Y,poisson_gof,math_model,CH0010/703010010,,M,HSX:FTM,MW,,NFLG,Plasma,SGA,Sanger,,,34,C,C,2,multiple,,,I/II,positive,,,,,,,,,,,,
Song,Sci Rep. 2016 Dec 2;6:38130. doi: 10.1038/srep38130.,Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences,2016,CHAVI001,,,Y,poisson_gof,math_model,CH1754/703011754,,M,HSX:FTM,MW,,NFLG,Plasma,SGA,Sanger,,,180,C,C,5,multiple,,,III,negative,,,,,,,,,,,,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,119534,,M,MSM,US-MA,1998,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,750000,389,V,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,135466,,M,MSM,US-MA,2001,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,588278,395,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,136172,,M,MSM,DE-BE,2009,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,433000,292,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,143200,,M,MSM,US-MA,2012,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,22300000,597,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,147984,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,401000,549,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,154162,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,2300000,429,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,159793,,M,MSM,DE-BE,2009,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,5100000,241,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,172508,,M,MSM,DE-BE,2009,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,4700000,192,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,176952,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,2430,764,IV,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,231603,,M,MSM,US-MA,2012,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,276504,805,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,255524,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,5700000,409,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,268977,,M,MSM,US-MA,2004,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,41000000,510,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,284160,,M,MSM,US-MA,1999,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,63700,399,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,290307,,M,MSM,DE-BE,2010,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,1400000,459,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,293050,,M,MSM,US-MA,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,1000001,554,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,296004,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,1600000,272,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,320435,,M,MSM,DE-BE,2010,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,6000000,377,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,328659,,M,MSM,US-MA,2002,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,5240000,307,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,328893,,M,MSM,DE-BE,2012,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,325000,211,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,361974,,M,MSM,US-MA,2011,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,2360000,576,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,366396,,,PWID,DE-BE,2013,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,10000000,175,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,383086,,M,MSM,US-MA,2012,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,804,861,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,394242,,M,MSM,US-MA,1998,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,1490000,413,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,395718,,M,MSM,US-MA,1997,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,8180000,551,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,433768,,,HSX:unknown,US-MA,1998,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,22100,549,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,464704,,M,MSM,DE-BE,2010,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,6800000,269,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,479693,,M,MSM,US-MA,2011,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,79700,477,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,481216,,M,MSM,US-MA,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,1000001,310,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,481811,,M,MSM,US-MA,2011,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,570000,292,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,489910,,M,MSM,US-MA,1999,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,500001,383,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,494131,,M,MSM,US-MA,2002,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,750001,435,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,509452,,M,MSM,US-MA,2005,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,244000,240,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,556743,,M,MSM,DE-BE,2010,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,1100000,203,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,571373,,M,MSM,DE-BE,2010,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,1,single,698000,552,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,574194,,M,MSM,US-MA,2003,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,2,multiple,14600000,350,V,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,585067,,M,MSM,DE-BE,2009,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,23300,432,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,587196,,M,MSM,DE-BE,2010,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,6400000,552,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,607523,,M,MSM,US-MA,2012,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,2112618,227,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,608647,,M,MSM,US-MA,2012,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,49500000,522,IV,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,635056,,M,MSM,DE-BE,2012,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,1000000,181,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,637829,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,9800000,373,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,654207,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,2,multiple,15000,622,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,678584,,M,MSM,US-MA,2012,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,66700,701,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,689801,,M,MSM,US-MA,2006,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,245000,595,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,702865,,M,MSM,US-MA,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,2,multiple,761000,582,IV,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,822582,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,2100000,283,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,848017,,,NOSO,US-MA,2002,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,475000,677,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,862898,,M,MSM,US-MA,2013,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,241777,541,V,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,863847,,M,MSM,DE-BE,2010,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,687000,972,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,868558,,M,MSM,US-MA,1999,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,252000,546,IV,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,880955,,M,MSM,US-MA,2001,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,38200000,602,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,882283,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,2,multiple,10000000,635,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,891439,,M,MSM,US-MA,2007,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,846000,314,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,891675,,M,MSM,DE-BE,2011,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,123000,420,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,906153,,M,MSM,DE-BE,2007,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,3800000,724,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,912218,,M,MSM,DE-BE,2004,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,750100,345,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,923040,,M,MSM,DE-BE,2009,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,3900000,283,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,929172,,M,MSM,US-MA,2000,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,547000,468,V,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,933384,,M,MSM,US-MA,2003,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,5000000,322,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,947915,,M,MSM,DE-BE,2013,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,3320000,426,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,950965,,M,MSM,US-MA,2011,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,706000,395,IV,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,954229,,M,MSM,DE-BE,2008,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,1700000,312,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,956306,,M,MSM,DE-BE,2012,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,664000,386,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,963987,,M,MSM,DE-BE,2004,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,2300000,448,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,981600,,M,MSM,US-MA,2003,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,123000,993,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,996401,,,HSX:unknown,US-MA,2002,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,7300000,364,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,1006_08,,,unknown,US-NC,1997,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,120000,NA,III,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,1012_09,,,unknown,US-CA,1997,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,370000,NA,III,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,1018_10,,,unknown,US-SC,1997,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,270000,NA,III,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,1051_11,,,unknown,US-SC,1997,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,180000,NA,II,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,1053_06,,,unknown,US-SC,1997,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,130000,NA,I,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,1059_09,,,unknown,US-CA,1998,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,B,B,NA,,500000,NA,III,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,poisson_gof,math_model,571373,,M,MSM,DE-BE,2010,S,Plasma,SGA,Roche 454,gp160,,NGS,B,B,1,single,698000,552,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,poisson_gof,math_model,654207,,M,MSM,DE-BE,2008,S,Plasma,SGA,Roche 454,gp160,,NGS,B,B,2,multiple,15000,622,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,poisson_gof,math_model,882283,,M,MSM,DE-BE,2008,S,Plasma,SGA,Roche 454,gp160,,NGS,B,B,2,multiple,10000000,635,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,poisson_gof,math_model,702865,,M,MSM,US-MA,2008,S,Plasma,SGA,Roche 454,gp160,,NGS,B,B,2,multiple,761000,582,IV,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,poisson_gof,math_model,574194,,M,MSM,US-MA,2003,S,Plasma,SGA,Roche 454,gp160,,NGS,B,B,2,multiple,14600000,350,V,positive,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,poisson_gof,math_model,1051_11,,,unknown,US-SC,1997,S,Plasma,SGA,Roche 454,gp160,,NGS,B,B,NA,,180000,NA,II,negative,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,622166,,M,MSM,DE-BE,2010,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,C,C,NA,,1500000,344,II/III,NA,,,,-,-,-,-,-,-,-,-,
Tully,PLoS Pathog. 2016 May 12(5): e1005619. https://doi.org/10.1371/journal.ppat.1005619,Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus,2016,,1,,,dist_hamming,distance,701114,,M,MSM,DE-BE,2009,S,Plasma,Nested RT-PCR,Roche 454,WG,,NGS,CRF02_AG,CRF02_AG,NA,,3000000,263,II/III,NA,,,,-,-,-,-,-,-,-,-,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX03,,M,MSM,CN-BJ,2007/05/22,S,Plasma,SGA,Sanger,gp160,,25,B,B,1,single,2150000,,I/II,negative,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX04,,M,MSM,CN-BJ,2007/06/27,S,Plasma,SGA,Sanger,gp160,,24,B,B,1,single,17560,,VI,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX06,,M,MSM,CN-BJ,2007/07/16,S,Plasma,SGA,Sanger,gp160,,22,B,B,1,single,498947,,IV,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX07,,M,MSM,CN-BJ,2007/07/26,S,Plasma,SGA,Sanger,gp160,,6,B,B,2,multiple,1558,,V,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX14,,M,MSM,CN-BJ,2007/05/09,S,Plasma,SGA,Sanger,gp160,,22,B,B,1,single,2480000,,V,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX20,,M,MSM,CN-BJ,2007/10/17,S,Plasma,SGA,Sanger,gp160,,26,B,B,1,single,64700,,I/II,negative,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX22,,M,MSM,CN-BJ,2007/05/11,S,Plasma,SGA,Sanger,gp160,,20,B,B,1,single,322000,,IV,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX35,,M,MSM,CN-BJ,2008/02/26,S,Plasma,SGA,Sanger,gp160,,17,B,B,1,single,11600,,I/II,negative,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX47,,M,MSM,CN-BJ,2008/06/24,S,Plasma,SGA,Sanger,gp160,,23,B,B,1,single,4480,,V,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX05,,M,MSM,CN-BJ,2007/06/19,S,Plasma,SGA,Sanger,gp160,,17,CRF01_AE,CRF01_AE,1,single,30211,,I/II,negative,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX09,,M,MSM,CN-BJ,2007/06/08,S,Plasma,SGA,Sanger,gp160,,16,CRF01_AE,CRF01_AE,1,single,77600,,IV,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX10,,M,MSM,CN-BJ,2007/03/08,S,Plasma,SGA,Sanger,gp160,,26,CRF01_AE,CRF01_AE,1,single,19300,,I/II,negative,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX12,,M,MSM,CN-BJ,2007/08/16,S,Plasma,SGA,Sanger,gp160,,17,CRF01_AE,CRF01_AE,1,single,3330,,V,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX15,,M,MSM,CN-BJ,2007/09/27,S,Plasma,SGA,Sanger,gp160,,23,CRF01_AE,CRF01_AE,1,single,1180000,,I/II,negative,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX21,,M,MSM,CN-BJ,2007/01/11,S,Plasma,SGA,Sanger,gp160,,15,CRF01_AE,CRF01_AE,1,single,14100,,VI,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX23,,M,MSM,CN-BJ,2007/08/11,S,Plasma,SGA,Sanger,gp160,,21,CRF01_AE,CRF01_AE,1,single,4380000,,IV,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX25,,M,MSM,CN-BJ,2007/12/11,S,Plasma,SGA,Sanger,gp160,,23,CRF01_AE,CRF01_AE,2,multiple,1740000,,I/II,negative,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX28,,M,MSM,CN-BJ,2007/07/12,S,Plasma,SGA,Sanger,gp160,,22,CRF01_AE,CRF01_AE,3,multiple,70200,,I/II,negative,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX11,,M,MSM,CN-BJ,2007/08/08,S,Plasma,SGA,Sanger,gp160,,18,CRF07_BC,CRF07_BC,2,multiple,11900,,V,positive,,,,,,,,,,,,
Chen,J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):403-12. doi:10.1097/QAI.0000000000000649,Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.,2015,Beijing You'an,,,,highlighter,haplotype,BJOX19,,M,MSM,CN-BJ,2007/10/16,S,Plasma,SGA,Sanger,gp160,,18,CRF07_BC,CRF07_BC,1,single,330000,,I/II,negative,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,1,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,multiple,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,3,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,single,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,4,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,single,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,10,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,single,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,11,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,single,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,12,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,single,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,14,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,single,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,15,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,single,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,18,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,single,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,19,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,single,,,,infant,,,,,,,,,,,,
Danaviah,PLoS One. 2015 Mar 20;10(3):e0120389.doi: 10.1371/journal.pone.0120389,Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission,2015,VTS,1,,,BEAST topology + TMRCA,phylogenetic,21,,INF,MTCT:PN,ZA-ZKN,,S,DBS,PCR,Sanger,gp120,,,C,C,NA,multiple,,,,infant,,,,,,,,,,,,
Deymier,PLoS Pathog. 2015 Sep 17;11(9):e1005154. doi: 10.1371/journal.ppat.1005154.,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance,2015,ZEHRP,,,Y,phylo_recip_topol,phylogenetic,ZM331,,M,HSX:FTM,ZM,2009/04/18,S,Plasma,SGA,Sanger,NFLG,9021,9,C,C,1,single,2864668,,II,negative,,,,,,,,,,,,
Deymier,PLoS Pathog. 2015 Sep 17;11(9):e1005154. doi: 10.1371/journal.ppat.1005154.,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance,2015,ZEHRP,,,Y,phylo_recip_topol,phylogenetic,ZM3618,,M,HSX:FTM,ZM,2009/06/18,S,Plasma,SGA,Sanger,NFLG,9021,8,C,C,1,single,16600000,,II,negative,,,,,,,,,,,,
Deymier,PLoS Pathog. 2015 Sep 17;11(9):e1005154. doi: 10.1371/journal.ppat.1005154.,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance,2015,ZEHRP,,,Y,phylo_recip_topol,phylogenetic,ZM3678,,M,HSX:FTM,ZM,2009/09/17,S,Plasma,SGA,Sanger,NFLG,9021,8,C,C,1,single,3017616,,II,negative,,,,,,,,,,,,
Deymier,PLoS Pathog. 2015 Sep 17;11(9):e1005154. doi: 10.1371/journal.ppat.1005154.,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance,2015,ZEHRP,,,Y,phylo_recip_topol,phylogenetic,ZM4248,,M,HSX:FTM,ZM,2010/06/04,S,Plasma,SGA,Sanger,NFLG,9021,6,C,C,1,single,24993584,,II,negative,,,,,,,,,,,,
Deymier,PLoS Pathog. 2015 Sep 17;11(9):e1005154. doi: 10.1371/journal.ppat.1005154.,Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance,2015,ZEHRP,,,Y,phylo_recip_topol,phylogenetic,ZM4473,,M,HSX:FTM,ZM,2011/06/07,S,Plasma,SGA,Sanger,NFLG,9021,9,C,C,1,single,16891328,,II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS1–0703,54,M,HSX:FTM,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,15,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS1–0919,58,M,HSX:FTM,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,16,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS2–0016,28,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,14,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS2–0174,33,M,HSX:FTM,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,16,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS2–0341,53,M,HSX:FTM,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,12,C,C,2,multiple,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS2–0358,34,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,16,C,C,2,multiple,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS2–0483,27,M,HSX:FTM,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,14,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS2–0802,42,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,14,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS2–1037,43,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,14,C,C,2,multiple,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS21–187,27,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,15,C,C,2,multiple,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS3–0268,21,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,14,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS3–0369,28,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,14,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS3–0458,25,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,14,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS3–0513,25,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,15,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS3–0759,21,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,14,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS3–0767,38,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,13,C,C,2,multiple,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS3–0942,28,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,12,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS33–182,22,M,HSX:FTM,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,12,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS5–0710,16,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,12,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,,,,phylo_recip_topol,phylogenetic,AS5–0968,22,M,HSX:FTM,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,15,C,C,2,multiple,,,I/II,negative,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,1,,,phylo_recip_topol,phylogenetic,AS1–0876,29,F,HSX:MTF,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,15,C,C,1,single,,,?,NA,,,,,,,,,,,,
Gounder,PLoS One. 2015; 10(3): 2015 Mar 17. doi: 10.1371/journal.pone.0119886,High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection,2015,HPP,1,,,phylo_recip_topol,phylogenetic,AS2–0945,26,M,HSX:FTM,ZA-KZN,,LT,Plasma,nested RT-PCR,Sanger,gag,,16,C,C,1,single,,,?,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0762,,M,MSM,US,,S,,SGA,Sanger,gp120,,20,B,B,1,single,15000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0823,,M,MSM,US,,S,,SGA,Sanger,gp120,,7,B,B,1,single,670000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0839,,M,MSM,US,,S,,SGA,Sanger,gp120,,19,B,B,1,single,350000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0841,,M,MSM,PE,,S,,SGA,Sanger,gp120,,4,B,B,1,single,69000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0879,,M,MSM,US,,S,,SGA,Sanger,gp120,,10,B,B,1,single,700,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0897,,M,MSM,US,,S,,SGA,Sanger,gp120,,20,B,B,1,single,210000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0923,,M,MSM,US,,S,,SGA,Sanger,gp120,,8,B,B,1,single,1400000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0938,,M,MSM,US,,S,,SGA,Sanger,gp120,,14,B,B,1,single,190000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0961,,M,MSM,US,,S,,SGA,Sanger,gp120,,22,B,B,1,single,250000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-0965,,M,MSM,US,,S,,SGA,Sanger,gp120,,6,B,B,1,single,180000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-1027,,M,MSM,CA,,S,,SGA,Sanger,gp120,,10,B,B,1,single,150000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-1046,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,1,single,420000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-1047,,M,MSM,PE,,S,,SGA,Sanger,gp120,,5,B,B,1,single,2300000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-1055,,M,MSM,US,,S,,SGA,Sanger,gp120,,6,B,B,1,single,67000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-1191,,M,MSM,CA,,S,,SGA,Sanger,gp120,,5,B,B,1,single,86000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-1211,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,1,single,1800000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-1368,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,1,single,9900,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,,,Y,pwise_dist_gtr,distance,502-1399,,M,MSM,PE,,S,,SGA,Sanger,gp120,,5,B,B,1,single,97000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA002,25,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,19,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA003,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,25,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA004,21,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA005,24,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,16,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA006,25,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,19,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA009,18,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA012,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,22,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA013,29,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,5,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA014,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,16,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA015,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,9,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA016,24,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA017,21,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,7,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA018,21,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA019,30,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA021,24,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,22,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA022,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA023,21,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,22,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA024,20,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA027,22,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA028,28,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,5,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA029,22,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA031,20,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,9,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA032,25,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,5,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA034,20,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,7,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA035,30,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,18,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA036,28,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA037,24,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA038,22,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,6,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA041,22,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,21,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA042,23,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,23,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA048,24,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,25,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA049,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,17,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA050,23,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,6,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA051,23,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA052,20,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,5,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA054,20,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,5,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA055,20,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,5,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA056,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,3,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA057,26,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA058,30,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA059,30,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA060,22,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA061,23,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA062,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,13,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA063,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA064,29,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,5,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA065,28,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,23,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA066,20,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,14,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA067,22,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA068,24,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA069,19,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA070,28,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,13,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA072,28,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA073,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,14,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA074,24,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,12,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA075,22,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA076,27,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA077,25,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,13,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA078,23,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA079,24,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,7,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA080,20,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,22,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA081,26,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,19,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA082,25,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA083,24,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,21,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA085,28,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA086,20,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,21,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA088,26,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,12,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA089,20,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,5,CRF01_AE,CRF01_AE,1,single,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA091,21,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,21,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA092,25,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,28,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA094,21,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,27,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA097,28,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,21,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA098,27,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA099,20,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,8,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA100,23,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,23,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA101,18,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,22,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA102,20,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,10,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA103,22,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,21,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA104,27,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,23,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA105,29,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA106,30,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,8,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA107,24,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,9,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA108,20,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,6,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA109,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA110,21,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,12,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA111,21,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA112,25,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,8,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA113,21,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA116,29,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,22,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA117,19,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,24,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA118,25,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,20,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA119,23,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,14,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA121,24,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,23,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA122,25,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,15,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA123,26,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,18,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA125,21,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,19,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA126,28,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,16,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA127,23,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,5,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA129,22,F,HSX:MTF,TH,,S,,SGA,Sanger,gp120,,13,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,RV144,,,,pwise_dist_gtr,distance,AA130,28,M,HSX:FTM,TH,,S,,SGA,Sanger,gp120,,11,CRF01_AE,CRF01_AE,2,multiple,,,,negative,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0053,,M,MSM,US,,S,,SGA,Sanger,gp120,,10,B,B,1,single,2900000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0062,,M,MSM,US,,S,,SGA,Sanger,gp120,,6,B,B,1,single,450000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0176,,M,MSM,US,,S,,SGA,Sanger,gp120,,14,B,B,1,single,61000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0223,,M,MSM,US,,S,,SGA,Sanger,gp120,,1,B,B,1,single,700,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0227,,M,MSM,US,,S,,SGA,Sanger,gp120,,14,B,B,1,single,2400000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0287,,M,MSM,US,,S,,SGA,Sanger,gp120,,9,B,B,1,single,400,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0309,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,1,single,95000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0322,,M,MSM,US,,S,,SGA,Sanger,gp120,,8,B,B,1,single,4700,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0341,,M,MSM,US,,S,,SGA,Sanger,gp120,,7,B,B,1,single,390000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0346,,M,MSM,US,,S,,SGA,Sanger,gp120,,16,B,B,1,single,390000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0364,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,1,single,460000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0388,,M,MSM,US,,S,,SGA,Sanger,gp120,,14,B,B,1,single,350000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0491,,M,MSM,PE,,S,,SGA,Sanger,gp120,,4,B,B,1,single,2500,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0524,,M,MSM,PE,,S,,SGA,Sanger,gp120,,10,B,B,1,single,100000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0525,,M,MSM,PE,,S,,SGA,Sanger,gp120,,5,B,B,1,single,12000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0572,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,1,single,7300000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0648,,M,MSM,PE,,S,,SGA,Sanger,gp120,,4,B,B,1,single,4600000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-0717,,M,MSM,US,,S,,SGA,Sanger,gp120,,10,B,B,1,single,120000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1400,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,1,single,150000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1478,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,1,single,23000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1500,,M,MSM,US,,S,,SGA,Sanger,gp120,,7,B,B,1,single,50000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1504,,M,MSM,US,,S,,SGA,Sanger,gp120,,18,B,B,1,single,58000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1512,,M,MSM,US,,S,,SGA,Sanger,gp120,,21,B,B,1,single,100000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1518,,M,MSM,US,,S,,SGA,Sanger,gp120,,20,B,B,1,single,44000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1619,,M,MSM,US,,S,,SGA,Sanger,gp120,,10,B,B,1,single,48000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1709,,M,MSM,US,,S,,SGA,Sanger,gp120,,11,B,B,1,single,250000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1799,,M,MSM,CA,,S,,SGA,Sanger,gp120,,5,B,B,1,single,4000000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1897,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,1,single,34000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-1926,,M,MSM,US,,S,,SGA,Sanger,gp120,,13,B,B,1,single,,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2000,,M,MSM,US,,S,,SGA,Sanger,gp120,,19,B,B,2,multiple,240000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2008,,M,MSM,US,,S,,SGA,Sanger,gp120,,10,B,B,2,multiple,,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2136,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,2,multiple,280000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2241,,M,MSM,US,,S,,SGA,Sanger,gp120,,22,B,B,2,multiple,130000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2254,,M,MSM,PE,,S,,SGA,Sanger,gp120,,6,B,B,2,multiple,120000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2289,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,2,multiple,81000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2305,,M,MSM,US,,S,,SGA,Sanger,gp120,,24,B,B,2,multiple,1100000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2349,,M,MSM,PE,,S,,SGA,Sanger,gp120,,4,B,B,2,multiple,230000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2437,,M,MSM,US,,S,,SGA,Sanger,gp120,,22,B,B,2,multiple,190000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2495,,M,MSM,US,,S,,SGA,Sanger,gp120,,3,B,B,2,multiple,400,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2586,,M,MSM,US,,S,,SGA,Sanger,gp120,,14,B,B,2,multiple,190000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2622,,M,MSM,PE,,S,,SGA,Sanger,gp120,,5,B,B,2,multiple,28000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2649,,M,MSM,PE,,S,,SGA,Sanger,gp120,,9,B,B,2,multiple,200000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2667,,M,MSM,US,,S,,SGA,Sanger,gp120,,5,B,B,2,multiple,21000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2717,,M,MSM,PE,,S,,SGA,Sanger,gp120,,13,B,B,2,multiple,15000,,,NA,,,,,,,,,,,,
Janes,Nat Med. 2015 Oct; 21(10): 1139–1141. 2015 Aug 31. doi: 10.1038/nm.3932,HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders,2015,HVTN502,1,,Y,pwise_dist_gtr,distance,502-2794,,M,MSM,PE,,S,,SGA,Sanger,gp120,,5,B,B,2,multiple,650000,,,NA,,,,,,,,,,,,
Le,Sci Rep. 2015; 5: 17607. Dec 3. doi: 10.1038/srep17607,Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR532/32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction.,2015,VIDUS,1,,,phylo_tp_asr_topol,phylogenetic,VIDUS_1,,,PWID,CA-BC,,LT,PMBC,nested RT-PCR,Roche 454,gp120,,NGS,B,B,1,single,,,,NA,,,,,,,,,,,,
Le,Sci Rep. 2015; 5: 17607. Dec 3. doi: 10.1038/srep17607,Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR532/32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction.,2015,VIDUS,1,,,phylo_tp_asr_topol,phylogenetic,VIDUS_2,,,PWID,CA-BC,,LT,PMBC,nested RT-PCR,Roche 454,gp120,,NGS,B,B,1,single,,,,NA,,,,,,,,,,,,
Zanini,eLife. 2015; 4: e11282. doi: 10.7554/eLife.11282,Population genomics of intrapatient HIV-1 evolution,2015,,,,,divergence,distance,p1,,F,HSX:MTF,SE,1996/11/08,LT,Plasma,One-step PCR,Illumina MiSeq,WG,,NGS,CRF01_AE,CRF01_AE,1,single,<500,537,VI,positive,,,,,,,,,,,,
Zanini,eLife. 2015; 4: e11282. doi: 10.7554/eLife.11282,Population genomics of intrapatient HIV-1 evolution,2015,,,,,divergence,distance,p2,,M,MSM,SE,2002/10/10,LT,Plasma,One-step PCR,Illumina MiSeq,WG,,NGS,B,B,1,single,31100,1185,V,positive,,,,,,,,,,,,
Zanini,eLife. 2015; 4: e11282. doi: 10.7554/eLife.11282,Population genomics of intrapatient HIV-1 evolution,2015,,,,,divergence,distance,p3,,M,MSM,SE,2000/01/27,LT,Plasma,One-step PCR,Illumina MiSeq,WG,,NGS,B,B,2,multiple,17300,694,VI,positive,,,,,,,,,,,,
Zanini,eLife. 2015; 4: e11282. doi: 10.7554/eLife.11282,Population genomics of intrapatient HIV-1 evolution,2015,,,,,divergence,distance,p5,,M,MSM,SE,2020/04/23,LT,Plasma,One-step PCR,Illumina MiSeq,WG,,NGS,B,B,1,single,<50,521,VI,positive,,,,,,,,,,,,
Zanini,eLife. 2015; 4: e11282. doi: 10.7554/eLife.11282,Population genomics of intrapatient HIV-1 evolution,2015,,,,,divergence,distance,p8,,M,MSM,SE,1998/07/15,LT,Plasma,One-step PCR,Illumina MiSeq,WG,,NGS,B,B,1,single,2900,460,V,positive,,,,,,,,,,,,
Zanini,eLife. 2015; 4: e11282. doi: 10.7554/eLife.11282,Population genomics of intrapatient HIV-1 evolution,2015,,,,,divergence,distance,p9,,M,MSM,SE,1997/03/10,LT,Plasma,One-step PCR,Illumina MiSeq,WG,,NGS,B,B,1,single,2300,720,VI,positive,,,,,,,,,,,,
Zanini,eLife. 2015; 4: e11282. doi: 10.7554/eLife.11282,Population genomics of intrapatient HIV-1 evolution,2015,,,,,divergence,distance,p10,,M,MSM,SE,1990/07/24,LT,Plasma,One-step PCR,Illumina MiSeq,WG,,NGS,B,B,2,multiple,594000,420,II,negative,,,,,,,,,,,,
Zanini,eLife. 2015; 4: e11282. doi: 10.7554/eLife.11282,Population genomics of intrapatient HIV-1 evolution,2015,,,,,divergence,distance,p11,,M,MSM,SE,2001/04/19,LT,Plasma,One-step PCR,Illumina MiSeq,WG,,NGS,B,B,1,single,12700,850,VI,positive,,,,,,,,,,,,
Zanini,eLife. 2015; 4: e11282. doi: 10.7554/eLife.11282,Population genomics of intrapatient HIV-1 evolution,2015,,,,,divergence,distance,p6,,M,HSX:FTM,SE,2002/11/26,LT,Plasma,One-step PCR,Illumina MiSeq,WG,,NGS,C,C,1,single,6800,480,IV,positive,,,,,,,,,,,,
Chaillon,PLoS One. 2014 Apr 9;9(4):e90421. doi: 10.1371/journal.pone.0090421,Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model,2014,PHPT-1,,,,BEAST topologies,phylogenetic,779,,INF,MTCT:IP,TH,,LT,plasma,PCR,sanger,gp120,,15,CRF01_AE,CRF01_AE,NA,single,,,,infant,,,,,,,,,,,,
Chaillon,PLoS One. 2014 Apr 9;9(4):e90421. doi: 10.1371/journal.pone.0090421,Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model,2014,PHPT-1,,,,BEAST topologies,phylogenetic,858,,INF,MTCT:IU,TH,,LT,plasma,PCR,sanger,gp120,,12,CRF01_AE,CRF01_AE,NA,single,,,,infant,,,,,,,,,,,,
Chaillon,PLoS One. 2014 Apr 9;9(4):e90421. doi: 10.1371/journal.pone.0090421,Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model,2014,PHPT-1,,,,BEAST topologies,phylogenetic,939,,INF,MTCT:IP,TH,,LT,plasma,PCR,sanger,gp120,,6,CRF01_AE,CRF01_AE,NA,multiple,,,,infant,,,,,,,,,,,,
Chaillon,PLoS One. 2014 Apr 9;9(4):e90421. doi: 10.1371/journal.pone.0090421,Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model,2014,PHPT-1,,,,BEAST topologies,phylogenetic,1005,,INF,MTCT:IU,TH,,LT,plasma,PCR,sanger,gp120,,32,CRF01_AE,CRF01_AE,NA,single,,,,infant,,,,,,,,,,,,
Chaillon,PLoS One. 2014 Apr 9;9(4):e90421. doi: 10.1371/journal.pone.0090421,Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model,2014,PHPT-1,,,,BEAST topologies,phylogenetic,1021,,INF,MTCT:IP,TH,,LT,plasma,PCR,sanger,gp120,,6,CRF01_AE,CRF01_AE,NA,single,,,,infant,,,,,,,,,,,,
Chaillon,PLoS One. 2014 Apr 9;9(4):e90421. doi: 10.1371/journal.pone.0090421,Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model,2014,PHPT-1,,,,BEAST topologies,phylogenetic,1110,,INF,MTCT:IU,TH,,LT,plasma,PCR,sanger,gp120,,6,CRF01_AE,CRF01_AE,NA,single,,,,infant,,,,,,,,,,,,
Chaillon,PLoS One. 2014 Apr 9;9(4):e90421. doi: 10.1371/journal.pone.0090421,Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model,2014,PHPT-1,,,,BEAST topologies,phylogenetic,1333,,INF,MTCT:IP,TH,,LT,plasma,PCR,sanger,gp120,,11,CRF01_AE,CRF01_AE,NA,single,,,,infant,,,,,,,,,,,,
Chaillon,PLoS One. 2014 Apr 9;9(4):e90421. doi: 10.1371/journal.pone.0090421,Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model,2014,PHPT-1,,,,BEAST topologies,phylogenetic,1391,,INF,MTCT:IP,TH,,LT,plasma,PCR,sanger,gp120,,11,CRF01_AE,CRF01_AE,NA,single,,,,infant,,,,,,,,,,,,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3141,44,M,PWID,TH,,S,Plasma,SGA,Sanger,gp41,,21,B,B,1,single,,,V,positive,6,,NO,88,64,112,,,,,0.5605,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3181,21,M,PWID,TH,,S,Plasma,SGA,Sanger,gp41,,21,B,B,1,single,,,VI,positive,8,,NO,165,132,198,,,,,<0.05,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3003,31,M,PWID,TH,,S,Plasma,SGA,Sanger,gp41,,17,B,B,1,single,,,IV,positive,6,,NO,122,74,167,,,,,0.6465,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3045,40,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,27,B,B,2,multiple,,,II,negative,6,,NO,31,23,39,,,,,0.8627,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3059,21,M,PWID,TH,,S,Plasma,SGA,Sanger,gp41,,12,B,B,2,multiple,,,V,positive,3,,NO,72,40,103,,,,,0.7054,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3007,20,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,31,CRF01_AE,CRF01_AE,3,multiple,,,V,positive,9,,NO,66,52,80,,,,,0.2493,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3017,53,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,32,CRF01_AE,CRF01_AE,2,multiple,,,V,positive,5,,NO,36,29,43,,,,,0.2222,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3022,40,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,31,CRF01_AE,CRF01_AE,1,single,,,II,negative,5,,NO,24,17,31,,,,,0.932,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3025,26,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,20,CRF01_AE,CRF01_AE,1,single,,,II,negative,8,,NO,58,47,70,,,,,0.5484,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3046,26,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,31,CRF01_AE,CRF01_AE,1,single,,,II,negative,5,,NO,20,12,27,,,,,0.8122,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3090,44,F,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,32,CRF01_AE,CRF01_AE,3,multiple,,,II,negative,4,,NO,15,9,21,,,,,0.7863,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3098,23,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,32,CRF01_AE,CRF01_AE,1,single,,,V,positive,13,,NO,117,108,126,,,,,<0.05,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3112,23,F,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,20,CRF01_AE,CRF01_AE,3,multiple,,,II,negative,3,,NO,17,11,22,,,,,0.3381,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3126,21,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,33,CRF01_AE,CRF01_AE,1,single,,,II,negative,7,,NO,28,20,37,,,,,0.7006,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3127,27,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,31,CRF01_AE,CRF01_AE,5,multiple,,,VI,positive,4,,NO,28,14,43,,,,,0.753,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3139,28,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,26,CRF01_AE,CRF01_AE,1,single,,,V,positive,13,,NO,113,99,127,,,,,<0.05,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3155,24,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,19,CRF01_AE,CRF01_AE,1,single,,,VI,positive,15,,NO,99,78,121,,,,,0.2258,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3202,24,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,30,CRF01_AE,CRF01_AE,1,single,,,V,positive,7,,NO,34,25,43,,,,,0.9077,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3210,24,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,22,CRF01_AE,CRF01_AE,2,multiple,,,II,negative,4,,NO,48,28,68,,,,,0.7774,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3220,21,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,30,CRF01_AE,CRF01_AE,1,single,,,V,positive,11,,NO,94,84,104,,,,,0.1754,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3002,21,F,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,24,CRF01_AE,CRF01_AE,2,multiple,,,IV,positive,11,,NO,90,75,104,,,,,<0.05,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3019,4,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,30,CRF01_AE,CRF01_AE,2,multiple,,,II,negative,5,,NO,31,22,40,,,,,0.8201,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3041,21,M,PWID,TH,,S,Plasma,SGA,Sanger,gp41,,18,CRF01_AE,CRF01_AE,1,single,,,V,positive,4,,NO,56,37,73,,,,,0.3018,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3043,29,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,30,CRF01_AE,CRF01_AE,1,single,,,V,positive,5,,NO,18,12,24,,,,,0.9438,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3054,22,M,PWID,TH,,S,Plasma,SGA,Sanger,gp41,,41,CRF01_AE,CRF01_AE,1,single,,,VI,positive,6,,NO,53,39,68,,,,,0.9008,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3063,30,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,22,CRF01_AE,CRF01_AE,1,single,,,V,positive,6,,NO,38,28,49,,,,,0.9514,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3067,32,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,23,CRF01_AE,CRF01_AE,1,single,,,V,positive,13,,NO,112,95,129,,,,,0.4794,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3078,27,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,20,CRF01_AE,CRF01_AE,1,single,,,II,negative,3,,NO,11,6,17,,,,,0.8695,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3084,26,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,33,CRF01_AE,CRF01_AE,1,single,,,V,positive,10,,NO,76,66,86,,,,,0.5447,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3104,25,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,23,CRF01_AE,CRF01_AE,3,multiple,,,V,positive,>15,,NO,na,,,,,,,na,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3110,31,M,PWID,TH,,S,Plasma,SGA,Sanger,gp41,,22,CRF01_AE,CRF01_AE,1,single,,,V,positive,3,,NO,101,71,130,,,,,0.7583,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3111,22,F,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,21,CRF01_AE,CRF01_AE,1,single,,,II,negative,4,,NO,30,21,39,,,,,0.2906,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3118,20,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,23,CRF01_AE,CRF01_AE,1,single,,,IV,positive,11,,NO,84,70,98,,,,,0.1104,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3131,26,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,30,CRF01_AE,CRF01_AE,1,single,,,V,positive,11,,NO,87,76,99,,,,,0.4296,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3135,21,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,30,CRF01_AE,CRF01_AE,1,single,,,V,positive,8,,NO,49,39,59,,,,,0.9266,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3151,21,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,21,CRF01_AE,CRF01_AE,2,multiple,,,V,positive,13,,NO,81,50,113,,,,,0.3031,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3152,21,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,35,CRF01_AE,CRF01_AE,1,single,,,V,positive,10,,NO,53,44,63,,,,,0.9472,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3153,23,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,34,CRF01_AE,CRF01_AE,1,single,,,V,positive,4,,NO,22,16,28,,,,,0.3139,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3162,26,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,21,CRF01_AE,CRF01_AE,1,single,,,V,positive,9,,NO,57,44,70,,,,,0.2576,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3184,44,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,30,CRF01_AE,CRF01_AE,1,single,,,VI,positive,10,,NO,91,79,104,,,,,0.06063,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3186,20,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,21,CRF01_AE,CRF01_AE,1,single,,,II,negative,2,,NO,8,1,8,,,,,0.6605,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3189,24,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,22,CRF01_AE,CRF01_AE,3,multiple,,,VI,positive,>15,,NO,na,,,,,,,na,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3192,26,M,PWID,TH,,S,Plasma,SGA,Sanger,gp41,,22,CRF01_AE,CRF01_AE,1,single,,,V,positive,4,,NO,62,44,81,,,,,0.5475,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3193,31,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,23,CRF01_AE,CRF01_AE,1,single,,,V,positive,6,,NO,41,31,50,,,,,0.3764,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3203,21,F,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,20,CRF01_AE,CRF01_AE,1,single,,,VI,positive,11,,NO,83,68,92,,,,,<0.05,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3212,49,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,23,CRF01_AE,CRF01_AE,1,single,,,IV,positive,8,,NO,67,58,76,,,,,0.5592,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3218,35,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,30,CRF01_AE,CRF01_AE,1,single,,,V,positive,15,,NO,94,77,110,,,,,<0.05,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3219,26,F,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,22,CRF01_AE,CRF01_AE,1,single,,,VI,positive,6,,NO,59,51,67,,,,,0.143,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3156,38,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,31,"CRF01_AE, B",recombinant,2,multiple,,,VI,positive,10,,NO,70,Phylo-Bootstrap Clusters,82,,,,,<0.05,
Sterrett,Open Forum Infect Dis. 2014 Sep; 1(2): ofu056. doi: 10.1093/ofid/ofu056,Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users,2014,VAX003,,,Y,"poisson_both, highlighter, phylo_recip_topol",pooled,3147,23,M,PWID,TH,,S,Plasma,SGA,Sanger,gp160,,31,CRF15_01B,CRF15_01B,2,multiple,,,VI,positive,9,,NO,61,46,76,,,,,<0.05,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_1,,M,MSM,US-CA,,LT,plasma,PCR,Roche 454,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_2,,M,MSM,US-CA,,LT,plasma,PCR,Roche 455,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_3,,M,MSM,US-CA,,LT,plasma,PCR,Roche 456,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_4,,M,MSM,US-CA,,LT,plasma,PCR,Roche 457,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_5,,M,MSM,US-CA,,LT,plasma,PCR,Roche 458,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_6,,M,MSM,US-CA,,LT,plasma,PCR,Roche 459,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_7,,M,MSM,US-CA,,LT,plasma,PCR,Roche 460,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_8,,M,MSM,US-CA,,LT,plasma,PCR,Roche 461,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_9,,M,MSM,US-CA,,LT,plasma,PCR,Roche 462,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_10,,M,MSM,US-CA,,LT,plasma,PCR,Roche 463,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_11,,M,MSM,US-CA,,LT,plasma,PCR,Roche 464,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_12,,M,MSM,US-CA,,LT,plasma,PCR,Roche 465,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_13,,M,MSM,US-CA,,LT,plasma,PCR,Roche 466,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_14,,M,MSM,US-CA,,LT,plasma,PCR,Roche 467,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_15,,M,MSM,US-CA,,LT,plasma,PCR,Roche 468,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_16,,M,MSM,US-CA,,LT,plasma,PCR,Roche 469,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_17,,M,MSM,US-CA,,LT,plasma,PCR,Roche 470,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_18,,M,MSM,US-CA,,LT,plasma,PCR,Roche 471,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_19,,M,MSM,US-CA,,LT,plasma,PCR,Roche 472,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_20,,M,MSM,US-CA,,LT,plasma,PCR,Roche 473,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_21,,M,MSM,US-CA,,LT,plasma,PCR,Roche 474,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_22,,M,MSM,US-CA,,LT,plasma,PCR,Roche 475,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_23,,M,MSM,US-CA,,LT,plasma,PCR,Roche 476,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_24,,M,MSM,US-CA,,LT,plasma,PCR,Roche 477,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_25,,M,MSM,US-CA,,LT,plasma,PCR,Roche 478,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_26,,M,MSM,US-CA,,LT,plasma,PCR,Roche 479,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_27,,M,MSM,US-CA,,LT,plasma,PCR,Roche 480,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_28,,M,MSM,US-CA,,LT,plasma,PCR,Roche 481,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_29,,M,MSM,US-CA,,LT,plasma,PCR,Roche 482,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_30,,M,MSM,US-CA,,LT,plasma,PCR,Roche 483,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_31,,M,MSM,US-CA,,LT,plasma,PCR,Roche 484,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_32,,M,MSM,US-CA,,LT,plasma,PCR,Roche 485,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_33,,M,MSM,US-CA,,LT,plasma,PCR,Roche 486,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_34,,M,MSM,US-CA,,LT,plasma,PCR,Roche 487,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_35,,M,MSM,US-CA,,LT,plasma,PCR,Roche 488,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_36,,M,MSM,US-CA,,LT,plasma,PCR,Roche 489,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_37,,M,MSM,US-CA,,LT,plasma,PCR,Roche 490,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_38,,M,MSM,US-CA,,LT,plasma,PCR,Roche 491,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_39,,M,MSM,US-CA,,LT,plasma,PCR,Roche 492,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_40,,M,MSM,US-CA,,LT,plasma,PCR,Roche 493,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_41,,M,MSM,US-CA,,LT,plasma,PCR,Roche 494,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_42,,M,MSM,US-CA,,LT,plasma,PCR,Roche 495,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_43,,M,MSM,US-CA,,LT,plasma,PCR,Roche 496,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_44,,M,MSM,US-CA,,LT,plasma,PCR,Roche 497,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_45,,M,MSM,US-CA,,LT,plasma,PCR,Roche 498,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_46,,M,MSM,US-CA,,LT,plasma,PCR,Roche 499,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_47,,M,MSM,US-CA,,LT,plasma,PCR,Roche 500,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_48,,M,MSM,US-CA,,LT,plasma,PCR,Roche 501,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_49,,M,MSM,US-CA,,LT,plasma,PCR,Roche 502,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_50,,M,MSM,US-CA,,LT,plasma,PCR,Roche 503,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_51,,M,MSM,US-CA,,LT,plasma,PCR,Roche 504,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_52,,M,MSM,US-CA,,LT,plasma,PCR,Roche 505,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_53,,M,MSM,US-CA,,LT,plasma,PCR,Roche 506,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_54,,M,MSM,US-CA,,LT,plasma,PCR,Roche 507,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_55,,M,MSM,US-CA,,LT,plasma,PCR,Roche 508,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_56,,M,MSM,US-CA,,LT,plasma,PCR,Roche 509,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_57,,M,MSM,US-CA,,LT,plasma,PCR,Roche 510,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_58,,M,MSM,US-CA,,LT,plasma,PCR,Roche 511,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_59,,M,MSM,US-CA,,LT,plasma,PCR,Roche 512,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_60,,M,MSM,US-CA,,LT,plasma,PCR,Roche 513,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_61,,M,MSM,US-CA,,LT,plasma,PCR,Roche 514,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_62,,M,MSM,US-CA,,LT,plasma,PCR,Roche 515,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_63,,M,MSM,US-CA,,LT,plasma,PCR,Roche 516,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_64,,M,MSM,US-CA,,LT,plasma,PCR,Roche 517,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_65,,M,MSM,US-CA,,LT,plasma,PCR,Roche 518,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_66,,M,MSM,US-CA,,LT,plasma,PCR,Roche 519,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_67,,M,MSM,US-CA,,LT,plasma,PCR,Roche 520,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_68,,M,MSM,US-CA,,LT,plasma,PCR,Roche 521,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_69,,M,MSM,US-CA,,LT,plasma,PCR,Roche 522,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_70,,M,MSM,US-CA,,LT,plasma,PCR,Roche 523,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_71,,M,MSM,US-CA,,LT,plasma,PCR,Roche 524,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_72,,M,MSM,US-CA,,LT,plasma,PCR,Roche 525,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_73,,M,MSM,US-CA,,LT,plasma,PCR,Roche 526,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_74,,M,MSM,US-CA,,LT,plasma,PCR,Roche 527,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_75,,M,MSM,US-CA,,LT,plasma,PCR,Roche 528,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_76,,M,MSM,US-CA,,LT,plasma,PCR,Roche 529,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_77,,M,MSM,US-CA,,LT,plasma,PCR,Roche 530,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_78,,M,MSM,US-CA,,LT,plasma,PCR,Roche 531,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_79,,M,MSM,US-CA,,LT,plasma,PCR,Roche 532,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_80,,M,MSM,US-CA,,LT,plasma,PCR,Roche 533,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_81,,M,MSM,US-CA,,LT,plasma,PCR,Roche 534,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_82,,M,MSM,US-CA,,LT,plasma,PCR,Roche 535,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_83,,M,MSM,US-CA,,LT,plasma,PCR,Roche 536,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_84,,M,MSM,US-CA,,LT,plasma,PCR,Roche 537,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_85,,M,MSM,US-CA,,LT,plasma,PCR,Roche 538,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_86,,M,MSM,US-CA,,LT,plasma,PCR,Roche 539,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_87,,M,MSM,US-CA,,LT,plasma,PCR,Roche 540,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_88,,M,MSM,US-CA,,LT,plasma,PCR,Roche 541,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_89,,M,MSM,US-CA,,LT,plasma,PCR,Roche 542,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_90,,M,MSM,US-CA,,LT,plasma,PCR,Roche 543,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_91,,M,MSM,US-CA,,LT,plasma,PCR,Roche 544,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_92,,M,MSM,US-CA,,LT,plasma,PCR,Roche 545,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_93,,M,MSM,US-CA,,LT,plasma,PCR,Roche 546,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_94,,M,MSM,US-CA,,LT,plasma,PCR,Roche 547,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_95,,M,MSM,US-CA,,LT,plasma,PCR,Roche 548,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_96,,M,MSM,US-CA,,LT,plasma,PCR,Roche 549,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_97,,M,MSM,US-CA,,LT,plasma,PCR,Roche 550,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_98,,M,MSM,US-CA,,LT,plasma,PCR,Roche 551,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_99,,F,PWID,US-CA,,LT,plasma,PCR,Roche 552,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_100,,F,PWID,US-CA,,LT,plasma,PCR,Roche 553,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_101,,F,PWID,US-CA,,LT,plasma,PCR,Roche 554,NFLG,,NGS,B,B,NA,single,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_102,,M,MSM,US-CA,,LT,plasma,PCR,Roche 555,NFLG,,NGS,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_103,,M,MSM,US-CA,,LT,plasma,PCR,Roche 556,NFLG,,NGS,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_104,,M,MSM,US-CA,,LT,plasma,PCR,Roche 557,NFLG,,NGS,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_105,,M,MSM,US-CA,,LT,plasma,PCR,Roche 558,NFLG,,NGS,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_106,,M,MSM,US-CA,,LT,plasma,PCR,Roche 559,NFLG,,NGS,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_107,,M,MSM,US-CA,,LT,plasma,PCR,Roche 560,NFLG,,NGS,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Wagner,J Infect Dis. 2014 Apr 1;209(7):1032-8.doi: 10.1093/infdis/jit633,Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States,2014,SDPIC,1,,,,phylogenetic,Wagner_108,,M,MSM,US-CA,,LT,plasma,PCR,Roche 561,NFLG,,NGS,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,PSF,,,,highlighter,haplotype,R463F,,F,HSX:MTF,RW,,LT,PBMC,SGA,Sanger,NFLG,,20,A1,A,1,single,150000000,,IV,positive,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,PSF,,,,highlighter,haplotype,R880F,,F,HSX:MTF,RW,,LT,PBMC,SGA,Sanger,NFLG,,22,A1,A,1,single,430843,,III,positive,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,191084,,F,HSX:MTF,UG,,LT,Plasma,SGA,Sanger,NFLG,,21,A1,A,2,multiple,34600,,IV,positive,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,191845,,F,HSX:MTF,UG,,LT,Plasma,SGA,Sanger,NFLG,,26,A1,A,1,single,31200,,IV,positive,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,9004SS,,F,HSX:MTF,UG,,LT,Plasma,SGA,Sanger,NFLG,,24,A1,A,1,single,29921,,IV,positive,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,191947,,F,HSX:MTF,UG,,LT,Plasma,SGA,Sanger,NFLG,,28,A1/D,recombinant,1,single,5466,,I,negative,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,191982,,F,HSX:MTF,UG,,LT,Plasma,SGA,Sanger,NFLG,,30,A1/D,recombinant,1,single,7156,,I,negative,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,190049,,F,HSX:MTF,UG,,LT,Plasma,SGA,Sanger,NFLG,,43,D,D,1,single,38266666,,I,negative,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,191647,,M,HSX:FTM,UG,,LT,Plasma,SGA,Sanger,NFLG,,28,D,D,1,single,242222,,I,negative,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,191727,,F,HSX:MTF,UG,,LT,Plasma,SGA,Sanger,NFLG,,82,D,D,3,multiple,15200,,IV,positive,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,191859,,F,HSX:MTF,UG,,LT,Plasma,SGA,Sanger,NFLG,,33,D,D,1,single,53334,,I,negative,,,,,,,,,,,,
Baalwa,Virology. 2013 Feb 5; 436(1): 33–48. doi: 10.1016/j.virol.2012.10.009,"Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones",2013,,,,,highlighter,haplotype,191882,,M,HSX:FTM,UG,,LT,Plasma,SGA,Sanger,NFLG,,35,D,D,1,single,15378,,I,negative,,,,,,,,,,,,
Frange,PLoS One. 2013; 8(7): e69144. Published online 2013 Jul 9. doi: 10.1371/journal.pone.0069144,Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner,2013,ANRS PRIMO,,,Y,phylo_tp_topol,phylogenetic,FRANGE_1,38,M,HSX:FTM,FR,2002/02/12,LT,plasma,SGA,Sanger,gp120,640,43,B,B,1,single,851138,,,positive,,0.11,NO,,,,,,,,,
Frange,PLoS One. 2013; 8(7): e69144. Published online 2013 Jul 9. doi: 10.1371/journal.pone.0069144,Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner,2013,ANRS PRIMO,,,Y,phylo_tp_topol,phylogenetic,FRANGE_2,28,M,MSM,FR,1998/03/25,LT,plasma,SGA,Sanger,gp120,646,25,B,B,1,single,50119,,,positive,,0.33,NO,,,,,,,,,
Frange,PLoS One. 2013; 8(7): e69144. Published online 2013 Jul 9. doi: 10.1371/journal.pone.0069144,Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner,2013,ANRS PRIMO,,,Y,phylo_tp_topol,phylogenetic,FRANGE_3,36,F,HSX:MTF,FR,1999/01/02,LT,plasma,SGA,Sanger,gp120,610,26,B,B,1,single,27542,,,positive,,0.11,NO,,,,,,,,,
Frange,PLoS One. 2013; 8(7): e69144. Published online 2013 Jul 9. doi: 10.1371/journal.pone.0069144,Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner,2013,ANRS PRIMO,,,Y,phylo_tp_topol,phylogenetic,FRANGE_4,21,M,MSM,FR,2000/06/26,LT,plasma,SGA,Sanger,gp120,611,33,B,B,1,single,331131,,,positive,,0.17,NO,,,,,,,,,
Frange,PLoS One. 2013; 8(7): e69144. Published online 2013 Jul 9. doi: 10.1371/journal.pone.0069144,Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner,2013,ANRS PRIMO,,,Y,phylo_tp_topol,phylogenetic,FRANGE_5,28,F,HSX:MTF,FR,1999/03/01,LT,plasma,SGA,Sanger,gp120,628,30,B,B,1,single,1174898,,,positive,,0.21,NO,,,,,,,,,
Frange,PLoS One. 2013; 8(7): e69144. Published online 2013 Jul 9. doi: 10.1371/journal.pone.0069144,Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner,2013,ANRS PRIMO,,,Y,phylo_tp_topol,phylogenetic,FRANGE_6,39,M,MSM,FR,2007/04/18,LT,plasma,SGA,Sanger,gp120,625,27,B,B,1,single,10233,,,positive,,0.16,NO,,,,,,,,,
Frange,PLoS One. 2013; 8(7): e69144. Published online 2013 Jul 9. doi: 10.1371/journal.pone.0069144,Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner,2013,ANRS PRIMO,,,Y,phylo_tp_topol,phylogenetic,FRANGE_7,29,M,MSM,FR,1999/06/16,LT,plasma,SGA,Sanger,gp120,635,19,B,B,1,single,67608,,,positive,,0.14,NO,,,,,,,,,
Frange,PLoS One. 2013; 8(7): e69144. Published online 2013 Jul 9. doi: 10.1371/journal.pone.0069144,Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner,2013,ANRS PRIMO,,,Y,phylo_tp_topol,phylogenetic,FRANGE_8,19,F,HSX:MTF,FR,2008/10/24,LT,plasma,SGA,Sanger,gp120,363,31,B,B,1,single,41687,,,positive,,0.18,NO,,,,,,,,,
Henn,PLoS Pathog. 2012 Mar; 8(3): e1002529. Mar 8. doi: 10.1371/journal.ppat.1002529,Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection,2012,,,,,Codon diversity,distance,9213,,INF,unknown,,,LT,Plasma,RT-PCR,Roche 454,WG,,NGS,B,B,1,single,9300000,,II,negative,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,7,50,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,18,A1,A,1,single,5012,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,86,30,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,5,A1,A,1,single,15849,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,107,34,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,33,A1,A,1,single,199526,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,177,28,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,62,A1,A,1,single,79433,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,178,53,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,24,A1,A,1,single,10000,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,190,40,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,16,A1,A,1,single,200,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,204,38,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,41,A1,A,1,single,1585,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,209,22,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,37,A1,A,1,single,12589,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,355,25,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,41,A1,A,1,single,15849,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,404,29,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,30,A1,A,1,single,1585,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,405,29,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,17,A1,A,1,single,1585,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,491,37,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,53,A1,A,1,single,39811,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,697,30,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,32,A1,A,1,single,10000,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,794,23,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,41,A1,A,1,single,63096,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,807,22,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,41,A1,A,1,single,25119,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,905,45,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,28,A1,A,1,single,31623,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,909,26,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,1140,55,A1,A,1,single,501187,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,945,31,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,35,A1,A,1,single,25119,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,46,21,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,28,A1,A,2,multiple,125893,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,65,32,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,39,A1,A,2,multiple,79433,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,168,30,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,41,A1,A,2,multiple,398107,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,237,40,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,40,A1,A,2,multiple,316228,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,245,29,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,28,A1,A,2,multiple,251189,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,620,35,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,38,A1,A,2,multiple,125893,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,740,30,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,18,A1,A,2,multiple,1995262,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,27,41,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,24,C,C,1,single,1000000,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,63,35,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,10,C,C,1,single,199526,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,66,36,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,32,C,C,1,single,15849,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,80,28,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,32,C,C,1,single,1585,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,276,22,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,40,C,C,1,single,31623,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,321,27,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,28,C,C,1,single,19953,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,497,22,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,31,C,C,1,single,63096,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,498,28,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,14,C,C,1,single,79433,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,558,35,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,29,C,C,1,single,316228,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,603,46,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,40,C,C,1,single,100000,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,838,26,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,45,C,C,1,single,15849,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,968,38,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,48,C,C,1,single,251189,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,171,38,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,25,C,C,2,multiple,100000,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,201,24,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,38,C,C,2,multiple,501,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,291,22,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,47,C,C,2,multiple,125893,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,530,23,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,27,D,D,1,single,10000,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,733,37,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,1095,43,D,D,1,single,199526,,,positive,,,,,,,,,,,,
Kiwelu,PLoS One. 2012; 7(10): e47605. doi: 10.1371/journal.pone.0047605.,HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies,2012,Moshi,,,,phylo_recip_topol,phylogenetic,871,32,F,HSX:MTF,TZ-09,,LT,PBMC,SGA,Sanger,gp120,,13,D,D,1,single,316,,,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,A-1811,31,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,19,C,C,2,multiple,1230269,,II,negative,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,B-2865,20,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,71,C,C,1,single,549541,,II,negative,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,C-3312,32,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,92,C,C,1,single,3630781,,II,negative,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,D-5018,27,M,HSX:FTM,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,77,C,C,2,multiple,2089296,,II,negative,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,E-3430,35,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,33,C,C,1,single,239883,,II,negative,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,F-3505,53,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,49,C,C,1,single,371535,,II,negative,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,G-3603,34,M,HSX:FTM,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,46,C,C,1,single,575440,,II,negative,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,H-5582,26,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,32,C,C,1,single,151356,,II,negative,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,OC-2381,25,M,HSX:FTM,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,41,C,C,1,single,120226,,IV,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,OG-2604,23,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,21,C,C,2,multiple,2951209,,V,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,,phylo_recip_topol,phylogenetic,OI-3354,30,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,27,C,C,1,single,6166,,IV,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,,phylo_recip_topol,phylogenetic,OK-2767,26,M,HSX:FTM,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,27,C,C,1,single,81283,,VI,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,,phylo_recip_topol,phylogenetic,ON-2870,36,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,5,C,C,1,single,398,,VI,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,,phylo_recip_topol,phylogenetic,OP-2927,26,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,22,C,C,1,single,47863,,VI,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,,phylo_recip_topol,phylogenetic,OS-3079,42,M,HSX:FTM,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,20,C,C,1,single,1514,,V,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,,phylo_recip_topol,phylogenetic,PD-3505,25,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,5,C,C,1,single,33113,,V,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,,phylo_recip_topol,phylogenetic,QC-5340,22,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,3,C,C,1,single,7244,,V,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,QR-5943,26,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,23,C,C,1,single,398,,IV,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,Y,phylo_recip_topol,phylogenetic,QT-6024,24,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,32,C,C,1,single,77625,,V,positive,,,,,,,,,,,,
Rossenkhan,PLoS One. 2012; 7(5): e35491. 2012 May 9. doi: 10.1371/journal.pone.0035491,"Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection",2012,Tshedimoso,,,,phylo_recip_topol,phylogenetic,QU-6029,25,F,HSX:MTF,BW,,LT,Plasma,SGA,Sanger,vif-rev1,,27,C,C,1,single,263027,,V-VI,positive,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,3002,0.4,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,46,C,C,2,multiple,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,3006,2.9,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,25,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,3009,1.4,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,43,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,3017,0.4,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,34,C,C,2,multiple,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,3032,0.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,39,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,3036,0.5,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,35,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,3037,0.7,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,34,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,3040,1.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,34,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4001,1.8,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,35,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4002,1.8,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,42,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4004,2.8,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,34,C,C,2,multiple,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4007,1.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,38,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4008,1.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,41,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4009,1.2,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,31,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4013,0.5,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,37,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4014,1.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,41,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4015,1.8,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,34,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4016,0.8,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,37,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4017,2.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,37,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4026,1.1,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,44,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4027,2.9,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,39,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4028,1.4,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,43,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4029,0.8,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,41,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4030,1.4,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,39,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4031,2.2,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,37,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4032,2.7,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,43,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4034,1.8,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,39,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4036,1,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,35,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4037,1,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,41,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4038,1.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,38,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4039,0.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,16,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4041,0.4,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,33,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4045,1.7,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,45,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4046,1.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,40,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4048,1.5,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,41,C,C,2,multiple,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4049,1.5,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,38,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4050,1.9,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,38,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4055,0.8,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,33,C,C,2,multiple,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4056,1.8,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,34,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4058,1.7,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,38,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4059,2.3,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,46,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4060,1,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,33,C,C,1,single,,,,infant,,,,,,,,,,,,
Sturdevant,PLoS Pathog. 2012 Dec; 8(12): e1003094 2012 Dec 27. doi: 10.1371/journal.ppat.1003094,Central Nervous System Compartmentalization of HIV-1 Subtype C Variants Early and Late in Infection in Young Children,2012,,,,Y,"BEAST TMRCA, Highlighter",pooled,4061,1.6,INF,MTCT:unknown,MW,,S,Plasma & CSF,SGA,Sanger,gp160,,36,C,C,1,single,,,,infant,,,,,,,,,,,,
Boeras,Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46): E1156–E1163. Nov 7. doi: 10.1073/pnas.1103764108,Role of donor genital tract HIV-1 diversity in the transmission bottleneck,2011,PSF,1,,Y,phylo_tp_asr_topol,phylogenetic,RW56F,,F,HSX:MTF,RW,,S,PBMC,SGA,Sanger,gp160,,40,A1,A,1,single,693,,,NA,,,,,,,,,,,,
Boeras,Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46): E1156–E1163. Nov 7. doi: 10.1073/pnas.1103764108,Role of donor genital tract HIV-1 diversity in the transmission bottleneck,2011,PSF,1,,Y,phylo_tp_asr_topol,phylogenetic,RW36M,,M,HSX:FTM,RW,,S,PBMC,SGA,Sanger,gp160,,41,A1,A,1,single,113510,,,NA,,,,,,,,,,,,
Boeras,Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46): E1156–E1163. Nov 7. doi: 10.1073/pnas.1103764108,Role of donor genital tract HIV-1 diversity in the transmission bottleneck,2011,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM292M,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gp160,,39,A1,A,1,single,129545,,II,negative,,,,,,,,,,,,
Boeras,Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46): E1156–E1163. Nov 7. doi: 10.1073/pnas.1103764108,Role of donor genital tract HIV-1 diversity in the transmission bottleneck,2011,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM201M,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gp120,,46,C,C,1,single,750000,,III/IV,positive,,,,,,,,,,,,
Boeras,Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46): E1156–E1163. Nov 7. doi: 10.1073/pnas.1103764108,Role of donor genital tract HIV-1 diversity in the transmission bottleneck,2011,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM216M,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gp160,,59,C,C,1,single,750000,,III/IV,positive,,,,,,,,,,,,
Boeras,Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46): E1156–E1163. Nov 7. doi: 10.1073/pnas.1103764108,Role of donor genital tract HIV-1 diversity in the transmission bottleneck,2011,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM221M,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gp160,,73,C,C,1,single,750000,,III/IV,positive,,,,,,,,,,,,
Boeras,Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46): E1156–E1163. Nov 7. doi: 10.1073/pnas.1103764108,Role of donor genital tract HIV-1 diversity in the transmission bottleneck,2011,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM238M,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gp120,,39,C,C,1,single,90791,,III/IV,positive,,,,,,,,,,,,
Boeras,Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46): E1156–E1163. Nov 7. doi: 10.1073/pnas.1103764108,Role of donor genital tract HIV-1 diversity in the transmission bottleneck,2011,ZEHRP,,,Y,phylo_tp_asr_topol,phylogenetic,ZM242F,,F,HSX:MTF,ZM,,S,,SGA,Sanger,gp120,,31,C,C,1,single,2974,,III/IV,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Buenos Aires MSM,,,,highlighter,haplotype,AR145477,,M,MSM,AR,,S,PBMC,SGA,Sanger,gp120,,11,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Buenos Aires MSM,,,,highlighter,haplotype,AR151263,,M,MSM,AR,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Buenos Aires MSM,,,,highlighter,haplotype,AR101815,,M,MSM,AR,,S,PBMC,SGA,Sanger,gp120,,5,B,B,2,multiple,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Buenos Aires MSM,,,,highlighter,haplotype,AR134742,,M,MSM,AR,,S,PBMC,SGA,Sanger,gp120,,14,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Buenos Aires MSM,,,,highlighter,haplotype,AR137681,,M,MSM,AR,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Buenos Aires MSM,,,,highlighter,haplotype,AR138910,,M,MSM,AR,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Buenos Aires MSM,,,,highlighter,haplotype,AR142467,,M,MSM,AR,,S,PBMC,SGA,Sanger,gp120,,11,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Buenos Aires MSM,,,,highlighter,haplotype,AR159687,,M,MSM,AR,,S,PBMC,SGA,Sanger,gp120,,10,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC05.QH0020,,M,HSX:FTM,TT,,S,PBMC,SGA,Sanger,gp120,,19,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC11.QH0053,,F,HSX:MTF,TT,,S,PBMC,SGA,Sanger,gp120,,7,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC20.QH0121,,M,HSX:FTM,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC22.QH0126,,F,HSX:MTF,TT,,S,PBMC,SGA,Sanger,gp120,,15,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC24.QH0532,,M,HSX:FTM,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC25.QH0535,,NA,HSX:unknown,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC31.QH0605,,F,HSX:MTF,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC33.QH0704,,M,HSX:FTM,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,2,multiple,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC34.QH0705,,M,HSX:FTM,TT,,S,PBMC,SGA,Sanger,gp120,,12,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC35.QH0712,,NA,HSX:unknown,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC41.QH0776,,NA,HSX:unknown,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC42.QH0791,,M,HSX:FTM,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,2,multiple,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC45.QH0865,,M,HSX:FTM,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,CHAVI:T&T,,,,highlighter,haplotype,SC47.QH0944,,M,HSX:FTM,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,2,multiple,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Trinidad STD Clinic,,,,highlighter,haplotype,TT27.DUK42010,,NA,HSX:unknown,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,2,multiple,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Trinidad STD Clinic,,,,highlighter,haplotype,TT28.DUK42011,,NA,HSX:unknown,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Trinidad STD Clinic,,,,highlighter,haplotype,TT31.DUK42043,,NA,HSX:unknown,TT,,S,PBMC,SGA,Sanger,gp120,,20,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Trinidad STD Clinic,,,,highlighter,haplotype,TT34.DUK42067,,NA,HSX:unknown,TT,,S,PBMC,SGA,Sanger,gp120,,13,B,B,1,single,,,,positive,,,,,,,,,,,,
Collins-Fairclough,PLoS One. 2011;6(6):e19995. doi: 10.1371/journal.pone.0019995.,Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad,2011,Trinidad STD Clinic,,,,highlighter,haplotype,TT37.DUK42118,,NA,HSX:unknown,TT,,S,PBMC,SGA,Sanger,gp120,,8,B,B,3,multiple,,,,positive,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_1,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_2,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_3,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_4,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_5,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_6,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_7,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_8,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_9,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_10,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_11,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_12,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_13,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_14,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_15,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_16,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_17,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_18,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_19,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_20,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_21,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_22,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_23,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_24,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_25,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_26,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_27,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_28,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,multiple,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_29,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,multiple,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_30,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,multiple,,,,negative,,,,,,,,,,,,
Cornelissen,Retrovirology. 2011; 8(Suppl 2): P14. doi: 10.1186/1742-4690-8-S2-P14,HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection,2011,Primo-SHM,1,,,phylogenetic topologies,phylogenetic,Cornelissen_31,,M,MSM,NL,,S,plasma,PCR,sanger,gp120,,NA,B,B,NA,multiple,,,,negative,,,,,,,,,,,,
Herbeck,J Virol. 2011 Aug; 85(15): 7523–7534. doi: 10.1128/JVI.02697-10,Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes,2011,WPIC,1,,,pwise_dist_hky,distance,R1/PIC87014,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,"9,217",,B,B,1,single,,,I,negative,,,,,,,,,,,,
Herbeck,J Virol. 2011 Aug; 85(15): 7523–7534. doi: 10.1128/JVI.02697-10,Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes,2011,WPIC,,,,pwise_dist_hky,distance,T2/PIC88403,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,"9,104",10,B,B,1,single,"290,040",,V,positive,,,,,,,,,,,,
Herbeck,J Virol. 2011 Aug; 85(15): 7523–7534. doi: 10.1128/JVI.02697-10,Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes,2011,WPIC,,,Y,pwise_dist_hky,distance,R2/PIC38051,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,"9,107",18,B,B,1,single,"620,820",,I,negative,,,,,,,,,,,,
Herbeck,J Virol. 2011 Aug; 85(15): 7523–7534. doi: 10.1128/JVI.02697-10,Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes,2011,WPIC,,,Y,pwise_dist_hky,distance,R3/PIC38417,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,"9,030",93,B,B,1,single,"472,810",,V,positive,,,,,,,,,,,,
Herbeck,J Virol. 2011 Aug; 85(15): 7523–7534. doi: 10.1128/JVI.02697-10,Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes,2011,WPIC,,,,pwise_dist_hky,distance,T4/PIC55751,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,"9,147",19,B,B,1,single,"40,600",,V,positive,,,,,,,,,,,,
Herbeck,J Virol. 2011 Aug; 85(15): 7523–7534. doi: 10.1128/JVI.02697-10,Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes,2011,WPIC,,,Y,pwise_dist_hky,distance,R4/PIC11286,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,"9,098",30,B,B,2,multiple,"2,804,000",,V,positive,,,,,,,,,,,,
Herbeck,J Virol. 2011 Aug; 85(15): 7523–7534. doi: 10.1128/JVI.02697-10,Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes,2011,WPIC,,,,pwise_dist_hky,distance,S1/PIC71101,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,"9,096",75,B,B,1,single,"377,060",,I,negative,,,,,,,,,,,,
Herbeck,J Virol. 2011 Aug; 85(15): 7523–7534. doi: 10.1128/JVI.02697-10,Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes,2011,WPIC,,,,pwise_dist_hky,distance,S2/PIC83747,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,"9,110",113,B,B,1,single,923,,I,negative,,,,,,,,,,,,
Herbeck,J Virol. 2011 Aug; 85(15): 7523–7534. doi: 10.1128/JVI.02697-10,Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes,2011,WPIC,,,,pwise_dist_hky,distance,S3/PIC90770,,M,MSM,US-WA,,LT,PBMC,SGA,Sanger,WG,"9,057",68,B,B,1,single,"469,830",,I,negative,,,,,,,,,,,,
Kishko,Retrovirology. 2011; 8: 67. Aug 15. doi: 10.1186/1742-4690-8-67,Genotypic and functional properties of early infant HIV-1 envelopes,2011,,,,,phylo_tp_topol,phylogenetic,P1189,,INF,MTCT:IP,USA,,S,Plasma,SGA,Sanger,gp160,,10,B,B,1,single,,,,infant,,,,,,,,,,,,
Kishko,Retrovirology. 2011; 8: 67. Aug 15. doi: 10.1186/1742-4690-8-67,Genotypic and functional properties of early infant HIV-1 envelopes,2011,,,,,phylo_tp_topol,phylogenetic,P1031,,INF,MTCT:IP,USA,,S,Plasma,SGA,Sanger,gp160,,11,B,B,2,multiple,,,,infant,,,,,,,,,,,,
Kishko,Retrovirology. 2011; 8: 67. Aug 15. doi: 10.1186/1742-4690-8-67,Genotypic and functional properties of early infant HIV-1 envelopes,2011,,,,,phylo_tp_topol,phylogenetic,P1024,,INF,MTCT:IP,USA,,S,Plasma,SGA,Sanger,gp160,,11,B,B,>2,multiple,,,,infant,,,,,,,,,,,,
Kishko,Retrovirology. 2011; 8: 67. Aug 15. doi: 10.1186/1742-4690-8-67,Genotypic and functional properties of early infant HIV-1 envelopes,2011,,,,,phylo_tp_topol,phylogenetic,P1046,,INF,MTCT:IP,USA,,S,Plasma,SGA,Sanger,gp160,,22,B,B,1,single,,,,infant,,,,,,,,,,,,
Kishko,Retrovirology. 2011; 8: 67. Aug 15. doi: 10.1186/1742-4690-8-67,Genotypic and functional properties of early infant HIV-1 envelopes,2011,,,,,phylo_tp_topol,phylogenetic,P1049,,INF,MTCT:IP,USA,,S,Plasma,SGA,Sanger,gp160,,10,B,B,1,single,,,,infant,,,,,,,,,,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,1,,,highlighter,haplotype,398-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,7,A,A,1,single,2370,,-,NA,,,,,,,185,88,354,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,1,,,highlighter,haplotype,401-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,6,C/D,recombinant,1,single,51500,,-,NA,,,,,,,25,9,73,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,216-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,8,A,A,1,single,>750001,,VI,positive,,,,,,,0,0,0,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,515-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,5,A,A,1,single,3660,,VI,positive,,,,,,,48,17,127,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,605-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,9,A/C,recombinant,1,single,434000,,V/VI,positive,,,,,,,48,28,84,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,246-F3,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,18,A/C,recombinant,1,single,439000,,VI,positive,,,,,,,62,36,91,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,477-F3,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,11,A/C,recombinant,1,single,406000,,VI,positive,,,,,,,324,188,523,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,49-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,11,A/C/D,recombinant,1,single,>750001,,III,positive,,,,,,,8,1,22,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,532-F0,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,9,A/D,recombinant,2,multiple,>750001,,I/II,negative,,,,,,,1953,762,4314,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,234-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,12,C,C,1,single,509000,,V/VI,positive,,,,,,,14,3,32,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,390-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,11,C,C,1,single,>750001,,V,positive,,,,,,,24,10,57,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,304-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,11,C,C,1,single,>750001,,V,positive,,,,,,,32,17,58,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,569-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,11,C,C,1,single,23800,,V/VI,positive,,,,,,,57,25,114,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,346-F4,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,8,C,C,1,single,26700,,VI,positive,,,,,,,78,28,156,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,541-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,11,C,C,1,single,66100,,VI,positive,,,,,,,100,56,162,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,556-F3,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,11,C,C,2,multiple,43300,,V,positive,,,,,,,366,189,792,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,142-F3,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,9,C,C,2,multiple,366000,,VI,positive,,,,,,,470,290,720,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,98-F4,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,6,C,C,2,multiple,5330,,V,positive,,,,,,,743,885,1615,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,21-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,11,C,C,2,multiple,21200,,V/VI,positive,,,,,,,1505,716,2957,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,410-F2,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,11,C/AC,recombinant,2,multiple,165000,,VI,positive,,,,,,,2104,933,4768,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,89-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,5,C/D,recombinant,1,single,>750001,,I/II,negative,,,,,,,0,0,0,,,
Nofemela,Virology. 2011 Jul 5;415(2):107-13. doi: 10.1016/j.virol.2010.12.027. Epub 2011 May 4,Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms.,2011,Mbeya,,,,highlighter,haplotype,54-F1,,F,HSX:MTF,TZ-14,,LT,,SGA,Sanger,gp160,,9,D,D,1,single,28200,,VI,positive,,,,,,,45,28,80,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF, Highlighter, BEAST TMRCA",pooled,A-1811,30,F,HSX:MTF,BW,2004/04/13,LT,,SGA,Sanger,gp120,,19,C,C,2,multiple,1230269,172,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,B-2865,20,F,HSX:MTF,BW,2005/08/30,LT,,SGA,Sanger,gp120,,33,C,C,1,single,549541,373,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,C-3312,32,F,HSX:MTF,BW,2005/12/07,LT,,SGA,Sanger,gp120,,30,C,C,1,single,3630781,202,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF, Highlighter, BEAST TMRCA",pooled,D-5018,27,M,HSX:FTM,BW,2006/11/14,LT,,SGA,Sanger,gp120,,22,C,C,2,multiple,2089296,286,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,E-3430,35,F,HSX:MTF,BW,2006/02/07,LT,,SGA,Sanger,gp120,,12,C,C,1,single,50,640,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,F-3505,53,F,HSX:MTF,BW,2006/04/11,LT,,SGA,Sanger,gp120,,13,C,C,1,single,371535,426,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,G-3603,34,M,HSX:FTM,BW,2006/06/30,LT,,SGA,Sanger,gp120,,11,C,C,1,single,575440,505,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,H-5582,26,F,HSX:MTF,BW,2007/06/10,LT,,SGA,Sanger,gp120,,12,C,C,1,single,2291,442,II,negative,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,O1-3354,30,F,HSX:MTF,BW,2005/12/16,LT,,SGA,Sanger,gp120,,12,C,C,1,single,98,578,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,OC-2381,25,M,HSX:FTM,BW,2005/02/15,LT,,SGA,Sanger,gp120,,7,C,C,1,single,120226,301,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,OG-2604,23,F,HSX:MTF,BW,2005/06/27,LT,,SGA,Sanger,gp120,,15,C,C,2,multiple,2951209,260,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF, Highlighter, BEAST TMRCA",pooled,OJ-2761,26,F,HSX:MTF,BW,2005/08/04,LT,,SGA,Sanger,gp120,,11,C,C,2,multiple,7762,438,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,OU-3091,27,M,HSX:FTM,BW,2005/10/17,LT,,SGA,Sanger,gp120,,11,C,C,1,single,89125,302,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,OW-3234,41,M,HSX:FTM,BW,2005/11/16,LT,,SGA,Sanger,gp120,,11,C,C,2,multiple,257040,234,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,PK-4872,30,M,HSX:FTM,BW,2006/08/31,LT,,SGA,Sanger,gp120,,8,C,C,2,multiple,1862,698,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF, Highlighter, BEAST TMRCA",pooled,PO-5062,20,F,HSX:MTF,BW,2006/12/13,LT,,SGA,Sanger,gp120,,6,C,C,NA,NA,759,460,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,PP-5065,23,F,HSX:MTF,BW,2006/12/15,LT,,SGA,Sanger,gp120,,8,C,C,2,multiple,1949845,319,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,QA-5099,28,M,HSX:FTM,BW,2007/01/11,LT,,SGA,Sanger,gp120,,13,C,C,1,single,102329,305,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,QI-5715,27,F,HSX:MTF,BW,2007/07/18,LT,,SGA,Sanger,gp120,,16,C,C,1,single,389045,292,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,QM-5849,37,F,HSX:MTF,BW,2007/08/28,LT,,SGA,Sanger,gp120,,7,C,C,1,single,50,879,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF, Highlighter, BEAST TMRCA",pooled,QP-5867,29,M,HSX:FTM,BW,2007/09/03,LT,,SGA,Sanger,gp120,,14,C,C,2,multiple,550,626,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,QR-5943,26,F,HSX:MTF,BW,2007/09/25,LT,,SGA,Sanger,gp120,,16,C,C,1,single,398,801,IV,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,QS-6020,26,F,HSX:MTF,BW,2007/10/19,LT,,SGA,Sanger,gp120,,7,C,C,1,single,398,1357,V,positive,,,,,,,,,,,,
Novitsky,PLoS One 2011 Feb 9;6(2):e16714.doi: 10.1371/journal.pone.0016714.,Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection,2011,Tshedimoso,,,Y,"Phylotopology, Distance, Poisson GOF",pooled,QT-6024,24,F,HSX:MTF,BW,2007/10/22,LT,,SGA,Sanger,gp120,,21,C,C,1,single,77625,522,V,positive,,,,,,,,,,,,
Rachinger,AIDS. 2011 May 15;25(8):1035-9. doi: 10.1097/QAD.0b013e3283467020,"Time-measured phylogenies of gag, pol and env sequence data reveal the direction and time interval of HIV-1 transmission",2011,,1,,,BEAST topologies,phylogenetic,Rachinger_3way,,M,MSM,,,LT,plasma,PCR,sanger,"gag, pol and env",,NA,B,B,NA,single,,,,negative,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI67,,M,MSM,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,34,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI127/Swiss_cohorts_pair5,,M,MSM,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,35,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI98/Swiss_cohorts_pair5,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI29,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI28,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI41,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI90,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI66,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI69,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI73,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI78,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,14,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI133,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI153,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI72/Swiss_cohorts_pair8,,M,MSM,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,31,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI118,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI58,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI75,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,10,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI56,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI6,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI2,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI3,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,C,C,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI8,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI9,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI15,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,14,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI16,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,G,G,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI17,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI19,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI20,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI22,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI23,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI25,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI24/Swiss_cohorts_pair2,,F,HSX:MTF,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,43,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI26,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI27,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI5,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI30,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI31,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI21,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,14,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI34,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI33,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI35,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI36,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI4,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI37,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI39,,M,MSM,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,23,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI40,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI43,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,A,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI44,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI46,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI52,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI53,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI55,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI57,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI59,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI60,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI61,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI63,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF02_AG,CRF02_AG,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI65,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI68,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF02_AG,CRF02_AG,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI71,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI11,,M,MSM,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,39,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI74,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI81,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI83,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,14,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI84,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI85,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,C,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI87,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI88,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,A,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI89,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI92/Swiss_cohorts_pair3,,M,MSM,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,27,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI91,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI93,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI95,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI97,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI99,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI101,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI102,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI103,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,C,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI104,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI106,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI107,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI108,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF01_AE,CRF02_AG,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI111,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI114,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI115,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI117,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI116,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI119,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI120,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI121,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI122,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,14,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI123,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI128,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI129,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI132,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI134,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,13,C,C,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI135,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI135,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI136,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI138,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,CRF12_BF,CRF12_BF,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI139,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI141,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI142,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI143/Swiss_cohorts_pair6,,F,HSX:MTF,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,33,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI147,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI148,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI149/Swiss_cohorts_pair4,,F,HSX:MTF,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,26,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI150,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,A,A,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI151,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI152,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI154,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI156,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,13,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI160,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI161,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI162,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI164,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI165,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI166,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,14,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI171,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI167,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI168,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI172,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI169,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI173,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI174,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI170,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI177,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI179,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI180,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI181,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI182,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI183,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,CRF02_AG,CRF02_AG,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI184,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI185,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI186,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,14,CRF01_AE,CRF01_AE,NA,single,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI187,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI188,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI189,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,NA,,,,,,,,,,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI190,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,positive,,,,,,,0,0,0,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI191,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,positive,,,,,,,48,17,127,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI192,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,15,A,A,NA,,,,,NA,,,,,,,185,88,354,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI194,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,14,B,B,NA,,,,,positive,,,,,,,48,28,84,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI195,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,CRF14_BG,CRF14_BG,NA,single,,,,positive,,,,,,,62,36,91,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI196,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,positive,,,,,,,324,188,523,,,
Rieder,Clin Infect Dis 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725.,Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection,2011,ZPHI,1,,,pwise_dist_tn93,distance,ZPHI197,,,unknown,CH-ZH,,S,Plasma,RT-PCR,Sanger,gp120,,16,B,B,NA,,,,,positive,,,,,,,8,1,22,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,,,Y,Phylo-Topology,phylogenetic,502-2349,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,4,B,B,1,single,230000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0006,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,0,B,B,1,single,19000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0053,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,10,B,B,1,single,2900000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0062,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,6,B,B,1,single,450000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0176,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,11,B,B,1,single,61000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0223,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,1,B,B,1,single,700,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0227,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,11,B,B,2,multiple,2400000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0287,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,4,B,B,1,single,400,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0309,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,95000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0322,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,4700,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0341,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,7,B,B,1,single,390000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0346,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,9,B,B,1,single,390000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0364,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,460000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0388,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,9,B,B,1,single,350000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0491,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,4,B,B,1,single,2500,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0524,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,10,B,B,1,single,100000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0525,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,12000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0572,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,7300000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0648,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,4,B,B,1,single,4600000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0717,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,6,B,B,1,single,120000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0762,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,9,B,B,1,single,15000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0823,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,7,B,B,1,single,670000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0839,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,12,B,B,2,multiple,350000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0841,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,4,B,B,1,single,69000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0879,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,2,multiple,700,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0897,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,10,B,B,1,single,210000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0923,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,8,B,B,1,single,1400000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0938,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,10,B,B,1,single,190000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0961,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,12,B,B,2,multiple,250000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-0965,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,4,B,B,2,multiple,180000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1027,,M,MSM,CA,,S,Plasma,SGA,Sanger,gag,,10,B,B,2,multiple,150000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1046,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,420000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1047,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,2300000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1055,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,6,B,B,1,single,67000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1115,,F,HSX:MTF,US,,S,Plasma,SGA,Sanger,gag,,4,B,B,1,single,64000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1174,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,10,B,B,2,multiple,210000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1191,,M,MSM,CA,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,86000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1221,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,1800000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1368,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,2,B,B,1,single,9900,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1399,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,5,B,B,2,multiple,97000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1400,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,150000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1478,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,23000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1500,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,4,B,B,1,single,50000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1504,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,8,B,B,2,multiple,58000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1512,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,11,B,B,1,single,100000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1518,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,10,B,B,2,multiple,44000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1619,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,10,B,B,2,multiple,48000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1709,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,11,B,B,2,multiple,250000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1799,,M,MSM,CA,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,4000000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1897,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,34000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1919,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,1,B,B,1,single,98000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-1926,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,8,B,B,1,single,,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2000,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,10,B,B,1,single,240000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2008,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,10,B,B,2,multiple,,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2136,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,280000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2241,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,11,B,B,1,single,130000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2254,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,6,B,B,1,single,120000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2289,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,81000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2305,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,14,B,B,4,multiple,1100000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2437,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,10,B,B,1,single,190000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2495,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,3,B,B,1,single,400,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2586,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,6,B,B,2,multiple,190000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2622,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,28000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2646,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,9,B,B,2,multiple,200000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2667,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,21000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2696,,M,MSM,US,,S,Plasma,SGA,Sanger,gag,,6,CRF02_AG,CRF02_AG,1,single,540000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2717,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,7,B,B,1,single,15000,,,NA,,,,,,,,,,,,
Rolland,Nat Med. 2011 Mar; 17(3): 366–371. doi: 10.1038/nm.2316,Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial,2011,HVTN502,1,,Y,Phylo-Topology,phylogenetic,502-2794,,M,MSM,PE,,S,Plasma,SGA,Sanger,gag,,5,B,B,1,single,650000,,,NA,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,Y,Phylo-Topology,phylogenetic,HDNDRPI034,47,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,163,B,B,16,multiple,75857758,240,III,negative,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,Y,Phylo-Topology,phylogenetic,HDNDRPI029,18,F,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,29,B,B,1,single,21878,440,IV,positive,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,Y,Phylo-Topology,phylogenetic,HTM385,24,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,22,B,B,1,single,234423,406,V,positive,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,Y,Phylo-Topology,phylogenetic,CQLDR03,42,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,21,B,B,1,single,102329,NA,V,positive,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,Y,Phylo-Topology,phylogenetic,HDNDRPI001,36,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,25,B,B,5,multiple,870964,690,V,positive,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,Y,Phylo-Topology,phylogenetic,HTM319,39,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,25,B,B,3,multiple,26915,520,V,positive,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,Y,Phylo-Topology,phylogenetic,HDNDRPI032,37,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,19,B,B,3,multiple,3388,1040,V,positive,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,,Phylo-Topology,phylogenetic,ACTDM580208,39,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,30,B,B,3,multiple,33884,387,VI,positive,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,Y,Phylo-Topology,phylogenetic,ACT54869022,28,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,27,B,B,1,single,2692,723,VI,positive,,,,,,,,,,,,
Bar,J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10.,Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users,2010,Montreal,,,Y,Phylo-Topology,phylogenetic,PSL024,46,M,PWID,CA-QC,,S,Plasma,SGA,Sanger,gp160,,21,B,B,3,multiple,28840,340,VI,positive,,,,,,,,,,,,
Fischer,PLoS One. 2010; 5(8): e12303. Aug 20. doi: 10.1371/journal.pone.0012303,Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing,2010,,,,,poisson_gof,math_model,CH40,,M,MSM,,,LT,,Nested PCR,Roche 454,NEF,,NGS,B,B,1,single,2197248,,I/II,negative,4,,,34,31,38,,,,0.136,0.981,
Fischer,PLoS One. 2010; 5(8): e12303. Aug 20. doi: 10.1371/journal.pone.0012303,Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing,2010,,,,,poisson_gof,math_model,CH40,,M,MSM,,,LT,,Nested PCR,Roche 454,gp120,,NGS,B,B,1,single,2197248,,I/II,negative,5,,,51,46,56,,,,0.195,0.895,
Fischer,PLoS One. 2010; 5(8): e12303. Aug 20. doi: 10.1371/journal.pone.0012303,Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing,2010,,,,,poisson_gof,math_model,SUMA,,M,MSM,,,LT,,Nested PCR,Roche 454,REV,,NGS,B,B,1,single,1485040,,I/II,negative,4,,,6,5,7,,,,0.018,0.228,
Fischer,PLoS One. 2010; 5(8): e12303. Aug 20. doi: 10.1371/journal.pone.0012303,Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing,2010,,,,,poisson_gof,math_model,SUMA,,M,MSM,,,LT,,Nested PCR,Roche 454,TAT,,NGS,B,B,1,single,1485040,,I/II,negative,4,,,7,5,9,,,,0.024,0.013,
Fischer,PLoS One. 2010; 5(8): e12303. Aug 20. doi: 10.1371/journal.pone.0012303,Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing,2010,,,,,poisson_gof,math_model,SUMA,,M,MSM,,,LT,,Nested PCR,Roche 454,gp120,,NGS,B,B,1,single,1485040,,I/II,negative,4,,,11,11,12,,,,0.04,0.891,
Fischer,PLoS One. 2010; 5(8): e12303. Aug 20. doi: 10.1371/journal.pone.0012303,Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing,2010,,,,,poisson_gof,math_model,WEAU,,M,MSM,,,LT,,Nested PCR,Roche 454,gp160,,NGS,B,B,1,single,355360,,I/II,negative,4,,,39,38,42,,,,0.12,0.001,
Fischer,PLoS One. 2010; 5(8): e12303. Aug 20. doi: 10.1371/journal.pone.0012303,Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing,2010,,,,,poisson_gof,math_model,WEAU,,M,MSM,,,LT,,Nested PCR,Roche 454,gp120,,NGS,B,B,1,single,355360,,I/II,negative,4,,,18,16,22,,,,0.054,0.841,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,CHAVI001,,,Y,"Poisson GOF, Highlighter,diversity",pooled,701010055,,M,MSM,US-NC,2006/10/05,S,Plasma,SGA,Sanger,gp160,2544,28,B,B,1,single,31513812,432,II,negative,3,-,NO,15,10,21,-,-,-,0.923,0.59,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,CHAVI001,,,Y,"Poisson GOF, Highlighter,diversity",pooled,701010068,,M,MSM,US-NC,2006/10/24,S,Plasma,SGA,Sanger,gp160,2595,89,B,B,7,multiple,3714386,109,IV,positive,115,-,NO,688,583,792,-,-,-,42.499,0,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,CHAVI001,,,Y,"Poisson GOF, Highlighter,diversity",pooled,700010106,,M,MSM,US-NC,2006/10/19,S,Plasma,SGA,Sanger,gp160,2595,40,B,B,1,single,84545454,277,II,negative,5,-,YES,13,8,18,-,-,-,0.8,0.634,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,CHAVI001,,,Y,"Poisson GOF, Highlighter,diversity",pooled,701010027,,M,MSM,US-NC,2006/08/29,S,Plasma,SGA,Sanger,gp160,2571,27,B,B,1,single,194744,542,V,positive,8,-,NO,42,32,52,-,-,-,2.552,0.977,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,CHAVI001,,,Y,"Poisson GOF, Highlighter,diversity",pooled,701010108,,M,MSM,US-NC,2007/07/28,S,Plasma,SGA,Sanger,gp160,2553,35,B,B,1,single,14711,592,V,positive,6,-,YES,39,34,45,-,-,-,2.376,0.099,CTL
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,CHAVI001,,,Y,"Poisson GOF, Highlighter,diversity",pooled,700010246,,M,MSM,US-NC,2007/06/07,S,Plasma,SGA,Sanger,gp160,2607,45,B,B,1,single,4395721,1012,IV,positive,6,-,YES,19,13,25,-,-,-,1.18,0.574,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,CHAVI001,,,Y,"Poisson GOF, Highlighter,diversity",pooled,700010238,,M,MSM,US-NC,2007/05/08,S,Plasma,SGA,Sanger,gp160,2595,38,B,B,3,multiple,596908,587,V,positive,19,-,NO,161,149,174,-,-,-,9.97,0,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013171,,M,MSM,US-NY,2002/02/06,S,Plasma,SGA,Sanger,gp160,2625,86,B,B,10,multiple,3700000,213,IV,positive,179,-,NO,662,525,792,-,-,-,41.37,0,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013211,,M,MSM,US-NY,2002/08/23,S,Plasma,SGA,Sanger,gp160,2619,30,B,B,2,multiple,19900000,846,III,negative,9,-,NO,54,44,64,-,-,-,3.38,0,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013226,,M,MSM,US-NY,2002/11/20,S,Plasma,SGA,Sanger,gp160,2574,33,B,B,1,single,26700000,175,II,negative,5,-,YES,15,9,21,-,-,-,0.936,0.825,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013240,,M,MSM,US-NY,2003/01/21,S,Plasma,SGA,Sanger,gp160,2568,66,B,B,3,multiple,2240000,297,II,negative,14,-,NO,66,56,76,-,-,-,4.041,0,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013242,,M,MSM,US-NY,2003/01/23,S,Plasma,SGA,Sanger,gp160,2580,37,B,B,1,single,5790000,251,IV,positive,5,-,YES,16,10,22,-,-,-,0.992,0.902,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013291,,M,MSM,US-NY,2003/06/04,S,Plasma,SGA,Sanger,gp160,2559,25,B,B,1,single,1490000,179,V,positive,8,-,NO,61,53,70,-,-,-,3.737,0.1,CTL
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013296,,M,MSM,US-NY,2003/08/05,S,Plasma,SGA,Sanger,gp160,2640,25,B,B,1,single,8050000,395,II,negative,7,-,NO,34,26,42,-,-,-,2.113,0.859,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013321,,M,MSM,US-NY,2003/10/10,S,Plasma,SGA,Sanger,gp160,2556,49,B,B,1,single,6250000,407,II,negative,8,-,YES,39,33,45,-,-,-,2.37,0.212,early stochastic mutations
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013327,,M,MSM,US-NY,2004/01/27,S,Plasma,SGA,Sanger,gp160,2535,24,B,B,1,single,8720000,248,IV,positive,4,-,NO,11,5,18,-,-,-,0.667,0.39,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013383,,M,MSM,US-NY,2005/04/05,S,Plasma,SGA,Sanger,gp160,2547,70,B,B,2,multiple,584000,531,II,negative,70,-,NO,554,334,572,-,-,-,33.58,0,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013396,,M,MSM,US-NY,2005/08/15,S,Plasma,SGA,Sanger,gp160,2577,39,B,B,1,single,1600000,581,IV,positive,5,-,NO,16,11,21,-,-,-,0.974,0.897,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013419,,M,MSM,US-NY,2006/03/14,S,Plasma,SGA,Sanger,gp160,2565,78,B,B,3,multiple,21200000,226,II,negative,80,-,YES,548,506,591,-,-,-,33.5,0,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013440,,M,MSM,US-NY,2006/10/17,S,Plasma,SGA,Sanger,gp160,2580,30,B,B,1,single,">100,000",205,II,negative,4,-,NO,23,18,28,-,-,-,1.379,0.116,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013446,,M,MSM,US-NY,2006/11/28,S,Plasma,SGA,Sanger,gp160,2594,23,B,B,1,single,">100,000",438,III,positive,7,-,NO,24,12,35,-,-,-,1.45,0,early stochastic mutations
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,4013448,,M,MSM,US-NY,2007/01/19,S,Plasma,SGA,Sanger,gp160,2625,54,B,B,4,multiple,28600000,536,II,negative,51,-,NO,4111,367,456,-,-,-,25.716,0,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,AD17,,M,MSM,US-NY,1999/06/14,S,Plasma,SGA,Sanger,gp160,2544,51,B,B,1,single,47600000,NA,II,negative,4,-,YES,8,5,11,-,-,-,0.471,0.162,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,AD75,,M,MSM,US-NY,2002/11/06,S,Plasma,SGA,Sanger,gp160,2556,54,B,B,1,single,21400000,NA,II,negative,3,-,YES,9,6,13,-,-,-,0.55,0.774,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,AD77,,M,MSM,US-NY,2002/11/15,S,Plasma,SGA,Sanger,gp160,2556,40,B,B,3,multiple,130000,NA,V,positive,11,-,NO,84,74,95,-,-,-,5.127,0.151,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,AD83,,M,MSM,US-NY,2003/01/22,S,Plasma,SGA,Sanger,gp160,2568,44,B,B,3,multiple,448000,NA,V,positive,33,-,YES,66,36,95,-,-,-,4,0,multiple variant transmission
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,HOBR0961,,M,MSM,US-AL,1991/10/31,S,Plasma,SGA,Sanger,gp160,2586,42,B,B,1,single,599238,794,II,negative,4,-,NO,17,13,22,-,-,-,1.022,0.503,
Li,PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.,High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men,2010,Li. et al. 2010,,,Y,"Poisson GOF, Highlighter,diversity",pooled,INME0632,,M,MSM,US-AL,1990/08/09,S,Plasma,SGA,Sanger,gp160,2580,46,B,B,1,single,2217670,739,II,negative,4,-,NO,12,8,16,-,-,-,0.737,0.845,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,H408,21,M,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,20,A,A,2,multiple,251189,,IV,positive,36,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,H410,24,M,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,27,A,A,3,multiple,630957,,III,positive,36,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,R053,3,F,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,21,A,A,3,multiple,398107,,IV,positive,12,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,H386,27,F,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,26,A,A,1,single,630957,,IV,positive,5,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,R163,32,F,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,21,A,A,1,single,316228,,I/II,negative,2,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,R392,41,M,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,29,A,A,1,single,501187,,IV,positive,4,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,R497,22,M,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,26,A,A,1,single,398107,,IV,positive,10,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,R526,30,M,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,28,A,A,1,single,501187,,I/II,negative,3,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,R575,22,M,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,18,A,A,1,single,630957,,IV,positive,5,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,R589,29,F,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,29,A,A,1,single,63096,,VI,positive,10,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,K08,30,M,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,22,A,A,1,single,1584893,,VI,positive,7,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,K84,18,M,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,29,A,A,1,single,251189,,IV,positive,5,,,,,,,,,,,
Masharsky,J Infect Dis. 2010 Jun 1;201(11):1697-702. doi: 10.1086/652702.,"A Substantial Transmission Bottleneck among Newly and Recently HIV-1-Infected Injection Drug Users in St Petersburg, Russia",2010,St Petersburg,,,,highlighter,haplotype,SC1283,29,M,PWID,RU-SPE,,S,,SGA,Sanger,gp160,,24,CRF06_cpx/ A,recombinant,2,multiple,50119,,VI,positive,97,,,,,,,,,,,
Zhang,PLoS One. 2010; 5(2): e9294. 2010 Feb 18. doi: 10.1371/journal.pone.0009294,Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants,2010,ZEHRP,,,,phylo_tp_asr_topol,phylogenetic,1449,,INF,MTCT:IP,ZM,,LT,PMBC,Nested PCR,Sanger,gp120,,26,A/C,recombinant,1,single,,,,infant,,,,,,,,,,,,
Zhang,PLoS One. 2010; 5(2): e9294. 2010 Feb 18. doi: 10.1371/journal.pone.0009294,Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants,2010,ZEHRP,,,,phylo_tp_asr_topol,phylogenetic,1084,,INF,MTCT:IP,ZM,,LT,PMBC,Nested PCR,Sanger,gp120,,25,C,C,1,single,,,,infant,,,,,,,,,,,,
Zhang,PLoS One. 2010; 5(2): e9294. 2010 Feb 18. doi: 10.1371/journal.pone.0009294,Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants,2010,ZEHRP,,,,phylo_tp_asr_topol,phylogenetic,1984,,INF,MTCT:IP,ZM,,LT,PMBC,Nested PCR,Sanger,gp120,,25,C,C,1,single,,,,infant,,,,,,,,,,,,
Zhang,PLoS One. 2010; 5(2): e9294. 2010 Feb 18. doi: 10.1371/journal.pone.0009294,Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants,2010,ZEHRP,,,,phylo_tp_asr_topol,phylogenetic,2617,,INF,MTCT:IP,ZM,,LT,PMBC,Nested PCR,Sanger,gp120,,27,C,C,1,single,,,,infant,,,,,,,,,,,,
Zhang,PLoS One. 2010; 5(2): e9294. 2010 Feb 18. doi: 10.1371/journal.pone.0009294,Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants,2010,ZEHRP,,,,phylo_tp_asr_topol,phylogenetic,2669,,INF,MTCT:IP,ZM,,LT,PMBC,Nested PCR,Sanger,gp120,,30,C,C,1,single,,,,infant,,,,,,,,,,,,
Zhang,PLoS One. 2010; 5(2): e9294. 2010 Feb 18. doi: 10.1371/journal.pone.0009294,Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants,2010,ZEHRP,,,,phylo_tp_asr_topol,phylogenetic,2873,,INF,MTCT:IP,ZM,,LT,PMBC,Nested PCR,Sanger,gp120,,29,C,C,1,single,,,,infant,,,,,,,,,,,,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,89,33,M,HSX:FTM,MW,2003/04/10,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,838444,,V,positive,NA,0.06,NO,26.59,-,-,38,17,61,1.6277,0.856,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,334,24,M,HSX:FTM,MW,2003/06/30,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,22000000,,I/II,negative,NA,0.03,NO,12.22,-,-,20,7,36,0.7273,0.854,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,393,23,F,HSX:MTF,MW,2003/07/17,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,12000000,,IV,positive,NA,0.04,NO,16.33,-,-,24,10,44,0.9913,0.799,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,626,22,M,HSX:FTM,MW,2003/09/16,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,711061,,IV,positive,NA,0.04,NO,16.38,-,-,22,8,38,1,0.725,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,665,27,M,HSX:FTM,MW,2003/09/24,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,67728,,IV,positive,NA,0.06,NO,26.29,-,-,36,17,63,1.6,0.63,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,682,22,M,HSX:FTM,MW,2003/09/29,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,17960,,I/II,negative,NA,0.03,NO,10.54,-,-,17,5,35,0.6278,0.909,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,985,20,M,HSX:FTM,MW,2004/02/11,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,2894737,,I/II,negative,NA,0.02,NO,8.26,-,-,14,3,32,0.498,0.922,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,1172,25,M,HSX:FTM,MW,2004/05/13,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,4805921,,I/II,negative,NA,0.03,NO,11.63,-,-,21,6,43,0.7,0.73,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,2052,18,F,HSX:MTF,MW,2006/03/24,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,339475,,I/II,negative,NA,0.03,NO,14.25,-,-,23,10,40,0.8696,0.665,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,2060,22,M,HSX:FTM,MW,2005/04/04,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,1530364,,I/II,negative,NA,0.04,NO,14.94,-,-,20,9,35,0.9091,0.66,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,1086,29,M,HSX:FTM,MW,2004/03/22,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,1406208,,I/II,negative,NA,0.05,YES,20.66,-,-,31,14,52,1.2428,0.942,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,2010,42,M,HSX:FTM,MW,2005/01/19,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,1203333,,IV,positive,NA,0.02,YES,10.05,-,-,15,5,29,0.6087,0.892,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,1176,26,M,HSX:FTM,MW,2004/05/14,S,Plasma,SGA,Sanger,gp160,,21,C,C,3,multiple,200000000,,I/II,negative,NA,0.1,NO,41.84,-,-,88,22,193,2.5238,0,Infection with 3 closely related viruses
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,1373,26,F,HSX:MTF,MW,2004/08/27,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,3221979,,I/II,negative,NA,0.06,NO,26.81,-,-,39,13,77,1.6147,0.228,Early stochastic events
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,1394,23,M,HSX:FTM,MW,2004/09/07,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,7341772,,I/II,negative,NA,0.06,NO,24.89,-,-,38,10,77,1.5211,0.552,Early stochastic events
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,2103,30,M,HSX:FTM,MW,2005/07/21,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,152364,,I/II,negative,NA,0.02,NO,10.52,-,-,18,2,44,0.6368,0.85,Early stochastic events
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,595,19,F,HSX:MTF,MW,2003/09/11,S,Plasma,SGA,Sanger,gp160,,28,C,C,1,single,1006864,,IV,positive,NA,0.07,NO,30.6,-,-,51,13,102,1.8704,0.169,Selection (possible Ab pressure)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,114,29,M,HSX:FTM,MW,2003/02/08,S,Plasma,SGA,Sanger,gp160,,27,C,C,3,multiple,99000000,,IV,positive,NA,1.75,NO,1.75,-,-,2343,871,4701,43.9088,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,478,18,M,HSX:FTM,MW,2003/04/24,S,Plasma,SGA,Sanger,gp160,,23,C,C,3,multiple,2166667,,I/II,negative,NA,1.92,NO,1.92,-,-,2413,825,4952,47.9051,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,1196,24,M,HSX:FTM,MW,2004/06/15,S,Plasma,SGA,Sanger,gp160,,23,C,C,3,multiple,30500000,,I/II,negative,NA,0.65,NO,0.65,-,-,850,311,1659,18.2451,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,ABRAHAMS_MW,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,1335,24,M,HSX:FTM,MW,2004/08/20,S,Plasma,SGA,Sanger,gp160,,21,C,C,3,multiple,576282,,IV,positive,NA,2.15,NO,2.15,-,-,5684,2175,11721,53.3048,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP45,41,F,HSX:MTF,ZA,2005/04/20,S,Plasma,SGA,Sanger,gp160,,16,C,C,1,single,12500,,I/II,negative,NA,0.02,NO,10.55,-,-,18,4,35,0.625,0.42,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP129,59,F,HSX:MTF,ZA,2006/06/13,S,Plasma,SGA,Sanger,gp160,,19,C,C,1,single,1800000,,IV,positive,NA,0.03,NO,15.04,-,-,22,6,42,0.9,0.346,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP174,42,F,HSX:MTF,ZA,2005/09/22,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,40000,,V,positive,NA,0.06,NO,23.72,-,-,33,15,54,1.4286,0.94,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP177,37,F,HSX:MTF,ZA,2006/03/07,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,359000,,I/II,negative,NA,0.03,NO,11.89,-,-,17,5,33,0.7,0.87,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP188,31,F,HSX:MTF,ZA,2007/01/25,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,13800000,,I/II,negative,NA,0.04,NO,15.18,-,-,22,7,40,0.9091,0.615,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP200,32,F,HSX:MTF,ZA,2005/10/11,S,Plasma,SGA,Sanger,gp160,,18,C,C,1,single,398000,,IV,positive,NA,0.04,NO,18.32,-,-,26,13,45,1.1111,0.708,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP206,36,F,HSX:MTF,ZA,2005/06/15,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,196000,,V,positive,NA,0.05,NO,22.07,-,-,29,15,49,1.3333,0.893,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP210,43,F,HSX:MTF,ZA,2005/05/03,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,468000,,I/II,negative,NA,0.01,NO,6.36,-,-,11,3,25,0.381,0.612,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP217,20,F,HSX:MTF,ZA,2005/12/02,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,3260000,,IV,positive,NA,0.02,NO,9.92,-,-,16,4,38,0.6,0.885,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP220,25,F,HSX:MTF,ZA,2007/02/15,S,Plasma,SGA,Sanger,gp160,,15,C,C,1,single,2070,,V,positive,NA,0.08,NO,33.04,-,-,45,17,75,1.9905,0.813,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP221,25,F,HSX:MTF,ZA,2006/03/02,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,24300,,I/II,negative,NA,0.07,NO,29.52,-,-,42,23,73,1.8,0.758,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP237,20,F,HSX:MTF,ZA,2007/03/06,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,1020000,,III,positive,NA,0.04,NO,18.05,-,-,26,9,46,1.0909,0.815,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP239,44,F,HSX:MTF,ZA,2005/08/10,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,95800,,V,positive,NA,0.06,NO,24.54,-,-,34,11,58,1.4855,0.852,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP40,31,F,HSX:MTF,ZA,2006/04/25,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,90500,,VI,positive,NA,0.14,YES,58.83,-,-,102,42,168,3.5411,0.142,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP63,32,F,HSX:MTF,ZA,2005/01/06,S,Plasma,SGA,Sanger,gp160,,19,C,C,1,single,3210000,,III,positive,NA,0.04,YES,17.35,-,-,30,10,53,1.0526,0.642,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP84,18,F,HSX:MTF,ZA,2005/02/16,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,559000,,V,positive,NA,0.04,YES,17.53,-,-,26,8,49,1.0476,0.506,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP85,24,F,HSX:MTF,ZA,2005/06/22,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,621000,,V,positive,NA,0.08,YES,31.47,-,-,53,20,101,1.9286,0.755,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP225,40,F,HSX:MTF,ZA,2005/10/25,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,63600000,,III,positive,NA,0.04,YES,22.25,-,-,25,12,46,1.357,0.959,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP8,38,F,HSX:MTF,ZA,2005/05/11,S,Plasma,SGA,Sanger,gp160,,19,C,C,1,single,207000,,V,positive,NA,0.18,NO,77.43,-,-,147,67,261,4.7251,0.041,Selection (possible CTL escape)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP269,21,F,HSX:MTF,ZA,2006/09/27,S,Plasma,SGA,Sanger,gp160,,18,C,C,1,single,2170,,VI,positive,NA,0.26,NO,116.11,-,-,205,110,325,7.0588,0.743,Selection (possible Ab pressure)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP37,20,F,HSX:MTF,ZA,2006/05/11,S,Plasma,SGA,Sanger,gp160,,20,C,C,3,multiple,248000,,IV,positive,NA,1.18,NO,1.18,-,-,5998,2192,12321,43.3211,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP69,39,F,HSX:MTF,ZA,2006/01/30,S,Plasma,SGA,Sanger,gp160,,20,C,C,5,multiple,15300,,I/II,negative,NA,1.29,NO,1.29,-,-,2449,1059,4622,33.7684,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP136,25,F,HSX:MTF,ZA,2006/06/29,S,Plasma,SGA,Sanger,gp160,,16,C,C,2,multiple,85300,,V,positive,NA,0.37,NO,0.37,-,-,605,221,1208,15.75,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP222,19,F,HSX:MTF,ZA,2006/04/05,S,Plasma,SGA,Sanger,gp160,,21,C,C,3,multiple,69700,,I/II,negative,NA,0.79,NO,0.79,-,-,1390,512,2767,28.1238,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP224,20,F,HSX:MTF,ZA,1900/01/06,S,Plasma,SGA,Sanger,gp160,,19,C,C,2,multiple,134800,,V,positive,NA,0.4,NO,0.4,-,-,687,257,1363,10.0819,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CAPRISA002,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,CAP260,27,F,HSX:MTF,ZA,2006/11/15,S,Plasma,SGA,Sanger,gp160,,18,C,C,2,multiple,17600,,V,positive,NA,1.23,NO,1.223,-,-,1702,750,3083,30.6667,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,703010131,20,M,HSX:FTM,MW,2007/03/15,S,Plasma,SGA,Sanger,gp160,,22,C,C,1,single,437369,,III,positive,NA,0.06,NO,24.31,-,-,32,15,58,1.4545,0.13,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,703010193,19,M,HSX:FTM,MW,2007/05/08,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,46724,,V,positive,NA,0.08,NO,31.97,-,-,43,22,65,1.9167,0.485,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,703010217,34,F,HSX:MTF,MW,2007/06/04,S,Plasma,SGA,Sanger,gp160,,25,C,C,1,single,102602,,V/VI,positive,NA,0.07,NO,27.63,-,-,40,22,58,1.68,0.89,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,704010042,38,M,HSX:FTM,ZA,2007/02/02,S,Plasma,SGA,Sanger,gp160,,42,C,C,1,single,133000,,V,positive,NA,0.07,NO,31.78,-,-,44,26,77,1.9524,0.407,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,704010083,25,F,HSX:MTF,ZA,2007/02/19,S,Plasma,SGA,Sanger,gp160,,24,C,C,1,single,>750000,,III,positive,NA,0.05,NO,20.39,-,-,28,13,44,1.2464,0.065,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,704809221,22,M,HSX:FTM,ZA,2007/08/13,S,Plasma,SGA,Sanger,gp160,,28,C,C,1,single,>750000,,I/II,negative,NA,0.06,NO,25.22,-,-,32,14,52,1.5608,0.251,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,706010164,27,M,HSX:FTM,ZA,2007/08/16,S,Plasma,SGA,Sanger,gp160,,19,C,C,1,single,23600,,IV,positive,NA,0.05,NO,20.8,-,-,38,13,72,1.2632,0.388,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,704810053,22,F,HSX:MTF,ZA,2007/09/11,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,25400,,V,positive,NA,0.05,YES,17.31,-,-,33,14,54,1.0526,0.642,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,703010159,18,F,HSX:MTF,MW,2007/03/23,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,73453,,II,positive,NA,0.07,NO,28.73,-,-,44,12,83,1.7211,0.301,Early stochastic events
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,703010054,28,M,HSX:FTM,MW,2007/01/19,S,Plasma,SGA,Sanger,gp160,,27,C,C,1,single,13936,,V,positive,NA,0.18,NO,81.99,-,-,136,67,220,4.9573,0.642,Selection (possible CTL escape)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,704010017,21,F,HSX:MTF,ZA,2006/12/05,S,Plasma,SGA,Sanger,gp160,,25,C,C,1,single,1100,,VI,positive,NA,0.17,NO,85.65,-,-,174,64,341,5.21,0,Selection (possible Ab pressure)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,704010056,28,M,HSX:FTM,ZA,2007/02/13,S,Plasma,SGA,Sanger,gp160,,21,C,C,1,single,3830,,VI,positive,NA,0.25,NO,121.64,-,-,264,102,492,7.4476,0,Selection (possible Ab pressure)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,704010069,23,F,HSX:MTF,ZA,2007/02/14,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,4040,,VI,positive,NA,0.12,NO,50.05,-,-,70,33,102,3.0751,0.085,Selection (possible Ab pressure)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,705010015,21,F,HSX:MTF,ZA,2007/01/12,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,47900,,V,positive,NA,0.11,NO,44.62,-,-,88,35,157,2.7115,0.594,Selection (possible CTL escape)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,705010110,23,M,HSX:FTM,ZA,2007/03/26,S,Plasma,SGA,Sanger,gp160,,20,C,C,1,single,38313,,VI,positive,NA,0.09,NO,38.84,-,-,61,24,107,2.3421,0.394,Selection (possible Ab pressure)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,706010018,19,F,HSX:MTF,ZA,2007/06/04,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,93700,,VI,positive,NA,0.24,NO,103.6,-,-,166,82,262,6.2451,0,Selection (possible Ab pressure)
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,705010026,25,F,HSX:MTF,ZA,2007/02/01,S,Plasma,SGA,Sanger,gp160,,23,C,C,1,single,8971,,V,positive,NA,0.08,NO,34.94,-,-,50,21,84,2.1107,0.966,Diversity in one lineage
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,705010078,22,M,HSX:FTM,ZA,2007/02/27,S,Plasma,SGA,Sanger,gp160,,26,C,C,1,single,255907,,V,positive,NA,0.05,NO,21.1,-,-,33,9,65,1.24,0.669,Diversity in one lineage
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,703010010,25,M,HSX:FTM,MW,2006/12/28,S,Plasma,SGA,Sanger,gp160,,22,C,C,3,multiple,408727,,III,positive,NA,0.41,NO,0.41,-,-,2143,540,4986,10.1732,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,703010200,24,M,HSX:FTM,MW,2007/05/18,S,Plasma,SGA,Sanger,gp160,,18,C,C,3,multiple,128677,,IV,positive,NA,1.23,NO,1.23,-,-,1691,664,3222,31.2353,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,703010228,19,M,HSX:FTM,MW,2007/06/07,S,Plasma,SGA,Sanger,gp160,,28,C,C,2,multiple,335000,,IV,positive,NA,1.45,NO,1.45,-,-,1188,451,2326,35.5344,0,
Abrahams,J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08,Quantitating the multiplicity of infection with human immunodeficiency Virus type 1 subtype C reveals a non-poisson distribution of transmitted variants,2009,CHAVI001,,,Y,"Poisson GOF, BEAST TMRCA, Highlighter",pooled,706010151,23,F,HSX:MTF,ZA,2003/08/23,S,Plasma,SGA,Sanger,gp160,,15,C,C,2,multiple,49000,,VI,positive,NA,0.93,NO,0.93,-,-,3448,1349,6679,24.0762,0,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,PSF,,,Y,phylo_tp_asr,phylogenetic,RW36M,,M,HSX:FTM,RW,2005/03/07,S,PBMC,SGA,Sanger,gp160,,41,A1,A,1,single,,,V,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM292M,,M,HSX:FTM,ZM,2005/03/24,S,PBMC,SGA,Sanger,gp160,,39,A1,A,1,single,,,II,negative,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,highlighter,haplotype,ZM184F,,F,HSX:MTF,ZM,2003/07/10,S,PBMC,SGA,Sanger,gp160,,26,C,C,1,single,,,V,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,,highlighter,haplotype,ZM197M,,M,HSX:FTM,ZM,2002/10/29,S,PBMC,SGA,Sanger,gp160,,,C,C,1,single,,,I,negative,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM198F,,F,HSX:MTF,ZM,2004/03/04,S,PBMC,SGA,Sanger,gp160,,41,C,C,NA,NA,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM201M,,M,HSX:FTM,ZM,2003/02/01,S,PBMC,SGA,Sanger,gp160,,46,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM205F,,F,HSX:MTF,ZM,2003/03/27,S,PBMC,SGA,Sanger,gp160,,42,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,highlighter,haplotype,ZM215F,,F,HSX:MTF,ZM,2002/10/03,S,PBMC,SGA,Sanger,gp160,,32,C,C,2,multiple,,,VI,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM216M,,M,HSX:FTM,ZM,2004/01/17,S,PBMC,SGA,Sanger,gp160,,59,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM221M,,M,HSX:FTM,ZM,2003/03/07,S,PBMC,SGA,Sanger,gp160,,73,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM229M,,M,HSX:FTM,ZM,2002/10/19,S,PBMC,SGA,Sanger,gp160,,29,C,C,2,multiple,,,VI,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM238M,,M,HSX:FTM,ZM,2002/10/29,S,PBMC,SGA,Sanger,gp160,,39,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM242F,,F,HSX:MTF,ZM,2003/01/25,S,PBMC,SGA,Sanger,gp160,,31,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM243F,,F,HSX:MTF,ZM,2004/03/09,S,PBMC,SGA,Sanger,gp160,,45,C,C,1,single,,,II,negative,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,highlighter,haplotype,ZM247F,,F,HSX:MTF,ZM,2003/11/01,S,PBMC,SGA,Sanger,gp160,,25,C,C,2,multiple,,,II,negative,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,highlighter,haplotype,ZM249M,,M,HSX:FTM,ZM,2003/08/12,S,PBMC,SGA,Sanger,gp160,,22,C,C,1,single,,,II,negative,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,,,Y,phylo_tp_asr,phylogenetic,ZM248F,,F,HSX:MTF,ZM,2003/06/05,S,PBMC,SGA,Sanger,gp160,,22,NA,NA,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,PSF,1,,,phylo_tp_asr,phylogenetic,RW41M,,M,HSX:FTM,RW,2005/01/21,S,PBMC,SGA,Sanger,gp160,,,A1,A,1,single,,,V,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,PSF,1,,,phylo_tp_asr,phylogenetic,RW19F,,F,HSX:MTF,RW,2005/02/02,S,PBMC,SGA,Sanger,gp160,,,A1,A,1,single,,,V,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,PSF,1,,,phylo_tp_asr,phylogenetic,RW35M,,M,HSX:FTM,RW,2005/02/28,S,PBMC,SGA,Sanger,gp160,,,A1,A,1,single,,,V,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,PSF,1,,Y,phylo_tp_asr,phylogenetic,RW56F,,F,HSX:MTF,RW,2005/04/21,S,PBMC,SGA,Sanger,gp160,,,A1,A,1,single,,,I,negative,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,PSF,1,,,phylo_tp_asr,phylogenetic,RW53F,,F,HSX:MTF,RW,2005/06/29,S,PBMC,SGA,Sanger,gp160,,,A1,A,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,PSF,1,,,phylo_tp_asr,phylogenetic,RW57F,,F,HSX:MTF,RW,2005/10/12,S,PBMC,SGA,Sanger,gp160,,,A1,A,2,multiple,,,V,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,PSF,1,,,phylo_tp_asr,phylogenetic,RW67M,,M,HSX:FTM,RW,2026/04/23,S,PBMC,SGA,Sanger,gp160,,,A1,A,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,1,,Y,phylo_tp_asr,phylogenetic,ZM190F,,F,HSX:MTF,ZM,2003/12/06,S,PBMC,SGA,Sanger,gp160,,,C,C,1,single,,,III/IV,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,1,,,highlighter,haplotype,ZM224F,,F,HSX:MTF,ZM,2002/11/05,S,PBMC,SGA,Sanger,gp160,,,C,C,2,multiple,,,V,positive,,,,,,,,,,,,
Haaland,PLoS Pathog. 2009 Jan 5(1):e1000274. doi: 10.1371/journal.ppat.100049,Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1,2009,ZEHRP,1,,,highlighter,haplotype,ZM233M,,M,HSX:FTM,ZM,2002/12/17,S,PBMC,SGA,Sanger,gp160,,,C,C,1,single,,,V,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,3021,36,M,HSX:FTM,US-MD,,LT,Plasma,SGA,Sanger,gag-pro-pol,,,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,3024,56,F,HSX:MTF,US-MD,,LT,Plasma,SGA,Sanger,gag-pro-pol,,,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,3036,37,M,HSX:FTM,US-MD,,LT,Plasma,SGA,Sanger,gag-pro-pol,,,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,3037,36,M,MSM,US-MD,,LT,Plasma,SGA,Sanger,gag-pro-pol,,NA,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,3041,36,F,PWID,US-MD,,LT,Plasma,SGA,Sanger,gag-pro-pol,,,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,3062,38,M,MSM,US-MD,,LT,Plasma,SGA,Sanger,gag-pro-pol,,NA,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,3077,34,M,HSX:FTM,US-MD,,LT,Plasma,SGA,Sanger,gag-pro-pol,,,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,3088,25,M,MSM,US-MD,,LT,Plasma,SGA,Sanger,gag-pro-pol,,NA,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,1002,30,M,MSM,US-CA,,LT,Plasma,SGA,Sanger,gag-pro-pol,,NA,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,1003,38,M,MSM,US-CA,,LT,Plasma,SGA,Sanger,gag-pro-pol,,NA,B,B,2,multiple,,,,negative,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,1004,38,M,MSM,US-CA,,LT,Plasma,SGA,Sanger,gag-pro-pol,,NA,B,B,1,single,,,,positive,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,1005,28,M,MSM,US-CA,,LT,Plasma,SGA,Sanger,gag-pro-pol,,NA,B,B,2,multiple,,,,negative,,,,,,,,,,,,
Kearney,J Virol. 2009 Mar;83(6):2715-27.doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30.,Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.,2009,AIEDRP,1,,,phylo_cohort_topol,phylogenetic,1006,36,M,MSM,US-CA,,LT,Plasma,SGA,Sanger,gag-pro-pol,,NA,B,B,1,single,,,,positive,,,,,,,,,,,,
Novitsky,Virology. 2009 Jan 5; 383(1): 47–59. Published online 2008 Oct 29. doi: 10.1016/j.virol.2008.09.017,Evolution of proviral gp120 over the first year of HIV-1 subtype C infection,2009,Tshedimoso,,,Y,Phylo-Topology,phylogenetic,A-1811,,F,HSX:MTF,BW,,LT,PMBC,SGA,Sanger,gp120,,19,C,C,2,multiple,,,I/II,negative,,,,,,,,,,,,
Novitsky,Virology. 2009 Jan 5; 383(1): 47–59. Published online 2008 Oct 29. doi: 10.1016/j.virol.2008.09.017,Evolution of proviral gp120 over the first year of HIV-1 subtype C infection,2009,Tshedimoso,,,Y,Phylo-Topology,phylogenetic,B-2865,,F,HSX:MTF,BW,2M6F,LT,PMBC,SGA,Sanger,gp120,,33,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Novitsky,Virology. 2009 Jan 5; 383(1): 47–59. Published online 2008 Oct 29. doi: 10.1016/j.virol.2008.09.017,Evolution of proviral gp120 over the first year of HIV-1 subtype C infection,2009,Tshedimoso,,,Y,Phylo-Topology,phylogenetic,C-3312,,F,HSX:MTF,BW,,LT,PMBC,SGA,Sanger,gp120,,30,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Novitsky,Virology. 2009 Jan 5; 383(1): 47–59. Published online 2008 Oct 29. doi: 10.1016/j.virol.2008.09.017,Evolution of proviral gp120 over the first year of HIV-1 subtype C infection,2009,Tshedimoso,,,Y,Phylo-Topology,phylogenetic,D-5018,,M,HSX:FTM,BW,,LT,PMBC,SGA,Sanger,gp120,,22,C,C,2,multiple,,,I/II,negative,,,,,,,,,,,,
Novitsky,Virology. 2009 Jan 5; 383(1): 47–59. Published online 2008 Oct 29. doi: 10.1016/j.virol.2008.09.017,Evolution of proviral gp120 over the first year of HIV-1 subtype C infection,2009,Tshedimoso,,,Y,Phylo-Topology,phylogenetic,E-3430,,F,HSX:MTF,BW,,LT,PMBC,SGA,Sanger,gp120,,12,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Novitsky,Virology. 2009 Jan 5; 383(1): 47–59. Published online 2008 Oct 29. doi: 10.1016/j.virol.2008.09.017,Evolution of proviral gp120 over the first year of HIV-1 subtype C infection,2009,Tshedimoso,,,Y,Phylo-Topology,phylogenetic,F-3505,,F,HSX:MTF,BW,,LT,PMBC,SGA,Sanger,gp120,,13,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Novitsky,Virology. 2009 Jan 5; 383(1): 47–59. Published online 2008 Oct 29. doi: 10.1016/j.virol.2008.09.017,Evolution of proviral gp120 over the first year of HIV-1 subtype C infection,2009,Tshedimoso,,,Y,Phylo-Topology,phylogenetic,G-3603,,M,HSX:FTM,BW,,LT,PMBC,SGA,Sanger,gp120,,11,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Novitsky,Virology. 2009 Jan 5; 383(1): 47–59. Published online 2008 Oct 29. doi: 10.1016/j.virol.2008.09.017,Evolution of proviral gp120 over the first year of HIV-1 subtype C infection,2009,Tshedimoso,,,Y,Phylo-Topology,phylogenetic,H-5582,,F,HSX:FTM,BW,,LT,PMBC,SGA,Sanger,gp120,,12,C,C,1,single,,,I/II,negative,,,,,,,,,,,,
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,Keele,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,SUMA0874,,M,MSM,US-AL,1991/05/13,S,Plasma,SGA,Sanger,WG,9033,6,B,B,1,single,939260,,II,negative,4,0.03,,11,7,15,,,,2.33,0.546,
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,Keele,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,WEAU0575,,M,MSM,US-AL,1990/05/30,S,Plasma,SGA,Sanger,WG,9028,9,B,B,1,single,216415,,II,negative,7,0.03,,14,8,21,,,,3.06,0.49,Early stochastic
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,Keele,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,TRJO4551,,M,MSM,US-AL,2001/10/10,S,Plasma,SGA,Sanger,WG,9051,7,B,B,1,single,8121951,,II,negative,7,0.06,,20,14,26,,,,4.29,0.836,
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,Keele,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,04013226-2,,M,MSM,US-NY,2002/11/20,S,Plasma,SGA,Sanger,WG,9068,8,B,B,1,single,26700000,,II,negative,10,0.08,,33,28,36,,,,7.04,0.269,Early stochastic
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,Keele,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,04013396-0,,M,MSM,US-NY,2005/08/16,S,Plasma,SGA,Sanger,WG,9049,4,B,B,1,single,1600000,,IV,positive,5,0.03,,12,7,17,,,,2.5,0.704,
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,CHAVI001,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,CH40/700010040,,M,MSM,US-NC,2006/07/11,LT,Serum,SGA,Sanger,WG,3593,9,B,B,1,single,2197248,,II,negative,4,0.04,,16,12,21,,,,1.372,0.251,
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,CHAVI001,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,CH58/700010058,,M,MSM,US-NC,2006/08/22,LT,Serum,SGA,Sanger,WG,9027,23,B,B,1,single,92581,,II,negative,9,0.06,,24,14,33,,,,5.05,0.941,Early stochastic
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,CHAVI001,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,CH77/700010077,,M,MSM,US-NC,2006/08/25,LT,Serum,SGA,Sanger,WG,9048,10,B,B,1,single,3565728,,II,negative,12,0.06,,27,16,37,,,,5.75,0.46,CTL selection
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,ZEHRP,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,ZM246F,,F,HSX:FTM,ZM,2003/01/14,S,Plasma,SGA,Sanger,WG,9054,12,C,C,2,multiple,10013800,,II,negative,5,0.03,,15,9,20,,,,3.1,0.671,
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,ZEHRP,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,ZM247F,,F,HSX:FTM,ZM,2003/10/28,S,Plasma,SGA,Sanger,WG,9040,4,C,C,1,single,10823500,,II,negative,8,0.05,,21,14,28,,,,4.5,0.967,
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,ZEHRP,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,ZM249M,,M,HSX:FTM,ZM,2003/08/05,S,Plasma,SGA,Sanger,WG,9040,8,C,C,1,single,">2,000,000",,IV,positive,220,1.19,,493,314,673,,,,106.197,0,Two strains
Salazar-Gonzalez,J Exp Med. 2009 Jun 8; 206(6): 1273–1289. doi: 10.1084/jem.20090378,"Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection",2009,Keele,,,Y,"poisson_both, phyl_recip_topol, diversity",pooled,WITO4160,,M,HSX:FTM,US-AL,2000/08/04,S,Plasma,SGA,Sanger,WG,9027,14,B,B,1,single,325064,,II,negative,8,0.04,,17,12,22,,,,3.57,0.923,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,864,,M,MSM,,Apr-88,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,4421,960,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,866,,M,MSM,,May-90,S,Plasma,SGA,Sanger,gp120,,12,B,B,NA,single,146996,1201,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,869,,M,MSM,,May-84,S,Plasma,SGA,Sanger,gp120,,13,B,B,NA,single,1157374,328,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,871,,M,MSM,,May-85,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,2156818,657,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,872,,M,MSM,,May-85,S,Plasma,SGA,Sanger,gp120,,17,B,B,NA,single,428293,1081,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,877,,M,MSM,,Jul-84,S,Plasma,SGA,Sanger,gp120,,17,B,B,NA,single,965,890,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,878,,M,MSM,,Jun-85,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,single,30778,1226,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,884,,M,MSM,,Feb-89,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,1479787,756,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,891,,M,MSM,,Nov-84,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,single,207787,700,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,892,,M,MSM,,Oct-84,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,73090,2575,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,898,,M,MSM,,Mar-89,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,single,5932,1255,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,899,,M,MSM,,Jun-84,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,single,30170,941,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,907,,M,MSM,,Jul-84,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,656468,488,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,914,,M,MSM,,Aug-84,S,Plasma,SGA,Sanger,gp120,,17,B,B,NA,single,1832811,673,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,916,,M,MSM,,Aug-84,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,308717,899,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,917,,M,MSM,,Mar-85,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,single,616267,816,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,925,,M,MSM,,Oct-85,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,single,22789,701,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,926,,M,MSM,,Aug-91,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,98983,547,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,929,,M,MSM,,Sep-98,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,7815,996,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,930,,M,MSM,,Oct-90,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,single,83322,998,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,932,,M,MSM,,Sep-85,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,99813,752,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,934,,M,MSM,,Aug-94,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,single,1860221,379,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,937,,M,MSM,,Apr-89,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,single,3042,1452,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,941,,M,MSM,,Nov-90,S,Plasma,SGA,Sanger,gp120,,14,B,B,NA,multiple,59345,777,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,942,,M,MSM,,Dec-95,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,multiple,13056548,335,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,952,,M,MSM,,May-86,S,Plasma,SGA,Sanger,gp120,,12,B,B,NA,multiple,806897,308,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,957,,M,MSM,,Jul-92,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,multiple,2133882,541,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,960,,M,MSM,,Feb-85,S,Plasma,SGA,Sanger,gp120,,11,B,B,NA,multiple,3375,1138,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,961,,M,MSM,,Feb-85,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,multiple,66765,1786,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,962,,M,MSM,,Feb-85,S,Plasma,SGA,Sanger,gp120,,11,B,B,NA,multiple,5798077,304,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,974,,M,MSM,,Sep-85,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,multiple,21115,723,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,975,,M,MSM,,Jul-84,S,Plasma,SGA,Sanger,gp120,,17,B,B,NA,multiple,15996,774,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,976,,M,MSM,,Mar-85,S,Plasma,SGA,Sanger,gp120,,19,B,B,NA,multiple,240469,511,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,977,,M,MSM,,Jul-84,S,Plasma,SGA,Sanger,gp120,,19,B,B,NA,multiple,1128784,506,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,981,,M,MSM,,Sep-84,S,Plasma,SGA,Sanger,gp120,,19,B,B,NA,multiple,2923145,662,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,993,,M,MSM,,Nov-84,S,Plasma,SGA,Sanger,gp120,,15,B,B,NA,multiple,1568576,531,,negative,,,,,,,,,,,,
Gottlieb,J Infect Dis. 2008 Apr 1; 197(7): 1011–1015. doi: 10.1086/529206,HIV-1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study,2008,MACS,,,,haplotyope,haplotype,998,,M,MSM,,Feb-90,S,Plasma,SGA,Sanger,gp120,,16,B,B,NA,multiple,6402,927,,negative,,,,,,,,,,,,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,700010019,,F,PWID,US-NC,2006-06-20,S,Plasma,SGA,Sanger,gp160,2586,33,B,B,>3,multiple,741499,,V,positive,63,2.386,NO,17,4,30,1661,875,2653,1.0000,0.853,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,700010040,,M,MSM,US-NC,2006-07-27,S,Plasma,SGA,Sanger,gp160,2556,29,B,B,1,single,298026,,V,positive,5,0.053,NO,23,17,30,26,12,41,1.3380,0.867,Non-star
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,700010058,,M,unknown,US-NC,2006-08-31,S,Plasma,SGA,Sanger,gp160,2625,46,B,B,1,single,394649,,III,positive,10,0.081,NO,36,28,44,51,35,71,2.0720,0.004,"Non-star, not Poisson"
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,700010077,,M,unknown,US-NC,2006-09-08,S,Plasma,SGA,Sanger,gp160,2568,51,B,B,1,single,144145,,V,positive,6,0.079,NO,35,29,41,45,27,65,2.0130,0.417,Non-star
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,701010016,,M,unknown,US-NC,2006-07-24,S,Plasma,SGA,Sanger,gp160,2619,20,B,B,2,multiple,1802,,V,positive,22,0.857,YES,-,-,-,295,127,500,NA,NA,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  1051-12,,F,unknown,US-SC,1997-10-17,S,Plasma,SGA,Sanger,gp160,2577,50,B,B,4,multiple,280000,,III,positive,71,2.711,NO,23,15,31,1060,434,2011,1.3570,0.822,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  12008-09,,NA,unknown,US-MO,1999-10-23,S,Plasma,SGA,Sanger,gp160,2562,31,B,B,2,multiple,>2000000,,II,negative,157,5.931,YES,-,-,-,2030,966,3626,NA,NA,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  62615-03,,NA,unknown,US-TX,1996-11-08,S,Plasma,SGA,Sanger,gp160,2565,28,B,B,3,multiple,2200000,,II,negative,78,2.925,NO,13,4,23,1135,526,2126,0.8000,0.678,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  63068-05,,NA,unknown,US,1997-01-16,S,Plasma,SGA,Sanger,gp160,2592,20,B,B,2,multiple,100000,,II,negative,39,1.519,NO,7,0,15,649,259,1228,0.4290,0.563,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  9026-07,,NA,unknown,US-TX,1998-09-03,S,Plasma,SGA,Sanger,gp160,2619,15,B,B,2,multiple,211703,,III,positive,29,1.121,NO,16,6,25,401,147,782,0.9230,0.816,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  9076-08,,NA,unknown,US-CA,1997-04-28,S,Plasma,SGA,Sanger,gp160,2586,32,B,B,2,multiple,410000,,III,positive,31,1.206,NO,16,9,23,419,152,824,0.9470,0.699,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  BORI 0637,,M,MSM,US-AL,1990-08-23,S,Plasma,SGA,Sanger,gp160,2647,29,B,B,5,multiple,2400000,,II,negative,77,2.954,NO,22,11,32,1951,905,3462,1.2730,0.655,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  CAAN5342,,M,MSM,US-AL,2004-04-13,S,Plasma,SGA,Sanger,gp160,2568,40,B,B,>2,multiple,608560,,V,positive,43,1.676,NO,21,12,30,879,391,1508,1.2090,0.938,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  PRB957-06,,NA,unknown,US-AL,1999-04-28,S,Plasma,SGA,Sanger,gp160,2556,36,B,B,4,multiple,>2000000,,II,negative,173,6.628,YES,-,-,-,1732,1288,4706,NA,NA,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  SC33,,M,HSX:FTM,TT,1994-10-24,S,Plasma,SGA,Sanger,gp160,2610,27,B,B,2,multiple,3277559,,II,negative,105,4.023,NO,20,11,28,1368,604,2448,1.1580,0.804,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  SC42,,M,HSX:FTM,TT,1995-01-18,S,Plasma,SGA,Sanger,gp160,2544,25,B,B,>3,multiple,1380000,,IV,positive,60,2.328,NO,-,-,-,1248,838,1735,NA,NA,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  TT27P,,M,HSX:FTM,TT,1998-01-19,S,Plasma,SGA,Sanger,gp160,2610,38,B,B,3,multiple,1489202,,IV,positive,139,5.295,NO,11,6,16,1764,878,3010,0.6430,0.880,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  Z03,,M,MSM,US-NC,1998-08-06,S,Plasma,SGA,Sanger,gp160,2586,22,B,B,3,multiple,726859,,V,positive,63,2.442,YES,-,-,-,907,411,1635,NA,NA,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  Z10,,M,MSM,US-NC,1999-03-24,S,Plasma,SGA,Sanger,gp160,2559,17,B,B,>2,multiple,327101,,VI,positive,53,2.054,NO,-,-,-,1197,779,1682,NA,NA,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  Z16,,M,MSM,US-NC,1999-08-30,S,Plasma,SGA,Sanger,gp160,2640,19,B,B,5,multiple,2375617,,V,positive,109,4.215,NO,66,47,86,2699,1308,4624,3.8550,0.933,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  Z18,,M,MSM,US-NC,2000-06-30,S,Plasma,SGA,Sanger,gp160,2580,34,B,B,3,multiple,2845823,,V,positive,65,2.508,NO,18,11,25,1244,570,2098,1.0380,0.774,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  Z29,,M,MSM,US-NC,2001-08-13,S,Plasma,SGA,Sanger,gp160,2565,16,B,B,>3,multiple,507401,,V,positive,53,2.008,NO,-,-,-,998,589,1455,NA,NA,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  Z30,,F,HSX:MTF,US-NC,2001-11-05,S,Plasma,SGA,Sanger,gp160,2580,30,B,B,2,multiple,1408114,,V,positive,27,1.044,NO,61,47,76,195,126,262,3.5670,0.534,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,  Z35,,M,MSM,US-NC,2003-01-15,S,Plasma,SGA,Sanger,gp160,2607,21,B,B,2,multiple,2281415,,IV,positive,29,1.133,NO,15,6,24,349,139,655,0.8890,0.476,
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,1001-07^,,F,unknown,US-MO,1997-02-12,S,Plasma,SGA,Sanger,gp160,2538,62,B,B,1,single,210000,,III,positive,7,0.028,YES,12,8,16,19,9,28,0.7100,0.640,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,1006-11,,M,unknown,US-AL,1997-06-05,S,Plasma,SGA,Sanger,gp160,2553,42,B,B,1,single,1600000,,III,positive,4,0.022,NO,10,5,14,15,5,25,0.5710,0.880,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,1012-11,,NA,unknown,US-CA,1997-04-07,S,Plasma,SGA,Sanger,gp160,2545,43,B,B,1,single,410000,,III,positive,6,0.070,NO,31,25,38,34,18,49,1.8280,0.195,Non-star
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,1018-10,,M,unknown,US-SC,1997-06-20,S,Plasma,SGA,Sanger,gp160,2625,50,B,B,1,single,270000,,III,positive,10,0.031,YES,12,7,16,18,9,28,0.6800,0.815,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,1053-07,,M,unknown,US-SC,1997-12-03,S,Plasma,SGA,Sanger,gp160,2616,60,B,B,1,single,1400000,,III,positive,2,0.017,YES,6,3,8,8,3,14,0.3500,0.459,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,1054-07,,M,unknown,US-SC,1997-11-30,S,Plasma,SGA,Sanger,gp160,2568,39,B,B,1,single,320000,,II,negative,5,0.035,NO,15,9,22,23,11,36,0.8890,0.161,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,1056-10,,M,unknown,US-SC,1998-01-14,S,Plasma,SGA,Sanger,gp160,2607,46,B,B,1,single,140000,,II,negative,4,0.027,NO,12,7,16,18,9,27,0.6960,0.824,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,1058-11,,M,unknown,US-SC,1998-03-18,S,Plasma,SGA,Sanger,gp160,2541,45,B,B,1,single,550000,,IV,positive,9,0.054,YES,22,15,29,33,19,48,1.2850,0.035,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,1059-09,,M,unknown,US-CA,1998-03-26,S,Plasma,SGA,Sanger,gp160,2561,39,B,B,1,single,2800000,,III,positive,8,0.052,YES,19,11,26,33,17,50,1.0890,0.379,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,12007-04,,NA,unknown,US,1999-10-22,S,Plasma,SGA,Sanger,gp160,2547,25,B,B,1,single,75815,,II,negative,4,0.025,YES,12,7,17,18,6,32,0.7200,0.128,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,CHAVI001,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,61792-03,,NA,unknown,US-TX,1996-07-29,S,Plasma,SGA,Sanger,gp160,2535,19,B,B,1,single,3700000,,II,negative,3,0.034,NO,15,8,22,18,6,32,0.8890,0.774,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,CHAVI001,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,62130-04,,NA,unknown,US-OH,1996-09-03,S,Plasma,SGA,Sanger,gp160,2583,11,B,B,1,single,600000,,II,negative,4,0.043,NO,19,6,31,23,4,44,1.0910,0.781,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,CHAVI001,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,62357-14,,M,unknown,US-TX,1996-10-02,S,Plasma,SGA,Sanger,gp160,2564,14,B,B,1,single,302000,,II,negative,3,0.044,NO,19,11,28,23,6,44,1.1210,0.673,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,6240-08,,M,unknown,US-MO,1995-11-22,S,Plasma,SGA,Sanger,gp160,2562,17,B,B,1,single,120000,,II,negative,4,0.044,NO,19,11,28,24,8,43,1.1470,0.718,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,6244-13,,M,unknown,US-TX,1996-06-25,S,Plasma,SGA,Sanger,gp160,2592,11,B,B,1,single,274000,,II,negative,4,0.047,NO,21,7,34,24,6,46,1.2360,0.707,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,6247-08,,M,unknown,US-FL,1997-04-07,S,Plasma,SGA,Sanger,gp160,2586,32,B,B,2,multiple,124000,,II,negative,5,0.057,NO,25,17,33,14,2,25,1.4450,0.000,"Non-star, not Poisson"
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,6248-07,,M,unknown,US-TX,1997-03-09,S,Plasma,SGA,Sanger,gp160,2661,20,B,B,1,single,87700000,,III,positive,5,0.087,YES,19,9,28,25,10,45,1.0890,0.821,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,62995-05,,NA,unknown,US,1997-01-03,S,Plasma,SGA,Sanger,gp160,2550,27,B,B,1,single,75000,,I,negative,3,0.030,NO,13,7,19,18,7,33,0.7690,0.762,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,63054-04,,NA,unknown,US,1997-01-19,S,Plasma,SGA,Sanger,gp160,2568,20,B,B,1,single,1153260,,II,negative,4,0.056,NO,25,16,33,30,13,50,1.4370,0.640,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,63215-03,,NA,unknown,US-TX,1997-02-12,S,Plasma,SGA,Sanger,gp160,2571,19,B,B,1,single,550000,,V,positive,4,0.018,YES,8,3,13,7,1,17,0.4440,0.588,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,63358-04,,NA,unknown,US-NC,1997-03-10,S,Plasma,SGA,Sanger,gp160,2601,27,B,B,1,single,260000,,II,negative,6,0.045,YES,20,13,27,27,12,44,1.1850,0.734,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,63396-07,,NA,unknown,US-CA,1997-03-12,S,Plasma,SGA,Sanger,gp160,2565,21,B,B,1,single,420000,,II,negative,2,0.005,NO,6,2,11,7,2,17,0.3810,0.612,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9010-09,,F,unknown,US-SC,1997-11-25,S,Plasma,SGA,Sanger,gp160,2568,19,B,B,1,single,146954,,II,negative,4,0.045,NO,20,11,29,28,14,46,1.1580,0.804,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9014-01,,M,unknown,US-SC,1997-11-13,S,Plasma,SGA,Sanger,gp160,2562,14,B,B,1,single,25680,,II,negative,3,0.041,NO,18,9,27,23,6,45,1.0770,0.731,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9015-07,,M,unknown,US-SC,1997-12-27,S,Plasma,SGA,Sanger,gp160,2562,36,B,B,1,single,500000,,II,positive,4,0.026,NO,11,7,16,17,7,28,0.6670,0.865,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9017-01,,M,unknown,US-SC,1997-12-26,S,Plasma,SGA,Sanger,gp160,2544,26,B,B,1,single,32390,,II,negative,4,0.021,NO,9,3,15,13,4,24,0.5380,0.140,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9019-03,,F,unknown,US-SC,1997-12-28,S,Plasma,SGA,Sanger,gp160,2583,18,B,B,1,single,571000,,V,positive,3,0.054,NO,24,17,30,30,13,50,1.3970,0.342,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9020-20,,F,unknown,US-CA,1998-06-16,S,Plasma,SGA,Sanger,gp160,2571,25,B,B,1,single,69238,,II,negative,5,0.058,NO,25,18,33,33,15,52,1.4730,0.910,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9021-14,,M,unknown,US-CA,1998-06-10,S,Plasma,SGA,Sanger,gp160,2556,34,B,B,1,single,143379,,II,negative,5,0.020,NO,9,3,15,11,3,19,0.5260,0.325,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9022-09,,M,unknown,US-FL,1997-08-31,S,Plasma,SGA,Sanger,gp160,2565,23,B,B,1,single,>500000,,III,positive,2,0.014,YES,6,2,10,6,1,14,0.3640,0.617,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9023-21,,M,unknown,US-NC,1998-07-07,S,Plasma,SGA,Sanger,gp160,2574,18,B,B,1,single,>500000,,II,negative,5,0.052,NO,23,12,33,32,13,53,1.3330,0.958,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9024-12,,NA,unknown,US-MS,1997-07-29,S,Plasma,SGA,Sanger,gp160,2620,25,B,B,1,single,>500000,,II,negative,4,0.061,NO,27,18,35,37,19,59,1.5530,0.615,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9025-11,,M,unknown,US-OR,1998-08-16,S,Plasma,SGA,Sanger,gp160,2598,19,B,B,1,single,>500000,,II,negative,4,0.037,NO,16,8,24,21,6,37,0.9420,0.863,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9028-07,,F,unknown,US-NC,1998-07-29,S,Plasma,SGA,Sanger,gp160,2566,23,B,B,1,single,>500000,,II,negative,2,0.021,NO,9,4,14,12,3,23,0.5220,0.447,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9029-12,,M,unknown,US-NC,1998-09-10,S,Plasma,SGA,Sanger,gp160,2598,22,B,B,1,single,>500000,,II,negative,5,0.030,YES,13,7,19,16,5,30,0.7620,0.132,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9030-15,,M,unknown,US-CA,1998-10-02,S,Plasma,SGA,Sanger,gp160,2553,19,B,B,1,single,>500000,,II,negative,9,0.061,NO,27,9,45,38,16,60,1.5560,0.000,Not Poisson
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9031-19,,M,unknown,US-NC,1998-02-16,S,Plasma,SGA,Sanger,gp160,2562,20,B,B,1,single,237938,,IV,positive,7,0.064,YES,27,18,35,29,12,48,1.5950,0.778,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9032-08,,M,unknown,US-AL,1998-07-30,S,Plasma,SGA,Sanger,gp160,2541,39,B,B,1,single,40815,,III,positive,2,0.022,NO,9,6,13,14,6,24,0.5640,0.212,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9033-16,,M,unknown,US-OR,1998-03-29,S,Plasma,SGA,Sanger,gp160,2568,20,B,B,1,single,454553,,III,positive,4,0.047,NO,21,12,29,28,11,45,1.2000,0.867,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9075-03,,NA,unknown,US-OH,1996-09-13,S,Plasma,SGA,Sanger,gp160,2583,22,B,B,1,single,360000,,II,negative,3,0.025,NO,11,5,17,14,3,26,0.6360,0.887,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,CHAVI001,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9077-12,,NA,unknown,US-NC,1999-12-04,S,Plasma,SGA,Sanger,gp160,2601,24,B,B,1,single,158300,,II,negative,4,0.034,NO,15,7,22,20,6,36,0.8700,0.305,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,CHAVI001,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,9079-09,,NA,unknown,US-CA,1999-12-11,S,Plasma,SGA,Sanger,gp160,2563,26,B,B,1,single,148320,,II,negative,5,0.032,NO,14,7,21,19,8,32,0.8430,0.910,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,MEMI4948,,M,MSM,US-AL,2003-01-28,S,Plasma,SGA,Sanger,gp160,2667,32,B,B,1,single,22686,,V,positive,12,0.186,NO,83,68,98,121,74,169,4.7660,0.026,"Non-star, not Poisson"
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,PRB926-04,,NA,unknown,US,1994-02-19,S,Plasma,SGA,Sanger,gp160,2577,14,B,B,1,single,756060,,II,negative,6,0.061,NO,27,11,43,38,15,64,1.5710,0.083,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,PRB931-06,,NA,unknown,US-WI,1995-09-11,S,Plasma,SGA,Sanger,gp160,2565,19,B,B,1,single,2000000,,III,positive,6,0.095,NO,42,31,53,46,23,73,2.3980,0.638,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,PRB956-04,,NA,unknown,US-VA,1997-08-19,S,Plasma,SGA,Sanger,gp160,2586,27,B,B,1,single,600000,,II,negative,4,0.034,NO,15,9,21,22,9,36,0.8890,0.787,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,PRB958-06,,NA,unknown,US-FL,2000-02-10,S,Plasma,SGA,Sanger,gp160,2625,24,B,B,1,single,678900,,III,positive,5,0.054,NO,24,17,31,31,14,48,1.3950,0.370,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,PRB959-02,,NA,unknown,US-SC,1999-11-17,S,Plasma,SGA,Sanger,gp160,2574,32,B,B,1,single,>2000000,,II,negative,5,0.029,NO,13,6,19,20,8,34,0.7500,0.178,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,REJO4541,,M,HSX:FTM,US-AL,2001-09-28,S,Plasma,SGA,Sanger,gp160,2601,21,B,B,1,single,722349,,V,positive,5,0.052,NO,23,13,33,33,14,54,1.3330,0.893,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,RHPA4259^^,,F,HSX:MTF,US-AL,2000-12-05,S,Plasma,SGA,Sanger,gp160,2586,31,B,B,1,single,1458354,,V,positive,6,0.052,YES,22,15,29,31,15,48,1.2860,0.957,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,SC05,,M,HSX:FTM,TT,1993-06-28,S,Plasma,SGA,Sanger,gp160,2575,30,B,B,1,single,9980952,,II,negative,4,0.049,NO,21,15,28,24,10,41,1.2460,0.571,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,SC11,,F,HSX:MTF,TT,1993-10-11,S,Plasma,SGA,Sanger,gp160,2562,20,B,B,1,single,1917073,,II,negative,2,0.008,NO,3,0,7,4,2,8,0.2110,0.694,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,SC20,,M,HSX:FTM,TT,1994-02-17,S,Plasma,SGA,Sanger,gp160,2581,43,B,B,1,single,2789313,,IV,positive,4,0.031,NO,14,8,19,20,10,33,0.7960,0.700,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,SC22,,F,HSX:MTF,TT,1994-03-16,S,Plasma,SGA,Sanger,gp160,2562,38,B,B,1,single,14304820,,II,negative,6,0.068,NO,30,22,38,39,21,58,1.7770,0.001,Not Poisson
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,SC31,,F,HSX:MTF,TT,1994-09-15,S,Plasma,SGA,Sanger,gp160,2577,36,B,B,1,single,4449612,,IV,positive,12,0.070,NO,31,18,44,48,29,69,1.7780,0.000,Not Poisson
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,SC45,,M,HSX:FTM,TT,1995-01-18,S,Plasma,SGA,Sanger,gp160,2550,29,B,B,1,single,6318529,,II,negative,4,0.040,NO,18,12,24,25,11,41,1.0340,0.619,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,SC51,,M,HSX:FTM,TT,1996-01-15,S,Plasma,SGA,Sanger,gp160,2568,33,B,B,1,single,4229703,,V,positive,4,0.052,NO,23,17,28,22,10,36,1.3210,0.063,Non-star
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,SUMA0874,,M,MSM,US-AL,1991-05-13,S,Plasma,SGA,Sanger,gp160,2544,35,B,B,1,single,939260,,II,negative,2,0.024,YES,10,6,13,12,4,22,0.5680,0.243,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,THRO4156,,M,MSM,US-AL,2000-08-01,S,Plasma,SGA,Sanger,gp160,2574,27,B,B,1,single,5413140,,V,positive,6,0.040,NO,17,9,26,27,12,42,1.0370,0.389,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,TRJO4551,,M,MSM,US-AL,2001-10-10,S,Plasma,SGA,Sanger,gp160,2601,18,B,B,1,single,8121951,,II,negative,6,0.080,NO,36,22,49,45,22,75,2.0580,0.902,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,TT28P,,M,HSX:FTM,TT,1998-01-20,S,Plasma,SGA,Sanger,gp160,2526,28,B,B,1,single,7468346,,V,positive,4,0.030,NO,13,8,19,18,7,31,0.7800,0.890,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,TT29P,,M,HSX:FTM,TT,1998-03-20,S,Plasma,SGA,Sanger,gp160,2574,20,B,B,1,single,14756436,,II,negative,3,0.019,NO,8,2,14,10,2,19,0.5000,0.884,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,TT31P,,F,HSX:MTF,TT,1998-10-02,S,Plasma,SGA,Sanger,gp160,2571,67,B,B,2,multiple,21826347,,II,negative,9,0.100,NO,45,39,50,38,25,51,2.5840,0.000,"Non-star, not Poisson"
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,TT34P,,M,HSX:FTM,TT,1998-01-13,S,Plasma,SGA,Sanger,gp160,2589,29,B,B,1,single,3050125,,V,positive,4,0.040,NO,18,11,24,24,10,40,1.0300,0.703,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,TT35P,,M,HSX:FTM,TT,1999-01-26,S,Plasma,SGA,Sanger,gp160,2568,43,B,B,1,single,1849301,,II,negative,4,0.031,YES,13,9,18,15,7,25,0.7860,0.862,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,WEAU0575,,M,MSM,US-AL,1990-05-30,S,Plasma,SGA,Sanger,gp160,2571,44,B,B,1,single,216415,,II,negative,6,0.052,NO,23,17,29,45,29,63,1.3400,0.462,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,WITO4160,,M,HSX:FTM,US-AL,2000-08-04,S,Plasma,SGA,Sanger,gp160,2619,16,B,B,1,single,325064,,II,negative,5,0.054,NO,24,12,36,34,12,58,1.3750,0.940,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z02,,M,HSX:FTM,US-NC,1998-05-27,S,Plasma,SGA,Sanger,gp160,2544,21,B,B,1,single,296111,,V,positive,5,0.059,NO,26,17,35,37,15,60,1.5140,0.947,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z05,,M,HSX:FTM,US-NC,1998-09-21,S,Plasma,SGA,Sanger,gp160,2565,15,B,B,1,single,3950942,,II,negative,4,0.066,NO,29,19,40,41,17,69,1.7140,0.693,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z13,,M,HSX:FTM,US-NC,1999-05-17,S,Plasma,SGA,Sanger,gp160,2571,31,B,B,1,single,53941,,V,positive,9,0.127,NO,57,45,68,79,48,112,3.2160,0.390,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z20,,M,MSM,US-NC,2000-11-01,S,Plasma,SGA,Sanger,gp160,2547,26,B,B,1,single,13466851,,III,positive,4,0.042,NO,18,12,25,26,12,42,1.0770,0.686,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z23,,M,MSM,US-NC,2001-02-01,S,Plasma,SGA,Sanger,gp160,2565,15,B,B,1,single,210521,,V,positive,2,0.031,NO,14,7,20,17,4,33,0.8000,0.206,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z27,,M,HSX:FTM,US-NC,2001-06-20,S,Plasma,SGA,Sanger,gp160,2568,25,B,B,1,single,178125,,V,positive,6,0.074,NO,33,22,44,44,24,70,1.9070,0.187,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z31,,M,MSM,US-NC,2001-12-09,S,Plasma,SGA,Sanger,gp160,2640,17,B,B,>1,multiple,6507075,,II,negative,12,0.248,NO,111,92,130,163,88,243,6.3310,0.152,Non-star
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z32,,M,MSM,US-NC,2002-02-09,S,Plasma,SGA,Sanger,gp160,2580,10,B,B,1,single,5788591,,IV,positive,4,0.046,NO,20,7,33,25,3,48,1.2000,0.800,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z33,,M,MSM,US-NC,2002-10-12,S,Plasma,SGA,Sanger,gp160,2559,21,B,B,1,single,158603,,II,negative,6,0.093,NO,41,31,52,51,23,77,2.3900,0.637,Non-star
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z34,,M,MSM,US-NC,2002-12-17,S,Plasma,SGA,Sanger,gp160,2583,18,B,B,1,single,2501242,,III,positive,6,0.062,NO,28,14,42,43,19,69,1.5880,0.109,NA
Keele,Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105.,Identification and characterization of transmitted and early founder Virus envelopes in primary HIV-1 infection,2008,Keele,,,Y,"Dist, Highlighter, Poisson GOF, Poisson Starlike, Poisson MRCA, BEAST MRCA",pooled,Z36,,M,unknown,US-NC,2003-01-29,S,Plasma,SGA,Sanger,gp160,2535,17,B,B,1,single,1480293,,VI,positive,7,0.110,NO,49,36,62,62,30,97,2.8090,0.890,NA
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_01,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_02,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_03,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_04,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_05,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_06,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_07,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_08,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_09,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_10,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_11,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_12,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_13,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_14,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_15,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_16,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_17,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_18,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_19,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_20,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_21,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_22,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_23,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_24,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IU_25,,INF,MTCT:IU,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_01,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_02,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_03,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_04,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_05,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_06,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_07,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_08,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_09,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_10,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_11,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_12,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_13,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_14,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_15,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_16,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_17,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_18,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_19,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_20,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_21,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_22,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Kwiek,AIDS. 2008 Apr 23; 22(7): 863–871. doi: 10.1097/QAD.0b013e3282f51ea0,The Molecular Epidemiology of HIV-1 Envelope Diversity During HIV-1 Subtype C Vertical Transmission in Malawian Mother-Infant Pairs,2008,,,,,HTA,molecular,Kwiek_IP_23,,INF,MTCT:IP,MW,,S,Plasma,RT-PCR,NA,gp120,,NA,C,C,NA,multiple,,,NA,infant,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM178F,,F,HSX:MTF,ZM-09,2003/01/18,LT,Plasma,SGA,Sanger,gp160,2613,26,C,C,1,single,15620,,VI,positive,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM180M,,M,HSX:FTM,ZM-09,2002/07/20,LT,Plasma,SGA,Sanger,gp160,2560,24,C,C,1,single,575040,,V,positive,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM184F,,F,HSX:MTF,ZM-09,2003/07/10,LT,Plasma,SGA,Sanger,gp160,2621,26,C,C,1,single,89340,,V,positive,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM206F,,F,HSX:MTF,ZM-09,2002/07/13,LT,Plasma,SGA,Sanger,gp160,2560,35,C,C,1,single,87480,,VI,positive,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM214M,,M,HSX:FTM,ZM-09,2003/07/02,LT,Plasma,SGA,Sanger,gp160,2568,35,C,C,2,multiple,198800,,VI,positive,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM215F,,F,HSX:MTF,ZM-09,2002/10/19,LT,Plasma,SGA,Sanger,gp160,2580,32,C,C,4,multiple,608560,,VI,positive,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM229M,,M,HSX:FTM,ZM-09,2002/10/19,LT,Plasma,SGA,Sanger,gp160,2592,29,C,C,4,multiple,1799820,,VI,positive,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM235F,,F,HSX:MTF,ZM-09,2002/12/20,LT,Plasma,SGA,Sanger,gp160,2565,28,C,C,1,single,227000,,V,positive,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM246F,,F,HSX:MTF,ZM-09,2003/01/14,LT,Plasma,SGA,Sanger,gp160,2532,27,C,C,1,single,10013800,,II,negative,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM247F,,F,HSX:MTF,ZM-09,2003/10/28,LT,Plasma,SGA,Sanger,gp160,2595,25,C,C,2,multiple,10823500,,II,negative,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM249M,,M,HSX:FTM,ZM-09,2003/08/05,LT,Plasma,SGA,Sanger,gp160,2563,24,C,C,1,single,">2,000,000",,IV,positive,,,,,,,,,,,,
Salazar-Gonzalez,J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07.,Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing,2008,ZEHRP,,,Y,"phyl_recip_topol, diversity, highlighter",pooled,ZM231F,,F,HSX:MTF,ZM-09,2002/12/17,LT,Plasma,SGA,Sanger,gp160,2545,48,NA,NA,1,single,87300,,V,positive,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QA032,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,14,A1,A,2,multiple,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QA203,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,14,NA,NA,2,multiple,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QA284,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,15,A1,A,1,single,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QA779,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,17,A2,A,1,single,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QA819,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,25,A,A,1,single,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QB424,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,21,A1,A,2,multiple,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QB596,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,16,A1,A,2,multiple,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QB670,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,10,A1,A,1,single,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QC100,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,12,D,D,1,single,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QC168,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,13,A1/D,recombinant,1,single,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QC890,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,16,A1,A,2,multiple,,,,NA,,,,,,,,,,,,
Sagar,AIDS Res Hum Retroviruses. 2006 May;22(5):430-7.,Diversity in HIV-1 Envelope V1-V3 Sequences Early in Infection Reflects Sequence Diversity Throughout the HIV-1 Genome but Does Not Predict the Extent of Sequence Diversity During Chronic Infection,2006,,1,,,pwise_dist_gtr,distance,QD883,,F,HSX:MTF,KE,,LT,PMBC,RT-PCR,Sanger,gp120,,15,A1,A,NA,NA,,,,NA,,,,,,,,,,,,
Derdeyn,"Science 26 Mar 2004: Vol. 303, Issue 5666, pp. 2019-2022 DOI: 10.1126/science.1093137",Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission,2004,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,109_MF,,F,HSX:MTF,ZM,,S,,SGA,Sanger,gp160,,13,C,C,1,single,,,,negative,,,,,,,,,,,,
Derdeyn,"Science 26 Mar 2004: Vol. 303, Issue 5666, pp. 2019-2022 DOI: 10.1126/science.1093137",Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission,2004,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,55_MF,,F,HSX:MTF,ZM,,S,,SGA,Sanger,gp160,,16,C,C,1,single,,,,negative,,,,,,,,,,,,
Derdeyn,"Science 26 Mar 2004: Vol. 303, Issue 5666, pp. 2019-2022 DOI: 10.1126/science.1093137",Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission,2004,Derdeyn et al. 2004,,,,phylo_tp_asr_topol,phylogenetic,106_MF,,F,HSX:MTF,ZM,,S,,SGA,Sanger,gp160,,13,C,C,1,single,,,,negative,,,,,,,,,,,,
Derdeyn,"Science 26 Mar 2004: Vol. 303, Issue 5666, pp. 2019-2022 DOI: 10.1126/science.1093137",Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission,2004,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,13_MF,,F,HSX:MTF,ZM,,S,,SGA,Sanger,gp160,,16,C,C,1,single,,,,negative,,,,,,,,,,,,
Derdeyn,"Science 26 Mar 2004: Vol. 303, Issue 5666, pp. 2019-2022 DOI: 10.1126/science.1093137",Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission,2004,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,53_FM,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gp160,,18,C,C,1,single,,,,negative,,,,,,,,,,,,
Derdeyn,"Science 26 Mar 2004: Vol. 303, Issue 5666, pp. 2019-2022 DOI: 10.1126/science.1093137",Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission,2004,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,135_FM,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gp160,,20,C,C,1,single,,,,negative,,,,,,,,,,,,
Derdeyn,"Science 26 Mar 2004: Vol. 303, Issue 5666, pp. 2019-2022 DOI: 10.1126/science.1093137",Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission,2004,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,83_FM,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gp160,,13,C,C,1,single,,,,negative,,,,,,,,,,,,
Derdeyn,"Science 26 Mar 2004: Vol. 303, Issue 5666, pp. 2019-2022 DOI: 10.1126/science.1093137",Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission,2004,Derdeyn et al. 2004,,,Y,phylo_tp_asr_topol,phylogenetic,71_FM,,M,HSX:FTM,ZM,,S,,SGA,Sanger,gp160,,11,G,G,1,single,,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z01,,F,HSX:MTF,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,31623,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z02,,M,HSX:FTM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,316228,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z03,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,199526,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z04,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,199526,,,positive,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z05,,M,HSX:FTM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,10000000,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z06,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,501187,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z07,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,5012,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z08,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,316228,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z09,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,25119,,,positive,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z10,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,199526,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z11,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,1258925,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z12,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,125893,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z13,,M,HSX:FTM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,50119,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z14,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,630957,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z15,,F,HSX:MTF,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,199526,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z16,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,1584893,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z17,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,2511886,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z18,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,3162278,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z20,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,12589254,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z23,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,199526,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z24,,M,HSX:FTM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,19952623,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z26,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,1258925,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z27,,M,HSX:FTM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,199526,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z29,,M,MSM,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,501187,,,negative,,,,,,,,,,,,
Ritola,J Virol. 2004 Oct; 78(20): 11208–11218. doi: 10.1128/JVI.78.20.11208-11218.2004,Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1,2004,,,,,HMA,molecular,Z30,,F,HSX:MTF,,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,1584893,,,negative,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F10,,F,HSX:MTF,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F11,,F,HSX:MTF,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F14,,F,PWID,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F15,,F,PWID,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F16,,F,PWID,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F2,,F,PWID,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F3,,F,HSX:MTF,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F4,,F,PWID,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F5,,F,PWID,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F7,,F,HSX:MTF,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,F9,,F,PWID,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,K-C,,F,HSX:MTF,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,M1,,M,MSM,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,M2,,M,MSM,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,M3,,M,PWID,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,M4,,M,PWID,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,,,,HMA,molecular,MEM,,F,HSX:MTF,US,,S,Plasma,RT-PCR,NA,gp120,,NA,B,B,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T135,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,A1,A,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T158,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T199,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,A1,A,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T263,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,A1,A,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T387,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T457,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T518,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T594,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T645,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2004 Jul; 78(13): 7279–7283.doi: 10.1128/JVI.78.13.7279-7283.2004,Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes,2004,,1,,,HMA,molecular,T650,,M,HSX:FTM,KE,,S,Plasma,RT-PCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,1,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,2,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,3,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,4,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,5,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,6,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,7,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,8,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,9,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,10,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,11,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,12,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,13,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,14,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,15,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,43,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,44,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,45,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,46,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,A,A,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,16,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,17,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,18,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,19,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,20,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,21,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,22,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,23,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,24,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,25,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,26,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,27,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,28,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,29,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,30,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,31,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,47,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,48,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,49,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,50,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C,C,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,52,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C/D,recombinant,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,53,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,C/D,recombinant,NA,multiple,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,37,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,CRF?,recombinant,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,38,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,CRF?,recombinant,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,39,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,CRF?,recombinant,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,40,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,CRF?,recombinant,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,41,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,CRF?,recombinant,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,42,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,CRF?,recombinant,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,32,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,D,D,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,33,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,D,D,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,34,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,D,D,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,35,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,D,D,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,36,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,D,D,NA,single,,,,infant,,,,,,,,,,,,
Renjifo,Virology 2003 Mar; 307(2): 278-282. doi: 10.1016/S0042-6822(02)00066-1,In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes.,2003,,,,,HMA,molecular,51,,INF,MTCT:IU,TZ-02,,S,PMBC,PCR,NA,gp120,,NA,D,D,NA,multiple,,,,infant,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_1,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_10,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_100,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_101,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_102,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_103,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_104,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_105,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_106,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_107,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_108,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_109,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_11,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_110,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_111,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_112,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_113,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_114,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_115,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_116,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_117,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_118,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_119,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_12,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_120,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_121,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_122,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_123,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_124,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_13,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_14,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_15,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_16,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_17,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_18,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_19,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_2,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_20,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_21,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_22,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_23,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_24,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_25,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_26,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_27,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_28,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_29,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_3,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_30,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_31,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_32,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_33,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_34,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_35,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_36,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_37,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_38,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_39,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_4,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_40,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_41,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_42,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_43,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_44,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_45,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_46,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_47,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_48,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_49,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_5,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_50,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_51,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_52,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_53,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_54,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_55,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_56,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_57,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_58,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_59,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_6,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_60,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_61,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_62,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_63,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_64,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_65,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_66,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_67,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_68,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_69,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_7,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_70,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_71,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_72,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_73,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_74,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_75,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_76,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_77,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_78,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_79,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_8,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_80,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_81,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_82,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_83,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_84,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_85,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_86,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_87,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_88,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_89,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_9,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,single,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_90,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_91,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_92,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_93,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_94,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_95,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_96,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_97,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_98,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Sagar,J Virol. 2003 Dec; 77(23): 12921–12926. doi: 10.1128/JVI.77.23.12921-12926.2003,Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression,2003,,1,,,HMA,molecular,Sagar_99,,F,HSX:MTF,KE,,S,PBMC,RT-qPCR,NA,gp120,,NA,,NA,NA,multiple,,,,NA,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IP1,,M,MTCT:IP,KE-28,,S,WB,Nested PCR,Sanger,gp120,,11,A,A,1,single,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IP2,,F,MTCT:IP,KE-28,,S,WB,Nested PCR,Sanger,gp120,,17,A,A,2,multiple,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IP3,,M,MTCT:IP,KE-28,,S,WB,Nested PCR,Sanger,gp120,,21,A,A,1,single,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IP4,,M,MTCT:IP,KE-28,,S,WB,Nested PCR,Sanger,gp120,,16,A,A,1,single,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IP5,,M,MTCT:IP,KE-28,,S,WB,Nested PCR,Sanger,gp120,,21,A,A,2,multiple,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IP6,,F,MTCT:IP,KE-28,,S,WB,Nested PCR,Sanger,gp120,,17,A,A,2,multiple,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IP7,,M,MTCT:IP,KE-28,,S,WB,Nested PCR,Sanger,gp120,,20,A,A,1,single,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IU1,,M,MTCT:IU,KE-28,,LT,WB,Nested PCR,Sanger,gp120,,32,A,A,1,single,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IU2,,F,MTCT:IU,KE-28,,LT,WB,Nested PCR,Sanger,gp120,,16,A,A,1,single,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IU3,,F,MTCT:IU,KE-28,,LT,WB,Nested PCR,Sanger,gp120,,33,A,A,2,multiple,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IU4,,M,MTCT:IU,KE-28,,LT,WB,Nested PCR,Sanger,gp120,,29,A,A,2,multiple,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IU5,,M,MTCT:IU,KE-28,,LT,WB,Nested PCR,Sanger,gp120,,36,A,A,2,multiple,,,,infant,,,,,,,,,,,,
Verhofstede,J Virol. 2003 Mar; 77(5): 3050–3057. doi: 10.1128/JVI.77.5.3050-3057.2003,Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A,2003,,,,,phylo_tp_topol,phylogenetic,IU6,,M,MTCT:IU,KE-28,,LT,WB,Nested PCR,Sanger,gp120,,20,A,A,2,multiple,,,,infant,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1001,,F,HSX:MTF,US,,S,Plasma,Nested PCR,Sanger,gp120,,66,B,B,1,single,,,,NA,,,,,,,,,,,,"can potentially infer fiebig from data in paper, but not clear."
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1002,,F,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,1,B,B,1,single,,,,NA,,,,,,,,,,,,paper acknowledges not possible to include risk group/transmission
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1006,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,48,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1011,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,4,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1013,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,2,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1016,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,1,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1018,,M,HSX:FTM,US,,S,Plasma,Nested PCR,Sanger,gp120,,57,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1026,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,1,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1028,,F,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,5,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1032,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,1,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1051,,F,HSX:MTF,US,,S,Plasma,Nested PCR,Sanger,gp120,,103,B,B,2,multiple,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1053,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,63,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1054,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,42,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1055,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,1,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1056,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,108,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1058,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,104,B,B,1,single,,,,NA,,,,,,,,,,,,
Delwart,AIDS. 2002 Jan 25;16(2):189-95. doi: 10.1097/00002030-200201250-00007.,Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection,2002,,,,Y,"HMA, Haplotype",pooled,1059,,M,unknown,US,,S,Plasma,Nested PCR,Sanger,gp120,,141,B,B,1,single,,,,NA,,,,,,,,,,,,
Learn,J Virol. 2002 Dec;76(23):11953-9. doi: 10.1128/jvi.76.23.11953-11959.2002.,Virus population homogenization following acute human immunodeficiency virus type 1 infection.,2002,WPIC,,,,HMA,molecular,WPIC_A,,M,MSM,US-WA,,S,Plasma,Nested PCR,NA,gp120,,NA,B,B,NA,multiple,,,,positive,,,,,,,,,,,,
Learn,J Virol. 2002 Dec;76(23):11953-9. doi: 10.1128/jvi.76.23.11953-11959.2002.,Virus population homogenization following acute human immunodeficiency virus type 1 infection.,2002,WPIC,,,,HMA,molecular,WPIC_B,,M,MSM,US-WA,,S,Plasma,Nested PCR,NA,gp120,,NA,B,B,NA,multiple,,,,positive,,,,,,,,,,,,
Learn,J Virol. 2002 Dec;76(23):11953-9. doi: 10.1128/jvi.76.23.11953-11959.2002.,Virus population homogenization following acute human immunodeficiency virus type 1 infection.,2002,WPIC,,,,HMA,molecular,WPIC_C,,M,MSM,US-WA,,S,Plasma,Nested PCR,NA,gp120,,NA,B,B,NA,multiple,,,,positive,,,,,,,,,,,,
Learn,J Virol. 2002 Dec;76(23):11953-9. doi: 10.1128/jvi.76.23.11953-11959.2002.,Virus population homogenization following acute human immunodeficiency virus type 1 infection.,2002,WPIC,,,,HMA,molecular,WPIC_D,,M,MSM,US-WA,,S,Plasma,Nested PCR,NA,gp120,,NA,B,B,NA,multiple,,,,positive,,,,,,,,,,,,
Learn,J Virol. 2002 Dec;76(23):11953-9. doi: 10.1128/jvi.76.23.11953-11959.2002.,Virus population homogenization following acute human immunodeficiency virus type 1 infection.,2002,WPIC,,,,HMA,molecular,WPIC_E,,M,MSM,US-WA,,S,Plasma,Nested PCR,NA,gp120,,NA,B,B,NA,single,,,,positive,,,,,,,,,,,,
Learn,J Virol. 2002 Dec;76(23):11953-9. doi: 10.1128/jvi.76.23.11953-11959.2002.,Virus population homogenization following acute human immunodeficiency virus type 1 infection.,2002,WPIC,,,,HMA,molecular,WPIC_F,,M,MSM,US-WA,,S,Plasma,Nested PCR,NA,gp120,,NA,B,B,NA,single,,,,positive,,,,,,,,,,,,
Learn,J Virol. 2002 Dec;76(23):11953-9. doi: 10.1128/jvi.76.23.11953-11959.2002.,Virus population homogenization following acute human immunodeficiency virus type 1 infection.,2002,WPIC,,,,HMA,molecular,WPIC_G,,M,MSM,US-WA,,S,Plasma,Nested PCR,NA,gp120,,NA,B,B,NA,single,,,,positive,,,,,,,,,,,,
Learn,J Virol. 2002 Dec;76(23):11953-9. doi: 10.1128/jvi.76.23.11953-11959.2002.,Virus population homogenization following acute human immunodeficiency virus type 1 infection.,2002,WPIC,,,,HMA,molecular,WPIC_H,,M,MSM,US-WA,,S,Plasma,Nested PCR,NA,gp120,,NA,B,B,NA,single,,,,positive,,,,,,,,,,,,
Long,AIDS Res Hum Retroviruses. 2002 May 20;18(8):567-76. doi: 10.1089/088922202753747914. ,"HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus",2002,,,,,genetic distance,distance,Q168,,W,HSX:MTF,KE,,S,PBMC,PCR,sanger,gp120,,13,UNKNOWN,NA,NA,single,,,,NA,,,,,,,,,,,,
Long,AIDS Res Hum Retroviruses. 2002 May 20;18(8):567-76. doi: 10.1089/088922202753747914. ,"HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus",2002,,,,,genetic distance,distance,Q461,,W,HSX:MTF,KE,,S,PBMC,PCR,sanger,gp120,,26,UNKNOWN,NA,NA,single,,,,NA,,,,,,,,,,,,
Nowak,HIV Med. 2002 Jan;3(1):1-11. doi: 10.1046/j.1464-2662.2001.00097.x.,The selection and evolution of viral quasispecies in HIV‐1 infected children,2002,,,,,phylogenetic topologies,phylogenetic,C1,,INF,MTCT:unknown,SE,,LT,PBMC,PCR,sanger,gp120,,44,B,B,NA,single,,,,infant,,,,,,,,,,,,
Nowak,HIV Med. 2002 Jan;3(1):1-11. doi: 10.1046/j.1464-2662.2001.00097.x.,The selection and evolution of viral quasispecies in HIV‐1 infected children,2002,,,,,phylogenetic topologies,phylogenetic,C2,,INF,MTCT:unknown,SE,,LT,PBMC,PCR,sanger,gp120,,71,B,B,NA,multiple,,,,infant,,,,,,,,,,,,
Nowak,HIV Med. 2002 Jan;3(1):1-11. doi: 10.1046/j.1464-2662.2001.00097.x.,The selection and evolution of viral quasispecies in HIV‐1 infected children,2002,,,,,phylogenetic topologies,phylogenetic,C3,,INF,MTCT:unknown,SE,,LT,PBMC,PCR,sanger,gp120,,60,B,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_A,,INF,MTCT:IP,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_B,,INF,MTCT:IP,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_C,,INF,MTCT:IP,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_D,,INF,MTCT:IP,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_E,,INF,MTCT:IP,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_F,,INF,MTCT:IP,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_G,,INF,MTCT:IP,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_H,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_I,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_J,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_K,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_L,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_M,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_N,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_O,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_P,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_Q,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,single,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_R,,INF,MTCT:IP,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,multiple,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_S,,INF,MTCT:IP,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,multiple,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_T,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,multiple,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_U,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,multiple,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_V,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,multiple,,,,infant,,,,,,,,,,,,
Dickover,J Virol. 2001 Mar; 75(5): 2194–2203. doi: 10.1128/JVI.75.5.2194-2203.2001,"Perinatal Transmission of Major, Minor, and Multiple Maternal Human Immunodeficiency Virus Type 1 Variants In Utero and Intrapartum",2001,,,,,HMA,molecular,Sagar_W,,INF,MTCT:IU,US-CA,,S,,RT-qPCR,NA,gp120,,NA,,B,NA,multiple,,,,infant,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q004,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,Y,HMA,molecular,Q03,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q032,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q048,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,D,D,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q093,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q098,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q099,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q156,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q210,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,Y,HMA,molecular,Q23,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q259,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q261,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q268,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q369,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q424,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q45,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,Y,HMA,molecular,Q47,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,Y,HMA,molecular,Q52,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,D,D,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q523,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,D,D,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q543,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q584,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q638,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,NA,NA,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q639,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q750,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q769,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,NA,NA,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q797,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,Y,HMA,molecular,Q84,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q842,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q850,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q920,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q936,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,D,D,NA,multiple,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,Q981,,F,HSX:MTF,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T128,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T210,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T227,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,D,D,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T250,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,C,C,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T284,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T316,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,D,D,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T334,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T444,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T572,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Long,Nat Med. 2000 Jan;6(1):71-5.doi: 10.1038/71563.,Gender differences in HIV-1 diversity at time of infection.,2000,,,,,HMA,molecular,T721,,M,HSX:FTM,KE-28,,S,PMBC,RT-PCR,NA,gp120,,NA,A,A,NA,single,,,-,NA,,,,,,,,,,,,
Wade,J Genl Virol. 1998 May 01;79(5):1055-1068 doi: 10.1099/0022-1317-79-5-1055,Analysis of human immunodeficiency virus type 1 env and gag sequence variants derived from a mother and two vertically infected children provides evidence for the transmission of multiple sequence variants.,1998,,,,,Phylo-Topology,phylogenetic,C3,,INF,MTCT:unknown,,,LT,PMBC,SGA,Sanger,gp120,,NA,B,B,NA,multiple,,,,infant,,,,,,,,,,,,
Wade,J Genl Virol. 1998 May 01;79(5):1055-1068 doi: 10.1099/0022-1317-79-5-1055,Analysis of human immunodeficiency virus type 1 env and gag sequence variants derived from a mother and two vertically infected children provides evidence for the transmission of multiple sequence variants.,1998,,,,,Phylo-Topology,phylogenetic,C4,,INF,MTCT:unknown,,,LT,PMBC,SGA,Sanger,gp120,,NA,B,B,NA,single,,,,infant,,,,,,,,,,,,
Wade,J Genl Virol. 1998 May 01;79(5):1055-1068 doi: 10.1099/0022-1317-79-5-1055,Analysis of human immunodeficiency virus type 1 env and gag sequence variants derived from a mother and two vertically infected children provides evidence for the transmission of multiple sequence variants.,1998,,,,,Phylo-Topology,phylogenetic,C3,,INF,MTCT:unknown,,,LT,PMBC,SGA,Sanger,gag,,NA,B,B,NA,multiple,,,,infant,,,,,,,,,,,,
Wade,J Genl Virol. 1998 May 01;79(5):1055-1068 doi: 10.1099/0022-1317-79-5-1055,Analysis of human immunodeficiency virus type 1 env and gag sequence variants derived from a mother and two vertically infected children provides evidence for the transmission of multiple sequence variants.,1998,,,,,Phylo-Topology,phylogenetic,C4,,INF,MTCT:unknown,,,LT,PMBC,SGA,Sanger,gag,,NA,B,B,NA,single,,,,infant,,,,,,,,,,,,
Briant,J Virol. 1995 Jun;69(6):3778-88.,Analysis of Envelope Sequence Variants Suggests Multiple Mechanisms of Mother-To-Child Transmission of Human Immunodeficiency Virus Type 1,1995,,,,,Phylo-Topology,phylogenetic,CA,,INF,MTCT:unknown,FR-31,,LT,PMBC,SGA,Sanger,gp120,,NA,B,B,NA,single,,,,infant,,,,,,,,,,,,
Briant,J Virol. 1995 Jun;69(6):3778-88.,Analysis of Envelope Sequence Variants Suggests Multiple Mechanisms of Mother-To-Child Transmission of Human Immunodeficiency Virus Type 1,1995,,,,,Phylo-Topology,phylogenetic,CB,,INF,MTCT:unknown,FR-31,,LT,PMBC,SGA,Sanger,gp120,,NA,B,B,NA,multiple,,,,infant,,,,,,,,,,,,
Briant,J Virol. 1995 Jun;69(6):3778-88.,Analysis of Envelope Sequence Variants Suggests Multiple Mechanisms of Mother-To-Child Transmission of Human Immunodeficiency Virus Type 1,1995,,,,,Phylo-Topology,phylogenetic,CC,,INF,MTCT:unknown,FR-31,,LT,PMBC,SGA,Sanger,gp120,,NA,B,B,NA,multiple,,,,infant,,,,,,,,,,,,
Briant,J Virol. 1995 Jun;69(6):3778-88.,Analysis of Envelope Sequence Variants Suggests Multiple Mechanisms of Mother-To-Child Transmission of Human Immunodeficiency Virus Type 1,1995,,,,,Phylo-Topology,phylogenetic,CD,,INF,MTCT:unknown,FR-31,,LT,PMBC,SGA,Sanger,gp120,,NA,B,B,NA,multiple,,,,infant,,,,,,,,,,,,
Poss,J Virol. 1995 Dec; 69(12): 8118–8122,Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.,1995,PAVE,,,Y,Haplotype,haplotype,Q03,,F,HSX:MTF,KE-28,,S,PMBC,PCR,Sanger,gp120 - proviral DNA,,10,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Poss,J Virol. 1995 Dec; 69(12): 8118–8122,Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.,1995,PAVE,,,Y,Haplotype,haplotype,Q23,,F,HSX:MTF,KE-28,,S,PMBC,PCR,Sanger,gp120 - proviral DNA,,15,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Poss,J Virol. 1995 Dec; 69(12): 8118–8122,Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.,1995,PAVE,,,Y,Haplotype,haplotype,Q47,,F,HSX:MTF,KE-28,,S,PMBC,PCR,Sanger,gp120 - proviral DNA,,14,A,A,NA,multiple,,,-,NA,,,,,,,,,,,,
Poss,J Virol. 1995 Dec; 69(12): 8118–8122,Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.,1995,PAVE,,,Y,Haplotype,haplotype,Q52,,F,HSX:MTF,KE-28,,S,PMBC,PCR,Sanger,gp120 - proviral DNA,,17,D,D,NA,multiple,,,-,NA,,,,,,,,,,,,
Poss,J Virol. 1995 Dec; 69(12): 8118–8122,Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.,1995,PAVE,,,Y,Haplotype,haplotype,Q84,,F,HSX:MTF,KE-28,,S,PMBC,PCR,Sanger,gp120 - proviral DNA,,15,A,A,NA,single,,,-,NA,,,,,,,,,,,,Same cohort as Long
Wolinsky,Science. 1992 Feb 28;255(5048):1134-7. doi: 10.1126/science.154631,Selective Transmission of Human Immunodeficiency Virus type-1 Variants From Mothers to Infants,1992,,,,,Haplotype,haplotype,T1,,INF,MTCT:unknown,,,S,PMBC,PCR,Sanger,gp120,,16,,NA,NA,single,,,,infant,,,,,,,,,,,,
Wolinsky,Science. 1992 Feb 28;255(5048):1134-7. doi: 10.1126/science.154631,Selective Transmission of Human Immunodeficiency Virus type-1 Variants From Mothers to Infants,1992,,,,,Haplotype,haplotype,T2,,INF,MTCT:unknown,,,S,PMBC,PCR,Sanger,gp120,,9,,NA,NA,single,,,,infant,,,,,,,,,,,,
Wolinsky,Science. 1992 Feb 28;255(5048):1134-7. doi: 10.1126/science.154631,Selective Transmission of Human Immunodeficiency Virus type-1 Variants From Mothers to Infants,1992,,,,,Haplotype,haplotype,T3,,INF,MTCT:unknown,,,S,PMBC,PCR,Sanger,gp120,,18,,NA,NA,single,,,,infant,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,